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Introduction
Background
Chronic kidney disease (CKD) is a major public health problem with an increasing 
prevalence.(1) CKD affects around 10% of the adult population worldwide and is 
associated with increased risk of end-stage renal disease (ESRD) mortality, as well as 
cardiovascular mortality.(2) In the last decades, an accumulating body of evidence 
suggests that the risk of CKD originates in early life.(3,4) The developmental origins of 
health and disease (DOHaD) hypothesis suggests that adverse exposures in fetal life and 
infancy might lead to permanent developmental adaptations which might be beneficial 
on the short term, but lead to an increased risk of renal and cardiovascular disease in 
later life.(5,6)
 In line with this DOHaD hypothesis, previous observational studies show that low 
birth weight is associated with higher risks of CKD and high blood pressure in adulthood.
(7-9) It has been hypothesized that a reduced number of nephrons in low birth 
weight children underlie these associations.(3) Brenner et al. suggested that adverse 
circumstances in utero lead to lead to fetal growth restriction and smaller kidneys with 
a lower number of nephrons, which in turn may lead to glomerular hyperfiltration and 
finally glomerulosclerosis. This might predispose an individual for CKD in later life. It 
is not possible to count absolute nephron number in vivo. Since nephron number is 
correlated with kidney volume, kidney volume can be used as proxy for nephron number 
in population studies.(10) Previous studies report a positive relationship between kidney 
volume and kidney function in adults and in children.(11-13) The association of kidney 
volume with blood pressure has not been  established yet.(12) The importance of early 
life kidney volume and function is emphasized by studies showing that variation in 
kidney function and blood pressure in childhood track into adulthood.(14,15) 
 Identifying critical periods and specific exposures relevant for kidney volume and 
function is important and may be helpful in development of preventive strategies to 
prevent CKD in the future. Subclinical differences in kidney volume and function in 
childhood might predispose individuals for an increased risk of CKD in later life. Therefore, 
the studies in this thesis aim to explore the associations between growth periods and 
patterns, and maternal and child factors, and kidney function in childhood (Figure 1.1). 
Fetal and infant growth  
Previous studies have shown associations of low birth weight with higher risks of CKD in 
later life.(7,9) Multiple post mortem studies showed a positive correlation between birth 
weight and nephron number.(16,17) Also, gestational age is positively associated with 
nephron number. Nephron number is lower in preterm born infants as compared to term 
born infants.(18) 
 To date, it is not exactly known which growth periods are critical for kidney 
development. Human kidney development starts in the 9th week and ends around the 
36th week of gestation.(19) In extremely premature born infants nephrogenesis was 
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observed until 40 days after birth.(18) Birth weight is used as a proxy for nephron number 
endowment.(20) However, birth weight is the outcome from various exposures and 
growth patterns in utero. Not only birth weight or gestational, but size for gestational age 
may be important for kidney development.(21) Size for gestational age is an endpoint 
from growth patterns in different trimesters in fetal life. Which periods are critical for 
kidney development is currently not exactly known. Moreover, fetal body growth and 
birth weight reflect overall growth. Specific kidney growth, in relation to body growth, 
might be important for kidney function in later life. Placental insufficiency is an important 
risk factor for impaired fetal growth(22) and is also associated with a reduced nephron 
number.(23) It has been shown that impaired fetal growth and placental insufficiency are 
associated with smaller fetal kidney volume.(24) Thus both fetal growth and placental 
function may affect kidney size.
Maternal and child factors 
Multiple maternal and child factors may influence nephron endowment and preservation 
of glomerular number after birth. Most previous studies used birth weight as a proxy for 
both an adverse fetal environment and lower nephron number.(3) Maternal smoking 
is an important, modifiable risk factor for low birth weight.(25-27) Animal studies 
previously showed that kidney morphology can change after fetal smoking exposure.
(28,29) It has been previously shown that maternal smoking is negatively associated with 
kidney development in third trimester.(30) It is not known whether this effect persists in 
postnatal life and what might be the effect of smoking on kidney function in childhood. 
Maternal and infant diet are factors that might influence kidney function in later life.(20) 
Animal studies show that increased maternal and infant protein intake leads to increased 
kidney growth.(31,32) Also, postnatal protein intake might be associated with kidney 
function and risk of hypertension in adulthood.(32,33) However, little is known about 
the association of early childhood diet and kidney volume and function in a healthy 
population. Estimation of glomerular filtration rate is an important tool in screening for 
and diagnosing kidney disease. Current estimations based on serum creatinine levels 
might have some limitations, such as the influence of body composition on creatinine 
levels.(34) Previous suggest that cystatin C based formula’s might give more accurate 
estimations of glomerular filtration rate.(35,36)
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Figure 1.1 Overview of the hypothesis on fetal and early childhood factors and childhood 
kidney function studied in this thesis
Fetal life
Placental function
Body growth
Kidney growth
Maternal smoking
Infancy 
Body growth & body composition 
Kidney growth
Protein intake
Suboptimal kidney development
Small kidney volume with lower number if neprons
Childhood kidney outcomes
Kidney volume
Estimated  glomerular ltration rate
Albuminuria
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Overall aims
The overall aims of the studies presented in this thesis are:
-  to examine which specific periods and patterns of body growth and kidney growth in 
fetal life and early infancy are associated with kidney function in childhood;
- to identify early life exposures related to kidney volume and function in childhood. 
General design
The studies presented in this thesis were embedded in the Generation R Study, a 
population based prospective cohort study from fetal life until young adulthood in 
Rotterdam, the Netherlands.(37) The Generation R Study is designed to identify early 
environmental and genetic determinants of growth, development and health in fetal life 
and childhood. All pregnant women living in the study area with a delivery date between 
April 2002 and January 2006 were eligible for enrolment in this study. Enrollment was 
aimed at early pregnancy, but was possible until the birth of the child. In total, 9,778 
mother were enrolled in the study, of whom 8,880 (91%) were included during pregnancy 
(Figure 1.2). Assessments were planned in early pregnancy (<18 weeks of gestation), 
mid-pregnancy (18 -25 weeks of gestation) and late pregnancy (≥ 25 weeks of gestation), 
and included parental physical examinations, maternal blood and urine collection, 
fetal ultrasound examinations, and self-administered questionnaires. In the preschool 
periods, from birth to 4 years of age, data collection was performed with all children 
by questionnaires and visits to the routine child health care centers. All children were 
invited to a dedicated research center in the Erasmus MC – Sophia’s Children’s Hospital 
to participate in detailed body composition and cardiovascular follow-up measurements 
at the age of 6 years. Measurements during this visit included anthropometrics, body 
composition, cardiovascular development and body fluid specimen collection. 
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Figure 1.2 Design and data collection in the Generation R Study
Total cohort
Enrolment during pregnancy (N = 8,879 mothers)
and at birth (N = 899 mothers)
Subgroup
Randomly selected subgroup of Dutch mothers, all 
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renal and placental vascular ultrasound
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Birth
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Outline of thesis
In Chapter 1.2, the cross sectional associations of childhood characteristics and ethnicity 
with kidney volume and -function are evaluated. 
 Chapter 2 focusses on the associations of growth in early life with kidney volume and 
function in childhood. In Chapter 2.1 studies on the associations of fetal first trimester 
growth with kidney outcomes in childhood are described. Chapter 2.2 evaluates the 
associations of fetal blood flow and fetal kidney size with childhood kidney volume and 
function. Longitudinal, repeated fetal and infant growth measures and their association 
with kidney volume and function are presented in Chapter 2.3. Chapter 2.4 describes 
specific growth periods and growth patterns of kidney volume and the association with 
kidney function in childhood. 
 In Chapter 3, studies focused on early life exposures and kidney volume and function 
in childhood are presented. In Chapter 3.1, studies on the associations of fetal smoke 
exposure with childhood kidney outcomes are described. Chapter 3.2 describes 
the association of protein intake in infancy with kidney outcomes in childhood.  The 
associations of childhood body composition with estimates of glomerular filtration rate 
based on creatinine and cystatin C concentration presented in Chapter 3.3. 
 Finally, Chapter 4 provides a general discussion of the main findings presented 
in thesis. We will discuss possible underlying mechanisms, implications and give 
suggestions for future studies.  
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Abstract
Background Subclinical impaired kidney growth and function in childhood may lead to 
kidney diseases and high blood pressure in adulthood. We assessed the cross-sectional 
associations of childhood characteristics with kidney size and function in a multi-ethnic 
cohort. 
Methods This study was embedded in a population-based cohort study of 6,397 
children at the median age of 6.0 years. We measured kidney volume, creatinine and 
cystatin C blood levels, microalbuminuria and blood pressure. Glomerular filtration rate 
was estimated. 
Results Childhood anthropometrics were positively associated with kidney volume, 
creatinine level and blood pressure (all p-values< 0.05). We observed sex and ethnic 
differences in all kidney size and function measures (all p-values< 0.05). Children with 
smaller kidneys had higher creatinine and cystatin C blood levels, leading to a lower 
estimated glomerular filtration rate (difference 5.68 ml/min per 1.73m² (95% confidence 
interval 5.14 to 6.12) per 1 SD increase in kidney volume). Larger kidney volume was 
associated with an increased risk of microalbuminuria. 
Conclusions Childhood kidney volume and function are influenced by sex, 
anthropometrics, and ethnicity. Kidney volume is related with kidney function but not 
with blood pressure. This study results may help to identify individuals at risk for kidney 
disease in an early stage. 
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Introduction
An accumulating body of evidence suggests that chronic kidney disease and 
hypertension have at least part of their origins in early life.(1) Various studies showed 
associations of low birth weight with kidney disease and hypertension in later life.(2) 
These associations may be explained by adverse exposures in early life that lead to 
smaller kidneys with a reduced number of nephrons, and subsequently to glomerular 
hyperfiltration and sclerosis.(3,4) These adaptations may predispose the individual to 
higher risks of impaired kidney function and eventually end-stage kidney disease in 
adulthood.(3,4) The importance of early life for later kidney outcomes is also shown by 
studies reporting that variations in kidney function and blood pressure in childhood 
track into adulthood.(5,6) Thus, subclinical differences in kidney function may already 
be present in childhood, and predispose the individual to kidney disease. Identification 
of these subclinical differences and their determinants is needed to develop preventive 
strategies focused on the earliest phase of life. Not much is known about the normal 
variation of measures of kidney size and function in population-based samples of 
children. Studies in adolescents suggest that anthropometrics and specific ethnic 
backgrounds correlate with kidney size and function.(7) Whether and to what extend 
childhood anthropometrics and ethnicity influence kidney size and function is not 
known. Also, the relations between kidney size and function in childhood have not been 
studied in large populations.
 Therefore, we assessed in a large population-based large-scale cohort study among 6,397 
school-age children, the variations of kidney size and function outcomes. We also evaluated 
the associations of kidney size measures with kidney function and blood pressure. 
Methods
 
Design and study population
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from fetal life onwards in Rotterdam, the Netherlands.(8) The study has been 
approved by the Medical Ethics Committee of the Erasmus Medical Center, Rotterdam. 
All participants or their parents gave written consent to the study. In total 9,778 mothers 
were enrolled in the study, and 8,305 of their children participated in the follow-up 
measurements in children atthe age of 6 years (median 6.0 years, 95% range 5.6-7.9). 
In total, 6,690 (81%) of these children visited the research center for renal follow-up 
measurements. We excluded children with echocardiographic evidence of congenital 
heart disease and kidney abnormalities, which may influence blood pressure (N=28) or 
kidney function (N=12). Kidney volume or blood pressure measurements were successfully 
performed in 6,397 children (Figure 1). Blood and urine samples for kidney function 
measurements were available in 4,291 and 6,173 of those children, respectively.
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Child characteristics
Anthropometrics At the age of 6 years, child height and weight were measured once 
without shoes and heavy clothing. Height was measured with a stadiometer. Body mass 
index (BMI) (kg/m2) and body surface area (BSA) (m2) were calculated. 
 Ethnicity As described previously, ethnic background of the child was defined by the 
country of birth of the parents.(9) All children were born in the city of Rotterdam, the second 
largest city in the Netherlands. Rotterdam, situated in the Western part of the Netherlands. 
The city has a strong multi-ethnic population. As a result of the colonial and immigrant 
worker history, the largest ethnic minority groups in the Netherlands are Cape Verdean, 
Dutch Antillean, Moroccan, Turkish, Surinamese-Creole and Surinamese-Hindustani.(10) 
Ethnic background of the child was defined by the country of birth of the parents, which is the 
commonly used demographic approach in the Netherlands.(9) We described the approach 
previously in detail.(8) Information about countries of birth was obtained by questionnaires 
from the parent(s) of the child. Children with both parents born in the Netherlands were 
classified as Dutch (N=3,537). The child was of non-Dutch ethnic origin if one of the parents 
was born abroad. If the parents were born in different countries, the country of birth of the 
mother determined the ethnic background.(9) We defined the following non-Dutch groups: 
Cape Verdean (N=194), Dutch Antillean (N=192), Moroccan (N=367), Surinamese (N=384) 
and Turkish (N=482). Since children with a Surinamese background are of mixed ethnic 
origin, Surinamese were further classified as: Surinamese-Creole (N=192) or Surinamese-
Hindustani (N=192) based on the ethnic origin of the Surinamese parent of the child.
(11) In the analyses on ethnic background, we excluded 1,044 children with a, non-Dutch 
European, African, Asian Western, Asian non-Western, American Western, American non-
Western and Surinamese-other ethnicity because of the small country specific sample sizes.
Kidney outcome variables 
Kidney dimensions: Left and right kidney biometrics were assessed with an ATL-Philips HDI 
5000 instrument (Seattle, WA, USA) equipped with a 2.0–5.0 MHz curved array transducer or 
with a General Electric Logiq E9 (Milwaukee, WI, USA) equipped with a 2.0-7.0 MHz curved 
array transducer. During the examination the child was awake in a quiet room and calm in 
a standardized prone position. We identified the left and right kidney in the sagittal plane 
along its longitudinal axis. We performed measurements of maximal bipolar kidney length, 
width and depth. At the level of the hilum kidney width and depth were measured. The cross-
sectional area in which the kidney appeared symmetrically round at its maximum width was 
used. Kidney volume was calculated using the equation of an ellipsoid: volume (cm3) = 0.523 
x length (mm) x width (mm) x depth (mm).(12) Combined kidney volume was calculated 
by summing right and left kidney volume. Quality checks were frequently carried out and 
feedback was provided to minimize inter-operator differences. Good reproducibility was 
pursued with intraobserver interclass correlation coefficients (ICC) ranged from 0.93 (left and 
right kidney width and right renal thickness) to 0.99 (left kidney length) and interobserver 
ICC ranged from 0.64 (right kidney thickness) to 0.90 (right kidney length).(13) 
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Kidney function: Blood samples were drawn by antecubital venipuncture. Missing samples 
were mainly due to no consent or crying of the child. Blood samples were collected in 
K2-EDTA tubes and temporally stored at the research centre in the fridge for a maximum 
of 4 hours. After completing the transport and collection, all blood samples underwent 
centrifugation for 10 minutes and stored at -80 °C. Serum creatinine was measured with 
the enzymatic method, on a Cobas c 502 analyser (Roche Diagnostic, Germany). We 
additionally measured serum cystatin C by a particle enhanced immunoturbidimetric 
assay on Cobas c 702 analyser (Roche Diagnostic, Germany). The intra-assay en inter-
assay coefficients of variation and analytical ranges for serum creatinine and cystatin C 
are given in the supplementary materials (Table S1). Estimated glomerular filtration rate 
(eGFR) was calculated according to the revised Schwartz formula from 2009(14); eGFR = 
36.5 * (height (cm)/creatinine (µmol/l). This formula has been validated in children.(14) 
Urine creatinine and albumin were determined on a Beckman-Coulter AU analyser. Urine 
creatinine levels were measured according to the Jaffe method. Albumin-creatinine ratio 
was calculated by dividing albumin concentration (mg/l) by creatinine concentration 
(mmol/l). Microalbuminuria was defined as an albumin-creatinine ratio between > 2.5 
and 25 mg/mmol for boys and between > 3.5 and 25 mg/mmol for girls.(15) 
 Blood pressure: Systolic and diastolic blood pressure was measured at the right 
brachial artery, four times with one minute intervals, using the validated automatic 
sphygmanometer Datascope Accutor Plus TM (Paramus, NJ, USA).(16) The measurements 
were conducted while the child was quietly lying in supine position. A cuff was selected 
with a cuff width approximately 40% of the arm circumference and long enough to cover 
90% of the arm circumference. 
Statistical analyses 
First, we performed multiple linear regression models to explore the cross-sectional 
associations of child sex, age, anthropometrics and ethnicity with combined kidney 
volume, kidney function measures and blood pressure. These analyses were adjusted 
for child sex, current age and body surface area. To enable comparison of effect 
estimates, we present the result as difference in outcome per standard deviation scores 
(Z-scores), for continuous variables and change per category for categorical variables. 
The associations of child characteristics with microalbuminuria were evaluated with 
logistic regression models. Second, we assessed the correlations of left and right kidney 
volume and total combined kidney volume with kidney function outcomes with Pearson 
correlation coefficients. We evaluated the associations of left and right kidney volume 
and total combined kidney volume with kidney function measures with multiple linear 
regression models for kidney function and blood pressure and logistic regression models 
for microalbuminuria. These regression models were adjusted for child sex, current age 
and body surface area. Appropriateness of fit for regression models was evaluated by 
checking residuals. All statistical analyses were performed using the Statistical Package 
for the Social Sciences version 20.0 for Windows (SPSS, Chicago, IL, USA).
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Results
Subject characteristics
Child characteristics are shown in Table 1. Boys were taller and had higher weight and 
larger body surface area than girls. At the age of 6 years (95% range 5.6 – 7.9 years), 
mean (SD) combined left and right kidney volume was 120.3 (23.5) cm³. Mean creatinine 
levels were 37.5 (5.6) µmol/l, mean cystatin C levels were 784 (82) µg/l and the mean 
glomerular filtration rate was 118.8 (16.5) ml/min per 1.73 m². Microalbuminuria was 
present in 7.5% of the participants, with a higher percentage in girls. Mean (SD) systolic 
and diastolic blood pressure were 102.7 (8.2) mmHg, and 60.7 (6.7) mmHg, respectively. 
The corresponding histograms of the kidney and blood pressure measurements are 
given in the supplementary materials (Figure S1). Children who did not provide blood 
samples (23%) had smaller combined kidney volumes and higher systolic and diastolic 
blood pressure than children who did provide blood samples (Table S2). 
Child characteristics and kidney related outcomes
Table 2 shows that girls had smaller kidneys, a higher prevalence of microalbuminuria 
and higher blood pressure than boys (all p-values <0.05). In contrast, girls had lower 
cystatin C levels than boys (difference -11 (95% CI -16 to -6) µg/l). In the whole study 
population, each SD (0.5 years) older age led to higher creatinine levels (1.07 (95% 
Confidence Interval (CI) 0.89 to 1.25) µmol/l), a lower glomerular filtration rate (-1.75 (95% 
CI -2.21 to -1.28) ml/min per 1.73 m²) and higher diastolic blood pressure (0.30 (95% CI 
0.10 to 0.50) mmHg). Childhood height and weight were positively associated with several 
kidney size and function measures (all p-values <0.05). Each SD (1.9 kg/m2) increase in 
body mass index was associated with a larger combined kidney volume (8.04 (95% CI 7.48 
to 8.61) cm³), higher blood creatinine levels (0.49 (95% CI 0.32 to 0.66) µmol/l), higher 
blood cystatin C levels (4 (95% CI 1 to 7) µg/l) and higher systolic and diastolic blood 
pressure (1.90 (95% CI 1.69 to 2.10), and 0.52 (95% CI 0.35 to 0.70) mmHg, respectively). 
As compared to Dutch children, Moroccan children had a larger combined kidney volume 
(difference 4.84 (95% CI 2.67 to 7.01) cm³) whereas Surinamese-Hindustani children had 
a smaller combined kidney volume (-8.16 (95% CI -11.11 to -5.20) cm³). As compared to 
Dutch children, Moroccan and Turkish children had a higher glomerular filtration rate, 
wheras Dutch Antillean and Surinamese-Creole children had a lower glomerular filtration 
rate (p-values <0.05). Also, systolic and diastolic blood pressure were higher in Cape 
Verdean (differences 1.77 (95% CI 0.60 to 2.95) mmHg, and (differences 1.67 (95% CI 0.67 
to 2.66) mmHg, respectively) and Turkish children (differences 2.73 (95% CI 1.96 to 3.50) 
mmHg and 2.23 (95% CI 1.58 to 2.88) mmHg, respectively) than in Dutch children. These 
associations were all independent from child sex, current age and body surface area.  
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Table 1. Subject characteristics (N= 6,397)
Total group
N= 6,397
Boys
N= 3,216
Girls
N= 3,181
P value
Age and anthropometrics
Age (years) 6.0 (5.6 – 7.9) 6.0 (5.6 – 8.0) 6.0 (5.6 – 7.8) 0.015
Height (cm) 119.5 (6.1) 119.9 (6.1) 119.0 (6.0) <0.001
Weight (kg) 23.3 (4.3) 23.5 (4.1) 23.2 (4.5) 0.010
Body mass index (kg/m2) 16.2 (1.9) 16.2 (1.8) 16.3 (2.0) 0.399
Body surface area (m2) 0.88 (0.09) 0.88 (0.09) 0.87 (0.10) <0.001
Ethnic background (%)
Cape Verdean 3.8 (194) 3.8 (98) 3.8 (96) 0.981
Dutch 56.7 (3 537) 56.9 (1 784) 56.6 (1 753) 0.821
Dutch Antilles 3.7 (192) 3.3 (85) 4.2 (107) 0.074
Moroccan 7.1 (367) 7.2 (189) 7.0 (178) 0.721
Surinamese - Creoles 3.7 (192) 4.1 (106) 3.4 (86) 0.192
Surinamese - Hindustani 3.7 (192) 3.4 (88) 4.1 (104) 0.178
Turkish 9.3 (482) 9.9 (259) 8.8 (223) 0.148
Kidney size and function
Kidney volume left (cm3) 61.3 (13.2) 62.3 (13.6) 60.3 (12.8) <0.001
Kidney volume right (cm3) 59.0 (12.2) 60.0 (12.7) 58.0 (11.7) <0.001
Kidney volume combined (cm3) 120.3 (23.5) 122.3 (24.2) 118.3 (22.6) <0.001
Creatinine (µmol/l) 37.5 (5.6) 37.6 (5.5) 37.3 (5.7) 0.073
Cystatin C (µg/l) 784 (82) 790 (81) 778 (83) <0.001
eGFR (ml/min per 1.73m²) 118.8 (16.4) 118.7 (16.2) 119.0 (16.6) 0.481
Urinary albumin (mg/l)
Urinary creatinine (mmol/l)
Microalbuminuria (%) 
6.1 (18.8)
5.4 (3.3)
7.5 (462)
4.7 (12.9)
5.8 (3.3)
6.9 (215)
7.5 (23.3)
5.1 (3.3)
8.2 (247)
<0.001
<0.001
<0.001
Systolic blood pressure (mmHg) 102.7 (8.2) 102.2 (7.9) 103.3 (8.4) <0.001
Diastolic blood pressure (mmHg) 60.7 (6.8) 60.0 (6.7) 61.4 (6.8) <0.001
Values are means (standard deviation), median (95% range) or percentage (number). 
T-tests were used for continuous variables, chi-square tests for categorical variables.
eGFR, glomerular filtration rate
| Chapter 1.2
| 30
Ta
b
le
 2
. A
ss
oc
ia
ti
on
s 
of
 c
hi
ld
 c
ha
ra
ct
er
is
ti
cs
 a
nd
 e
th
ni
ci
ty
 w
it
h 
ki
dn
ey
 v
ol
um
e 
an
d 
fu
nc
ti
on
Di
ffe
re
nc
e (
95
%
 CI
) 
in
 ki
dn
ey
 si
ze
Di
ffe
re
nc
e (
95
%
 CI
) 
in
 ki
dn
ey
 fu
nc
tio
n
Di
ffe
re
nc
e (
95
%
 CI
) 
in
 b
lo
od
 p
re
ss
ur
e
Co
m
bi
ne
d 
ki
dn
ey
 vo
lu
m
e
(cm
3 )
Cr
ea
tin
in
e 
(µ
m
ol
/l)
Cy
st
at
in
 C 
(µ
g/
l)
eG
FR
 
(m
l/m
in
 p
er
 1.
73
m
²)
M
icr
o-
al
bu
m
in
ur
ia
(O
R)
†
Sy
st
ol
ic 
bl
oo
d 
pr
es
su
re
 (m
m
Hg
)
Di
as
to
lic
 b
lo
od
 
pr
es
su
re
 (m
m
Hg
)
Gi
rls
 co
m
pa
re
d t
o b
oy
s
(N
=
 6,
39
7)
-2
.6
0*
*
(-3
.6
0 t
o -
1.
60
)
-0
.1
6
(-0
.4
7 t
o 0
.1
6)
-1
1*
*
(-1
6 t
o -
6)
0.
24
(-0
.7
4 t
o 1
.2
2)
1.
21
**
(1
.0
0 t
o 1
.4
6)
1.
28
**
(0
.8
8 t
o 1
.6
7)
1.
54
**
(1
.2
0 t
o 1
.8
8)
Ag
e (
ye
ar
s)
(1
 SD
 =
 0.
5 y
rs)
 
(N
=
 6,
39
7)
-0
.4
4
(-1
.0
2 t
o 0
.1
4)
1.
07
**
(0
.8
9 t
o 1
.2
5)
1
(-1
 to
 4)
-1
.7
5*
*
(-2
.2
1 t
o -
1.
28
)
1.
15
*
(1
.0
3 t
o 1
.2
8)
0.
12
(-0
.1
2 t
o 0
.3
5)
0.
30
**
(0
.1
0 t
o 0
.5
0)
An
th
ro
po
m
et
ric
s
(N
=
 6
,3
89
)
He
ig
ht
 (c
m
)
(1
 SD
 =
 6.
1 c
m
)
(N
=
 6,
38
9)
11
.3
0*
*
(1
0.
68
 to
 11
.9
2)
1.
02
**
(0
.8
3 t
o 1
.2
1)
3
(0
 to
 6)
2.
65
**
(2
.0
7 t
o 3
.2
3)
1.
03
(0
.9
2 t
o 1
.1
5)
1.
65
**
(1
.4
1 t
o 1
.8
9)
0.
48
**
(0
.2
7 t
o 0
.6
8)
W
eig
ht
 (k
g)
(1
 SD
 =
 4.
3 k
g)
(N
=
 6,
38
9)
12
.3
5*
*
(1
1.
77
 to
 12
.9
3)
0.
90
**
(0
.7
2 t
o 1
.0
9)
5*
*
(2
 to
 7)
1.
10
**
(0
.5
4 t
o 1
.6
7)
0.
84
**
(0
.7
5 t
o 0
.9
5)
2.
36
**
(2
.1
4 t
o 2
.5
9)
0.
66
**
(0
.4
6 t
o 0
.8
6)
Bo
dy
 m
as
s i
nd
ex
 (k
g/
m
2)
(1
 SD
 =
 1.
9  
kg
/m
2)
(N
=
 6,
38
9)
8.
04
**
(7
.4
8 t
o 8
.6
1)
0.
49
**
(0
.3
2 t
o 0
.6
6)
4*
*
(1
 to
 7)
-0
.3
7
(-0
.8
9 t
o 0
.1
5)
0.
80
**
(0
.7
1 t
o 0
.8
9)
1.
90
**
(1
.6
9 t
o 2
.1
0)
0.
52
**
(0
.3
5 t
o 0
.7
0)
Et
hn
ici
ty
 
(N
=
 5,
15
6)
Du
tch
(N
=
 3,
53
7)
Re
fer
en
ce
Re
fer
en
ce
Re
fer
en
ce
Re
fer
en
ce
Re
fer
en
ce
Re
fer
en
ce
Re
fer
en
ce
Ca
pe
 Ve
rd
ea
n
(N
=
 19
4)
-1
.3
3
(-4
.2
5 t
o 1
.5
8)
0.
31
(-0
.6
1 t
o 1
.2
3)
-2
3*
*
(-3
8 t
o -
9)
-1
.2
7
(-4
.1
5 t
o 1
.6
0)
1,
18
(0
.7
0 t
o 2
,0
1)
1.
77
**
(0
.6
0 t
o 2
.9
5)
1.
67
**
(0
.6
7 t
o 2
.6
6)
Du
tch
 A
nt
ill
es
(N
=
 19
2)
-0
.7
7
(-3
.7
5 t
o 2
.2
1)
1.
40
**
(0
.4
9 t
o 2
.3
2)
-1
5*
(-2
9 t
o 0
)
-5
.2
7*
*
(-8
.1
3 t
o -
2.
40
)
1,
10
(0
.6
4 t
o 1
.9
1)
0.
45
(-0
.7
3 t
o 1
.6
3)
1.
21
*
(0
.2
0 t
o 2
.2
1)
M
or
ro
ca
n
(N
=
 36
7)
4.
84
**
(2
.6
7 t
o 7
.0
1)
-2
.6
6*
*
(-3
.3
4 t
o -
1.
98
)
-1
6*
*
(-2
6 t
o -
5)
7.
20
**
(5
.0
7 t
o 9
.3
2)
1.
10
(0
.7
4 t
o 1
.6
5)
0.
87
(-0
.0
0 t
o 1
.7
3)
-0
.1
0
(-0
.8
3 t
o 0
.6
4)
| Kidney size and function in a multi-ethnic 
| 31
Su
rin
am
es
e -
 Cr
eo
les
(N
=
 19
2)
-2
.0
6
(-5
.0
4 t
o 0
.9
2)
1.
79
**
(0
.8
7 t
o 2
.7
2)
-1
8*
(-3
3 t
o -
3)
-5
.5
6*
*
(-8
.4
5 t
o -
2.
66
)
0.
89
(0
.4
9 t
o 1
.6
2)
1.
37
*
(1
.8
7 t
o 2
.5
5)
1.
15
*
(1
.1
5 t
o 2
.1
6)
Su
rin
am
es
e -
 H
in
du
sta
ni
(N
=
 19
2)
-8
.1
6*
*
(-1
1.
71
 to
 -5
.2
0)
0.
46
(-0
.4
5 t
o 1
.3
6)
17
*
(3
 to
 31
)
-1
.5
3
(-4
.3
6 t
o 1
.3
0)
0.
47
(0
.2
2 t
o 1
.0
2)
0.
29
(-0
.8
9 t
o 1
.4
7)
1.
29
*
(0
.2
9 t
o 2
.2
9)
Tu
rk
ish
(N
=
 48
2)
1.
67
(-0
.2
9 t
o 3
.6
2)
-1
.5
0*
*
(-2
.1
2 t
o -
0.
89
)
-2
(-1
2 t
o 8
)
2.
86
**
(0
.9
2 t
o 4
.8
0)
0.
98
(0
.6
7 t
o 1
.4
3)
2.
73
**
(1
.9
6 t
o 3
.5
0)
2.
23
**
(1
.5
8 t
o 2
.8
8)
Va
lu
es
 a
re
 r
eg
re
ss
io
n 
co
ef
fic
ie
nt
s 
(9
5%
 C
on
fid
en
ce
 in
te
rv
al
 (
C
I) 
ba
se
d 
on
 m
ul
ti
pl
e 
re
gr
es
si
on
 m
od
el
s 
an
d 
re
fle
ct
 t
he
 d
iff
er
en
ce
 f
or
 e
ac
h 
ou
tc
om
e 
fo
r c
hi
ld
 c
ha
ra
ct
er
is
ti
cs
. A
na
ly
se
s 
fo
cu
se
d 
on
 e
th
ni
c 
di
ff
er
en
ce
s 
in
 k
id
ne
y 
ou
tc
om
es
 w
er
e 
pe
rf
or
m
ed
 a
m
on
g 
ch
ild
re
n 
fr
om
 D
ut
ch
, 
D
ut
ch
-A
nt
ill
es
, M
or
oc
ca
n,
 S
ur
in
am
es
e 
 a
nd
 T
ur
ki
sh
 c
hi
ld
re
n 
on
ly
, b
ec
au
se
 th
e 
ot
he
r g
ro
up
s 
w
er
e 
to
o 
sm
al
l (
se
e 
te
xt
).
† 
 O
dd
’s 
ra
ti
o’
s 
(9
5%
 C
on
fid
en
ce
 i
nt
er
va
l) 
ba
se
d 
on
 l
og
is
ti
c 
re
gr
es
si
on
 m
od
el
s 
an
d 
re
fle
ct
 t
he
 d
iff
er
en
ce
 f
or
 e
ac
h 
ou
tc
om
e 
fo
r 
ch
ild
 
ch
ar
ac
te
ri
st
ic
s.
M
od
el
s 
ar
e 
ad
ju
st
ed
 fo
r c
hi
ld
 s
ex
 a
nd
 c
ur
re
nt
 a
ge
 a
nd
 b
od
y 
su
rf
ac
e 
ar
ea
.
eG
FR
, e
st
im
at
ed
 g
lo
m
er
ul
ar
 fi
lt
ra
ti
on
 ra
te
* 
p<
0.
05
, *
*p
<
0.
01
Ta
b
le
 2
. C
on
ti
nu
ed
| Chapter 1.2
| 32
Kidney dimensions, kidney function and blood pressure
Correlation coefficients between kidney volume, kidney function and blood pressure are 
presented in the Supplementary material (Table S3) and show that combined kidney 
volume was inversely correlated with blood creatinine (r=-0.30, p-value < 0.001) and cystatin 
C (r=-0.27, p-value < 0.001) levels and positively correlated with glomerular filtration rate 
(r=0.31, p-value< 0.001) and urinary albumin–creatinine ratio (r=0.10, p-value < 0.001). 
Kidney volume and kidney function were not correlated with systolic and diastolic blood 
pressure. Table 3 shows that each SD ( 23.5 m3) increase in combined kidney volume was 
related with a lower blood creatinine level (-2.06 µmol/l (95% CI -2.26 to -1.85)), lower 
blood cystatin C level (-29 (95% CI -32 to -26) µg/l) and a higher glomerular filtration rate 
(5.68 (5.14 to 6.12) ml/min per 1.73m²). A larger combined kidney volume was associated 
with a higher risk of microalbuminuria (OR 1.19 (95% CI 1.05 to 1.36 per SD). Kidney length, 
width and depth were all associated with the kidney function outcomes (Table 3). The 
effect estimates for the associations of left and right kidney width with creatinine, cystatin 
C, glomerular filtration rate and microalbuminuria were larger than the effect estimates for 
the associations of left and right kidney depth with kidney function measures with these 
outcomes. Right kidney depth was negatively associated with diastolic blood pressure, left 
kidney width was positively associated with systolic and diastolic and left kidney depth 
was negatively associated with diastolic blood pressure (all p-values <0.05, Table 3). 
Kidney volume was not consistently associated with systolic and diastolic blood pressure. 
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Table 3. Associations of kidney dimensions with kidney function and blood pressure
Difference (95%) kidney function Difference (95%) blood pressure
Kidney 
characteristics
Creatinine
(µmol/l)
Cystatin C
(µg/l)
eGFR (ml/min 
per 1.73m²)
Microalbuminuria
(OR) †
Systolic blood 
pressure (mmHg)
Diastolic blood 
pressure (mmHg)
Right kidney 
Length
(1SD = 5.7mm)
-1.49**
(-1.67 to -1.30)
-19**
(-22 to -17)
4.77**
(4.26 to 5.27)
1.17*
(1.04 to 1.31)
-0.13
(-0.37 to -0.11)
-0.03
(-0.22 to 0.182)
Width
(1SD = 3.3mm)
-1.23**
(-1.41 to -1.06)
-17**
(-19 to -14)
3.84**
(3.34 to 4.34)
1.07
(0.95 to 1.19)
0.09
(-0.14 to 0.32)
0.05
(-0.14 to 0.25)
Depth
(1SD = 4.57mm)
-0.90**
(-1.09 to -0.70)
-12**
(-15 to -9)
3.12**
(2.54 to 3.69)
1.08
(0.96 to 1.22)
-0.23
(-0.48 to 0.02)
-0.23*
(-0.44 to -0.01)
Volume
(1SD = 12.2cm3)
-1.85**
(-2.05 to -1.65)
-25**
(-28 to -21)
5.33**
(4.80 to 5.86)
1.16*
(1.02 to 1.31)
-0.12
(-0.38 to 0.14)
-0.11
(-0.34 to 0.12)
Left kidney
Length
(1SD = 6.35mm)
-1.13**
(-1.31 to -0.95)
-15**
(-18 to -121)
3.86**
(3.35 to 4.37)
1.17**
(1.04 to 1.31)
0.07
(-0.17 to 0.30)
-0.01
(-0.21 to 0.19)
Width
(1SD = 3.29mm)
-1.03**
(-1.21 to -0.86)
-18**
(-20 to -15)
3.35**
(2.84 to 3.86)
1.13*
(1.02 to 1.27)
0.31**
(0.09 to 0.54)
0.23*
(0.03 to 0.43)
Depth
(1SD = 4.71mm)
-0.91**
(-1.10 to -0.71)
-12**
(-15 to -9)
3.19**
(2.62 to 3.76)
1.02
(0.90 to 1.15)
-0.19
(-0.43 to 0.06)
-0.23*
(-0.44 to -0.02)
Volume
(1SD = 13.3cm3)
-1.56**
(-1.76 to -1.37)
-23**
(-26 to -20)
4.74**
(4.21 to 5.27)
1.16*
(1.02 to 1.31)
0.10
(-0.16 to 0.35)
-0.02
(-0.24 to 0.20)
Combined
kidney volume
(1SD = 23.5cm3)
-2.06**
(-2.26 to -1.85)
-29**
(-32 to -26)
5.68**
(5.14 to 6.12)
1.19**
(1.05 to 1.36)
-0.02
(-0.30 to 0.25)
-0.09
(-0.33 to 0.15)
Values are regression coefficients (95% CI) based on multiple regression models and 
reflect the difference for each outcome for different kidney dimensions. 
† Odd’s ratio’s (95% CI) based on logistic regression models and reflect the difference for 
each outcome for child characteristics.
All models are adjusted for child sex and current age, body surface area, sonographer 
and ultrasound device. 
eGFR, estimated glomerular filtration rate
* p<0.05, **p<0.01
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N = 8,305
Children participating at age 6 years
N = 1,868 Excluded
No visit to research center or no successful 
measurements of kidney size or function
N = 6,437
Children with successful kidney size or function 
measurements
N = 40 Excluded
Congenital cardiac disease or kidney abnormalities
N = 6,397
Childhood measurements
- Kidney volume N = 5,941
- Creatinine - Cystatin C N = 4,291
- Albuminuria N = 6,173
- Blood pressure N = 6,243
Figure 1.
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Discussion
We described a population-based large-scale cohort study, as resource for further studies 
focussed on early risk factors and later life consequences of kidney size and function 
variation in childhood. We observed that among school-age children, anthropometrics, 
sex and ethnicity are associated with kidney volume and function. Smaller kidney volume 
is associated with lower kidney function but not with blood pressure in childhood.
Methodological considerations
A major strength of this study is the large size of the population-based cohort. Our 
analyses were based on more than 6,000 children with kidney volume, kidney function 
and blood pressure measurements. Of the children who participated in the study at 6 
years, more than 75% did participate in the kidney follow-up studies. Of all children 
who visited the research center at the age of 6 years, 96% provided kidney size, blood 
pressure and microalbuminuria measurements, and 67% provided blood samples 
for measurements of creatinine and cystatin C levels. Not all participants in the study 
gave consent for collecting blood samples. Children without blood samples had smaller 
kidney dimensions and higher blood pressure. These differences might have led to 
underestimation of the observed associations between kidney dimensions and kidney 
function. However, differences in characteristics between participants with and without 
blood samples were small, and not clinically relevant. Our observed mean values for 
creatinine, cystatin C, estimated glomerular filtration rate, microalbuminuria and blood 
pressure are within the range of previous population-based studies in the same age 
range.(17-19) We used well-established methods to measure kidney size and function.
(13,20) We used kidney size as proxy for of kidney development. The number of nephrons 
cannot be measured in vivo. Post-mortem studies in humans showed that a lower 
nephron number is associated with lower weight at birth and hypertension in adults.
(21,22) Hinchliffe et al. demonstrated in eleven spontaneously aborted foetuses a strong 
correlation between kidney volume and glomerular number up to 40 weeks of gestation.
(23) Other post-mortem studies in humans showed consistent positive associations 
between kidney size and glomerular number.(24,25) Therefore, kidney volume seems 
to be a good surrogate for nephron number. Still, glomerular enlargement due to 
glomerulosclerosis and hyperfiltration may attenuate the observed differences in kidney 
volume, this might have underestimated the associations.(26) Since exact measurement 
of glomerular filtration rate in a population-based sample is not feasible, we used plasma 
creatinine levels to estimate glomerular filtration rate. Limitations of this approach is the 
active creatinine secretion by the proximal tubule and the relation of blood creatinine 
levels with muscle mass.(27) Blood cystatin C levels might be a better protein to 
estimate glomerular filtration rate, because the production rate is constant and it is freely 
filtered.(28) It has been suggested that cystatin C is less dependent from children’s body 
weight, height and sex than creatinine.(29) Studies focused on the question whether 
creatinine or cystatin C is most accurate for estimating glomerular filtration in children 
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are inconclusive.(17,30) In adults with and without chronic kidney disease cystatin C 
seems more accurate.(31) We used the revised Schwartz 2009 formula to estimate the 
glomerular filtration rate 6 year old children. This formula is validated in children with 
chronic kidney disease, but tends to underestimate the estimated glomerular filtration 
rate in adolescents. Whether, this underestimation is also present in healthy children 
at the of 6 years is not known yet.(32) We used the urine albumin-creatinine ratio to 
evaluate albuminuria in a random urine sample.(33) We collected urine samples random 
during the day. The variability would probably be lower if we collected first morning 
void samples. This might have caused a random and error and loss of power.(34) We 
used a shygmamometer for blood pressure measurement, which might be different from 
manual blood pressure measurement. However, we used a valid instrument and we do 
not think that blood pressure measurement influences our main results.(35)
Childhood characteristics and kidney outcomes 
Girls had smaller kidneys than boys at the age of 6 years. This finding is consistent with 
previous findings in our study in fetal life and early childhood,(12) but results seem not 
consistent.(36) In adults, kidney volume seems to be larger in men than in women.(37) 
Creatinine level and glomerular filtration rate did not differ between sexes. We observed 
higher cystatin C levels in boys than in girls. A similar difference was found in a study 
among 719 adolescents aged 12 to 19 years.(29) However, a study among 135 healthy 
children aged from 1 to 15 years found no differences in cystatin C levels between boys 
and girls.(38) This might be due to the broader age range and the limited sample size. 
The sex differences may arise from the school-age period. Studies in adults showed that 
males have higher cystatin C levels than females.(39) The underlying mechanisms for 
these sex differences may include differences in body composition, other than body 
surface area. Also, prevalence of microalbuminuria was higher in girls compared to boys. 
This difference was explained by lower urine albumin levels and higher urine creatinine 
levels in boys compared to girls. Previous studies in childhood and adolescents found 
similar associations.(40,41) These differences may be explained by higher urine creatinine 
levels in boys caused by a larger muscle mass. Several studies in adults showed higher 
urine creatinine levels in men than in women and lower urine creatinine levels in adults 
with lower muscle mass.(29,42) Girls had higher systolic and diastolic blood pressure 
than boys. Similar differences have been reported in others studies, but these seem 
inconclusive.(43,44) 
 In adults, a high body mass index is associated with kidney disease and hypertension.(7,45) 
Various previous studies reported a positive association of body mass index with blood 
pressure(46,47) in childhood, which is in line with the results of our study. We found a 
positive association of body mass index with creatinine and cystatin C levels but not 
with glomerular filtration rate. A recent study among 107 children aged 11 years found 
an increased prevalence of hypertension in obese children, only a small difference in 
albuminuria, but no changes in creatinine, cystatin C and glomerular filtration rate.(48)
We observed an inverse association of body mass index and the risk of microalbuminuria, 
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which was mainly driven by an increase in urine creatinine excretion. We are not aware 
of other studies that observed similar associations and could not fully explain this 
association. Further studies focused on body composition rather than on body mass 
index may further elucidate the mechanisms underlying this observed association.
 Kidney function and chronic kidney disease prevalence in adults varies across ethnic 
groups.(49) Studies in the Netherlands demonstrated that hypertension and kidney 
dysfunction are more prevalent among African, Surinamese and Dutch Antilles adults 
compared to Dutch adults.(50) The prevalence of hypertension is lower in Turkish and 
Moroccan than in Dutch adults.(51) Ethnic background is associated with blood pressure 
distribution.(52) Not much is known about the differences in variation in kidney size 
and function and blood pressure between these specific ethnic groups in childhood. A 
recent study among 6,643 children aged 11 to 16 years in the United Kingdom found 
small differences in blood pressure between different ethnic groups.(53) The highest 
blood pressure was observed in black African and Caribbean individuals. Another 
study in the United States among 534 children aged 6 to 10 years found higher blood 
creatinine levels in blacks than in whites and Hispanics and higher urinary creatinine 
levels in blacks and Hispanics than in whites.(41) Also, a study in the United States 
among 719 subjects showed that cystatin C levels are higher in white than in black 
and Mexican adolescents.(29) The ethnic populations in our study are most frequent 
in the Netherlands. We observed ethnic differences in kidney volume, kidney function 
and blood pressure in school-age children. We are not aware of other studies in these 
groups. We observed small and subclinical ethnic differences in kidney volume, kidney 
function and blood pressure in children aged 6 years. The observed differences reflect 
a 4% to 7% change in combined kidney volume and a 1% to 6% change in  estimated 
glomerular filtration rate. Although these differences were without clinical relevance 
at young age, our results suggest that children from Cape Verdean, Dutch Antilles and 
Surinamese groups living in the Netherlands have higher risks of development of renal 
and cardiovascular disease in later life. Further studies are needed to evaluate whether 
these ethnic differences predispose individuals for impaired kidney function in later life. 
Kidney volume and function differed across ethnic groups. It has been suggested that 
these ethnic differences might be explained by differences in body composition.(29) 
However, in the present study, we analyzed the associations of ethnic background with 
kidney function with adjustment for body surface area. The observed ethnic differences 
in kidney outcomes may be explained by both environmental and genetic factors related 
to kidney growth and function.(54,55) Further studies are needed to examine whether 
the observed ethnic differences lead to ethnic differences in kidney disease in adulthood. 
The ethnic populations in our study are most frequent in the Netherlands, and strongly 
related to the specific colonial and workers migration patterns. The observed ethnic 
distribution reflect the specific populations in the largest cities in the Netherlands, but 
are different from large cities in other countries. We used a demographic definition of 
ethnicity. This might not  fully reflect the ethnic differences. Further studies are needed 
to evaluate kidney function differences in other ethnic populations.
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Kidney size and function
To our knowledge, this is the first study with this large sample size to find an association 
between kidney volume and kidney function in childhood. We observed inverse associations 
of kidney volume with creatinine and cystatin C levels and positive associations with 
glomerular filtration rate. Another study among 257 healthy children older than 6 months, 
indicated that renal mass is inversely associated with creatinine levels in serum.(56) A study 
in 116 healthy children aged 1 to 15 years found a strong posistive correlation between 
ultrasonographic kidney size and glomerular filtration rate.(57) A previous study among 
672 Australian Aborigines with a high prevalence of kidney disease, suggested that smaller 
kidneys predisposed to higher blood pressure and albuminuria.(1) A recent study among 
1,748 Italian children, older than 6 months with and without urethral or kidney diseases, 
suggested that variation in serum creatinine levels were partially explained by renal 
mass.(56) In the same study, no correlation between kidney size and blood pressure was 
found.(56) These findings are in line with the hyperfiltration hypothesis which state that 
smaller kidneys lead to hyperfiltration, sclerosis and impaired renal function. We did not 
observe associations of childhood kidney size with blood pressure. It might be that kidney 
dimensions do not influence blood pressure in childhood yet. Further research is needed 
to study the associations between kidney volume in childhood and kidney function in 
adulthood. In contrast with our hypothesis, in our study kidney volume is associated 
with an increased risk of microalbuminuria. We cannot explain this finding. We observed 
inverse associations of kidney volume with creatinine and cystatin C levels and positive 
associations with estimated glomerular filtration rate. Differences in kidney function at 
the age of 6 years were small but might predispose individuals to  increased risk of kidney 
diseases in later life.
Conclusion and perspectives
The present study in a multi-ethnic cohort showed that childhood anthropometrics, sex 
and ethnicity were associated with kidney size and function measures. Also, kidney volume, 
was negatively associated with kidney function but not with blood pressure at the age of 
6 years. A larger kidney volume was associated with an increased risk of microalbuminuria. 
This study provides a unique resource for future studies on the early risk factors and later 
life consequences of kidney size and function variation in childhood.
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Supplementary table 1. Creatinine and cystatin C assay coefficient of variation and 
analytical ranges
Intra-assay coefficient of variation Inter-assay coefficient of variation Analytical range
Creatinine (µmol/l) 0.92% at 84.2 µmol/l
0.51% at 368.4 µmol/l
1.37% at 84.2 µmol/l
0.71% at 368.4 µmol/l
5-2 700 µmol/l
Cystatin C (mg/l) 1.65% at 1.09 mg/l
1.25% at 4.33 mg/l
1.65% at 1.09 mg/l
1.13% at 4.33 mg/l
0.4-8.0 mg/l
Supplementary table 2. Subject characteristics (N=6,397)
Group with blood samples
N=4,300
Group without blood samples
N=2,097
P value
Age and anthropometrics
Age (years) 6.0 (5.7 – 8.0) 6.0 (5.6 – 7.6) 0.001
Height (cm) 119.7 (6.1) 119.0 (6.0) <0.001
Weight (kg) 23.4 (4.2) 23.1 (4.3) 0.023
Body mass index (kg/m2) 16.2 (1.8) 16.2 (2.0) 0.671
Body surface area (m2) 0.88 (0.09) 0.87 (0.09) <0.001
Ethnic background (%)
Cape Verdean 3.7 (128) 3.9 (66) 0.685
Dutch 57.4 (2 403) 55.3 (1 134) 0.122
Dutch Antilles 3.8 (132) 3.6 (60) 0.667
Moroccan 7.1 (248) 7.1 (119) 0.914
Surinamese - Creoles 3.7 (128) 3.8 (64) 0.844
Surinamese - Hindustani 3.8 (132) 3.6 (60) 0.667
Turkish 8.6 (300) 10.8 (182) 0.013
Kidney growth and function
Kidney volume left (cm3) 61.6 (13.4) 60.8 (13.0) 0.038
Kidney volume right (cm3) 59.2 (12.4) 58.6 (11.9) 0.043
Kidney volume combined (cm3) 120.8 (23.7) 119.4 (23.1) 0.032
Creatinine (µmol/l) 37.5 (5.6) NA NA
Cystatin C (µg/l) 784 (82) NA NA
eGFR (ml/min per 1.73m²) 118.8 (16.4) NA NA
Micro albuminuria (%) 7.6 (316) 7.4 (146) 0.803
Systolic blood pressure (mmHg) 102.4 (8.0) 103.4 (8.6) <0.001
Diastolic blood pressure (mmHg) 60.5 (6.7) 61.1 (7.1) 0.001
Values are means (standard deviation), median (95% range) or percentage (number) 
T-tests were used for continuous variables, chi-square tests for categorical variables 
eGFR, estimated glomerular filtration rate. NA, not applicable
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Abstract
Background Fetal restricted abdominal blood flow may lead to smaller kidneys with a 
reduced number of nephrons, and subsequently to impaired kidney function in later life. 
Methods In a population-based prospective cohort study among 923 pregnant women 
and their children, we measured third trimester fetal growth characteristics and kidney 
dimensions. We assessed fetal blood flow distribution by umbilical and cerebral artery 
resistance indices. At the median age of 5.9 years (95% range 5.7–6.6), we measured 
kidney dimensions, creatinine and cystatin C blood levels, microalbuminuria and blood 
pressure, and estimated the glomerular filtration rate. 
Results A preferential fetal blood flow to the upper body parts at expense of the 
abdominal organs, reflected by higher ratio of fetal umbilical/cerebral  artery pulsatility 
indexes, was associated with a smaller kidney volume and lower risk of microalbuminuria. 
Larger fetal kidney volume was associated with smaller childhood kidney volume, lower 
creatinine and cystatin C levels and higher estimated glomerular filtration rate, but not 
with microalbuminuria and blood pressure.  As compared to children with a normal fetal 
blood flow and fetal combined kidney volume, children with a high U/C ratio and small 
fetal combined kidney volume had the highest creatinine levels (difference 2.16µmol/l, 
95% confidence interval 0.52, 3.81), and lowest estimated glomerular filtration rate 
(difference -6.36ml/min per 1.73m², 95% confidence interval -11.78, -0.94).
Conclusions and Relevance Fetal blood flow redistribution at expense of the abdominal 
organs, and smaller fetal kidney size are associated with lower kidney function in school-
age children, independent of later kidney growth. 
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Introduction
Suboptimal development of the fetal kidney, in response to an adverse intrauterine 
environment, leads to common kidney diseases in later life.(1) Late pregnancy is a critical 
period for kidney development and diseases. Nephrogenesis continues until 36 weeks 
of gestation, after which the induction of nephron numbers ceases.(2) A permanent 
reduction of kidney size and number of nephrons leads to a smaller glomerular filtration 
surface area, which might predispose the individual to decreased kidney function in 
childhood and development of kidney disease and hypertension in adulthood.(3,4) This 
hypothesis is mainly supported by studies showing consistent associations of low birth 
weight with higher risks of kidney disease and hypertension in later life. Although the 
observed effects from these studies were small, they are important from an etiological 
perspective.(5,6) The potential role of smaller kidneys with a reduced number of 
nephrons in the observed associations of birth weight with kidney disease in later life 
is further supported by animal and human post mortem studies. A post-mortem study 
in 20 humans showed that individuals with hypertension had fewer glomeruli than 
normotensive controls.(7) Also, birth weight is positively correlated with kidney size and 
glomerular number.(8,9) 
 Animal studies demonstrated a reduction in glomeruli number due to vascular 
placental insufficiency.(10) Placental insufficiency is an important risk factor for fetal 
growth restriction and low birth weight.(11) Also, we recently demonstrated that 
increased third trimester placental insufficiency is associated with a higher blood 
pressure in childhood.(12) Fetal growth restriction in response to placental insufficiency 
is characterized by a preferential blood flow to the brain at expense of the trunk.(13) This 
fetal blood flow redistribution is caused by a lower cerebral arterial resistance,(11) and 
can be measured as a higher umbilical artery pulsatility index (PI) and lower cerebral 
artery PI, which leads to a higher ratio of these measures (higher U/C ratio).(14) Whether 
and to what extend impaired abdominal or more specifically, kidney blood flow and 
kidney growth restriction during fetal life lead to risk factors for kidney disease in later 
life is unknown. 
 We evaluated in a population-based prospective cohort study among 923 pregnant 
women and their children, the associations of blood flow redistribution, at expense of 
the abdominal organs, and impaired kidney growth during fetal life with kidney function 
in school-age children. We also explored whether any association was explained by 
childhood kidney size.
Methods
Design and study population
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from fetal life onwards in Rotterdam, the Netherlands. All children were 
| Chapter 2.1
| 52
born between April 2002 and January 2006. Enrollment was aimed at early pregnancy 
at the routine fetal ultrasound examination in pregnancy but was allowed until birth 
of the child. In total, 9,778 mothers and their children were included in the study. More 
detailed assessments of fetal and postnatal growth and development were conducted 
in a random subgroup of 1,232 Dutch mothers and children (response 80%).(15) Twin 
pregnancies (n = 15) and pregnancies leading to perinatal death (n = 2) were excluded 
from the analysis, leading to 1,215 singleton live births. Third trimester blood flow 
distribution and fetal kidney measurements were successfully performed in 1,201 
singleton live born children, of whom 925 children (77%) visited the research center for 
follow up measurements at the median age of 5.9 (95% range 5.7 – 6.6) years. Childhood 
kidney measurements were successfully performed in 923 children (Flow chart is given 
in Figure 1). Written informed consent was obtained from all parents. The study has been 
approved by the Medical Ethics Committee of the Erasmus Medical Center, Rotterdam.
 
Third trimester fetal measurements
Third trimester fetal ultrasound examinations were performed at a median gestational 
age of 30.3 (95% range 28.5 – 32.7) weeks. 
 Fetal growth: Gestational age was established by first trimester ultrasound measurements.
(16) Fetal head circumference, abdominal circumference, and femur length were measured 
and estimated fetal weight was calculated using the formula by Hadlock et al.(17)
 Fetal blood flow distribution: We measured fetal blood flow distribution as inverse of 
the corresponding resistance indices in the umbilical and cerebral artery by pulsed-wave 
Doppler, as described previously.(11) The pusatility index (PI) in a fetal artery reflects 
the difference between the peak systolic and minimum diastolic velocities divided by 
the mean velocity during the cardiac cycle and is inversely related to the flow in this 
artery. Thus, a higher PI reflects a lower flow in this artery. Colour imaging was used 
to optimize placement of the pulsed wave Doppler gate in every measurement. For 
each measurement three consecutive uniform waveforms, during fetal apnoea and 
without fetal movement, were recorded and the mean of these measurements was 
used for further analysis. Umbilical artery PI was determined in a free-floating loop of 
the umbilical cord. A raised umbilical artery PI indicates increased vascular resistance 
and lower blood flow in the lower body parts.(18) Middle cerebral artery Doppler 
measurements were performed with colour Doppler visualization of the circle of Willis 
in the fetal brain, and flow-velocity waveforms were obtained in the proximal part of 
the cerebral arteries. Reductions in the middle cerebral artery PI are a valid indicator of 
fetal blood redistribution in favour of the brains.(19) Fetal blood redistribution in favour 
to the brain at expense of the trunk, including the abdominal organs, is indicated by 
a higher ratio between the umbilical artery PI and the cerebral artery PI (higher U/C 
ratio).(14) Intra- and inter-observer analyses showed good reproducibility for all Doppler 
measurements, as described previously (all intra-class correlation coefficients > 0.80).(13) 
The mean (SD) PI observed in our study were in line with a previous longitudinal study 
focused on serial measurements.(20)  
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Fetal kidney dimensions: In a sagittal plane, the maximum longitudinal kidney lengths 
were measured placing the callipers on the outer edges of the caudal and cranial side(21). 
Antero-posterior and transverse kidney diameters were measured perpendicular to each 
other, outer tot outer, in an axial plane. The cross-sectional area in which the kidney 
appeared symmetrically round at its maximum width was used.(22) Kidney volume was 
calculated using the equation of an ellipsoid: volume (cm3) = 0.523 x length (mm) x 
width (mm) x depth (mm).(23) Combined kidney volume was calculated by summing 
right and left kidney volume. 
Childhood kidney outcomes
Childhood kidney dimensions: Left and right kidney biometrics were at the median age 
of 5.9 (95% range 5.7 – 6.6) years. We identified the left and right kidney in the sagittal 
plane along its longitudinal axis. We performed measurements of maximal bipolar 
kidney length, width and depth. Kidney width and depth were measured at the level of 
the hilum. The cross-sectional area in which the kidney appeared symmetrically round 
at its maximum width was used. We calculated left and right kidney volume by using 
the same ellipsoid equation as for fetal kidney volume.(23) We previously reported good 
intra-observer and inter-observer correlation coefficients.(24) 
 Childhood kidney function: Blood creatinine levels were measured with an enzymatic 
method on a Cobas c 502 analyzer (Roche Diagnostics, Germany), and cystatin C 
levels by a particle enhanced immunoturbidimetric assay on a Cobas c 702 analyzer 
(Roche Diagnostics, Germany). Quality control samples demonstrated intra- and inter-
assay coefficients of variation ranging from 0.51% to 1.37% and from 1.13% to 1.65%, 
respectively. Estimated glomerular filtration rate (eGFR) was calculated according to the 
revised Schwartz 2009 formula(25); eGFR = 36.5 * (height (cm)/creatinine (µmol/l)(25) 
Urine creatinine (mmol/l) and urine albumin (mg/l) levels were determined on Beckman 
Coulter AU analyser, creatinine levels were measured according to the Jaffe method. We 
calculated the albumin-creatinine ratio. For boys microalbuminuria was defined as an 
albumin-creatinine ratio between 2.5 and 25 mg/mmol, for girls we used a ratio between 
3.5 and 25 mg/mmol.(26)
 Childhood blood pressure: Systolic and diastolic blood pressure were measured at the 
right brachial artery, four times with one minute intervals, using the validated automatic 
sphygmanometer Datascope Accutor Plus TM (Paramus, NJ, USA).(27) A cuff was selected 
which was long enough to cover 90% of the arm length and the cuff-width to cover 
approximately 40% of the arm circumference.
Covariates
Information on maternal age, pre-pregnancy body mass index, parity, educational level, 
smoking during pregnancy, folic acid use during pregnancy, gestational hypertensive 
complications was obtained by questionnaires and registries.(28) Maternal height was 
measured without shoes and pre-pregnancy body mass index (BMI) was calculated 
(kg/m2). Date of birth, infant sex and birth weight were obtained from midwife and 
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hospital registries. At the age of 6 years, child height and weight were measured without 
shoes and heavy clothing, and body surface area was calculated. 
Statistical analysis
First, we performed correlation analyses using scatterplots and Pearson correlation 
coefficients to explore the relation between gestational age with U/C ratio and fetal 
kidney volume. To explore whether fetal kidney size was disproportionally affected by 
fetal blood flow redistribution, we performed linear regression models with gestational 
age as independent variable and fetal kidney volume/estimated fetal weight as 
dependent variable, and stratified these analyses for U/C ratio. Second, the associations 
of fetal blood flow distribution and kidney growth with kidney function outcomes were 
analysed in a stepwise approach. We performed correlation analyses using scatterplots 
and Pearson correlation coefficients. Next we performed multiple linear regression 
models. The models were first adjusted for gestational age and estimated fetal weight 
at third trimester measurement, and child sex, current age and body surface area (Basic 
model). Analyses focused on estimated glomerular filtration rate were not further adjusted 
for body surface area since this is included in the Schwartz 2009 formula. These models 
were additionally adjusted for potential confounders including maternal age, parity, 
educational level, pre-pregnancy body mass index, smoking status during pregnancy, 
pregnancy complications (pre-eclampsia and pregnancy induced hypertension), 
gestational age at birth and gestational age adjusted birth weight (Confounder model). 
This confounder model was considered as the main model. We additionally adjusted 
the Confounder model for childhood combined kidney volume to explore whether 
any association was explained by childhood combined kidney volume (Kidney volume 
model). Third, we tested potential combined effects and interactions between fetal 
blood flow and fetal kidney volume on childhood outcomes and performed stratified 
multiple linear regression analyses where the interaction terms were significant. We also 
tested the interaction between estimated fetal weight and umbilical/cerebral ratio with 
fetal kidney volume. We performed a sensitivity analysis using gestational age adjusted 
birth weight as an additional index of final nephron number instead of fetal kidney 
volume .To reduce the possibility of potential bias associated with missing data (less 
than 17%), missing values in maternal, fetal and child covariates were imputed using the 
multiple imputations procedure with five imputations and these datasets were analyzed 
together. Further information about the methods of multiple imputation are given in the 
Supplemental file. All statistical analyses were performed using the Statistical Package 
for the Social Sciences version 20.0 for Windows (SPSS Inc, Chicago, IL, USA).
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Results
Subject characteristics
Maternal, fetal and child characteristics are shown in Table 1. Observed data before 
multiple imputations are presented in the Supplementary material (Supplementary 
Table S1). Non-response analysis showed that as compared to mothers of children not 
included in the analysis, mothers of children included in the study were older, higher 
educated, smoked less frequently during pregnancy, more frequently nulliparous, and 
more frequently users of folic acid supplements. Furthermore, children included in 
the study had a higher birth weight and gestational age at birth and were more often 
girls (Supplementary Table S2). Subject characteristics in different strata of U/C ratio 
and different strata of fetal kidney volume are given in Supplementary Tables S3 and 
S4. Gestational age was slightly shorter in the high umbilical/cerebral ratio group as 
compared to the normal and low cerebral/umbilical ratio group, but differences were 
small (< 0.2 weeks). In Supplemental Figure S4 and S5 the scatterplots and the 
correlations of gestational age and estimated fetal weight with fetal kidney volume/
estimated fetal weight are shown. There was no significant interaction of gestational age 
or estimated fetal weight with umbilical/cerebral ratio (p-value>0.05), suggesting that 
the associations of gestational age and estimated fetal weight with fetal kidney volume/
estimated fetal weight are not modified by the U/C ratio. 
Fetal blood flow redistribution and childhood kidney outcomes 
Scatterplots for the observed correlations between blood flow redistribution, fetal kidney 
dimensions and childhood kidney outcomes are shown in Supplementary Figures S1, 
S2 and S3. Table 2 shows that in the main confounder model a higher U/C ratio, which 
reflects a preferential blood flow to the upper body parts at expense of the trunk and 
abdominal organs, was associated with a smaller childhood combined kidney volume 
(-2.58 cm³ per 1 SDS increase in ratio, 95% Confidence Interval (CI) -4.01, -1.14) and a 
lower risk for microalbuminuria (Odds ratio 0.71 per 1 SDS increase in U/C ratio, 95% CI 
0.51, 0.97). Fetal blood flow distribution was not associated with childhood creatinine 
and cystatin C levels, estimated glomerular filtration rate and blood pressure. Results 
from the basic model were similar as those from the confounder model. The effect 
estimates for associations of fetal blood flow distribution with microalbuminuria were 
attenuated towards zero by additional adjustment for childhood kidney size. The effect 
of stepwise adjustment of covariates in the associations of third trimester U/C ratio and 
third trimester fetal kidney dimensions with childhood kidney outcomes are given in 
Supplementary Tables S5 and S6. R squares for the effect estimates for the associations 
of third trimester U/C ratio and third trimester fetal kidney dimensions with childhood 
kidney outcomes were all between 0.20 and 0.25 (Supplementary Tables S7 and S8). 
We also evaluated the associations of estimated fetal weight and fetal kidney volume in 
different strata of U/C ratio and found no differences in effect estimates between high, 
normal and low U/C ratio (p-value > 0.05) (Supplementary Table S9).
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Table 1. Subject characteristics (N=923) 
Maternal characteristics 
Age, (y) 32.2 (23.4 – 39.4)
Height, (cm) 171 (6.3)
Pre-pregnancy weight, (kg) 69.0 (13.0)
Pre-pregnancy body mass index, (kg/m2) 23.6 (4.2)
Parity ≥1, (%) 37.7 (348)
Educational level, (%)
 Primary/secondary 34.1(315)
 Secondary or higher 65.9 (608)
Smoking during pregnancy, (%)
 Yes 21.5 (198)
 No 78.5 (745)
Folic acid supplement use, (%)
 Yes 90.9 (839)
 No 9.1 (84)
Pregnancy induced hypertension, (%)
 Yes 5.6 (52)
 No 94.4 (871)
Preeclampsia, %
 Yes 3.1 (29)
 No 96.9 (894)
Fetal characteristics
General
Gestational age at measurement, (wk) 30.3 (28.5 – 32.7)
Estimated fetal weight, (g) 1634 (263)
Blood flow distribution
Umbilical artery PI 0.97 (0.16)
Middle cerebral artery PI 1.97 (0.33)
U/C ratio middle cerebral artery 0.50 (0.11)
Fetal kidney biometrics
Right kidney volume, (cm3) 10.64 (3.07)
Left kidney volume, (cm3) 9.94 (2.76)
Combined kidney volume, (cm3) 20.56 (5.48)
Birth and infant characteristics
Gestational age at birth, (wk) 40.3 (36.4 – 42.4)
Birth weight, (g) 3534 (509)
Sex boys, (%) 50.3 (464)
Childhood characteristics
Age at follow up, (y) 5.9 (5.7 – 6.6)
Height, (cm) 119 (5.2)
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Weight, (kg) 22.6 (3.2)
Body mass index, (kg/m2) 15.9 (1.4)
Body surface area, (m2) 0.86 (0.07)
Kidney volume left, (cm3) 61.4 (12.6)
Kidney volume right, (cm3) 59.5 (11.7)
Kidney volume combined, (cm3) 120.9 (22.1)
Creatinine, (µmol/l) 36.8 (4.9)
Cystatin C, (µg/l) 790 (74)
Estimated glomerular filtration rate ml/min per 1.73m² 120.2 (15.8)
Estimated glomerular filtration rate/cm3 kidney volume 1.02 (0.19)
Microalbuminuriaa, (%) 7.1 (62)
Systolic blood pressure, (mmHg) 102.2 (7.7)
Diastolic blood pressure, (mmHg) 60.1 (6.3)
Values are means (SD), medians (95% range), or % (numbers). 
aDefined as levels between 2.5-25.0 mg/mmol (boys) and 3.5-25.0 mg/mmol (girls)
 
Fetal kidney volume and childhood kidney outcomes
Table 3 shows that in the main confounder model a larger fetal combined kidney volume 
was associated with larger childhood combined kidney volume (3.96 cm³ per 1 SDS 
increase in volume, 95% CI 2.43, 5.49), lower creatinine levels (-1.22 µmol/l per 1 SDS 
increase in volume, 95% CI -1.63, -0.80), lower cystatin C levels (-18 µg/l per 1 SDS increase 
in volume, 95% CI -25, -12) and higher eGFR (4.45 ml/min per 1.73m² per 1 SDS increase in 
volume, 95% CI 3.08, 5.83), but not with microalbuminuria and blood pressure at the age 
of 6 years. These effect estimates were largely similar for the basic models. Also, additional 
adjustment for childhood kidney volume did not materially change the effect estimates. 
Fetal blood flow distribution, fetal kidney volume and childhood function 
Figure 2 shows the combined effects of fetal blood flow and kidney volume on childhood 
kidney outcomes. The interaction terms between fetal blood flow and fetal kidney 
volume were significant for the analyses focused on creatinine levels and eGFR. Figures 
2a and 2b show that as compared to children with a normal fetal blood flow and fetal 
combined kidney volume, children with a low U/C ratio and large fetal combined kidney 
volume had the lowest creatinine levels and highest eGFR. The linear association of fetal 
combined kidney volume with creatinine levels and eGFR was significant in children 
with a normal or low U/C ratio (p-values < 0.05), but not in children with higher U/C 
ratio (Table S11). When we used gestational age adjusted birth weight as an additional 
index of final nephron number instead of fetal kidney volume, we observed similar 
results (Supplementary Figure S6). Lower gestational age adjusted birth weight was 
Table 1. Continued
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associated with smaller childhood kidneys with a lower eGFR. The interaction between 
U/C ratio and gestational age adjusted birth weight for the associated with childhood 
kidney outcomes were not significant. When we used GFR/cm3 kidney volume instead of 
GFR, no differences in results were observed in the final models.
Figure 1. Associations of fetal blood flow, fetal combined kidney volume, and childhood 
kidney volume with childhood eGFR (N= 613)
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Bars represent regression coefficients (95% CIs) based on multiple regression models 
and reflect the associations of fetal blood flow and kidney volume (A), fetal blood 
flow and childhood kidney volume (B), and fetal and childhood kidney volume (C) 
(tertiles) with childhood eGFR. Models are adjusted for maternal age, parity, education 
level, prepregnancy body mass index, smoking status during pregnancy, folic acid use 
during pregnancy, maternal pregnancy complications (hypertension, preeclampsia), 
gestational age at third trimester measurement, third trimester estimated fetal weight, 
child sex, gestational age, and gestational age–adjusted birth weight, and current age. 
P<0.01 for the interaction between fetal blood flow and fetal combined kidney volume 
for the association with childhood eGFR. The P value for the interaction between fetal 
blood flow and childhood combined kidney volume and for interaction between fetal 
combined kidney volume and childhood combined kidney volume is not significant.
Discussion 
We observed that that third trimester fetal blood flow redistribution, at expense of the 
trunk and abdominal organs, and restricted fetal kidney growth are associated with 
smaller kidney volume and lower kidney function in school-age children. Fetal blood 
flow and fetal kidney size was not associated with childhood blood pressure. 
 An adverse fetal environment may lead to smaller kidneys with a reduced number 
of nephrons.(29) These kidney adaptations may lead to a reduced glomerular filtration 
surface area, hyperfiltration and eventually glomerular sclerosis and chronic kidney 
disease.(2,3) Thus far, this hypothesis is mainly supported by studies showing associations 
of low birth weight with higher risks of kidney disease and hypertension in adulthood.
(5,6) Also, post-mortem studies showed that nephron number is lower in children with a 
low birth weight, or small kidney size, and in adults with primary hypertension.(7-9) Studies 
in rats showed that fetal growth restriction, induced by bilateral uterine artery ligation, 
leads to an increased risk of kidney disease and higher blood pressure in adulthood.(30,31) 
In a study among 7,457 adults aged 20 to 30 years in Norway, intrauterine growth 
restriction was associated with low-normal kidney function. In this study the effect sizes 
were small and participation in follow-up measurements was less than 50%.(32) Another 
study among 82 young adults born before 32 weeks of gestation in the Netherlands, 
observed no consistent associations of preterm birth in combination with intra-uterine 
growth restriction with kidney function.(33)
 Animal studies showed a reduction in glomerular and nephron number due to 
vascular placental insufficiency.(10,34) We observed in a previous study within the same 
cohort that fetal blood flow redistribution at expense of the abdominal organs, leads to 
smaller fetal kidneys.(21) In this study, we did not observe differences in the association 
of gestational age and fetal weight and fetal kidney volume between high, normal and 
low U/C ratio groups. In the present follow-up study, we observed that fetal blood flow 
redistribution is also associated with smaller kidneys and impaired kidney function in 
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children. Surprisingly, we observed that fetal blood redistribution at expense of the 
abdominal organs was associated with a lower risk of microalbuminuria, independent 
of potential confounders and childhood kidney size. We could not explain this finding. 
Blood flow through the umbilical arteries, reflects the arterial resistance and blood flow 
to the intra-abdominal arteries, including the descending aorta and renal artery.(19) 
More detailed studies focused on the directly measured renal artery blood flow might 
give more information about the fetal and childhood consequences of impaired fetal 
kidney blood flow. 
 A recent cross-sectional study, among 257 healthy children in Italy older than 6 
months, indicated that childhood kidney size was inversely correlated with creatinine 
levels.(35) In line with that study, we observed an inverse association of fetal kidney size 
with creatinine and cystatin C levels in childhood, and a positive association with eGFR. 
Previously, we observed in the same cohort as the present study that small fetal kidney 
size tends to track in early childhood.(36) However, in the current study, the associations 
of fetal kidney volume with childhood kidney function outcomes were independent of 
childhood kidney size. These findings suggest that fetal kidney size may have permanent 
effects, independent of later kidney growth, on kidney function in later life. Within the 
group with the highest U/C ratio, reflecting blood flow redistribution at expense of the 
abdominal organs, there was no clear association between fetal kidney volume and 
childhood kidney function. This suggests that there might be another pathway, besides 
via fetal kidney volume, by which fetal blood redistribution affects kidney function in 
childhood. Fetal kidney size was not associated with childhood microalbuminuria or 
blood pressure. It might be that differences in these more clinical markers of kidney 
dysfunction appear at older ages.  
 The results from this study are important from an etiological perspective. They 
suggest that suboptimal abdominal blood flow and kidney growth in fetal life have 
persistent consequences. However, the observed effect estimates were small and reflect 
subclinical changes in kidney function in school-age children. None of the children had 
a known clinical kidney disease. Longitudinal studies reported tracking of risk factors for 
kidney and cardiovascular disease during childhood.(37,38) Also, the consequences of 
impaired kidney growth might not yet be fully detectable in early childhood, but might 
become more evident in later life. It has been suggested that fetal adverse adaptations 
can be compensated for many years until for example hypertension occurs.(5) 
 The biological mechanisms underlying the associations of low birth weight with kidney 
diseases in adulthood may also include other mechanisms than smaller kidneys with a 
lower number of nephrons with glomerular hyperfiltration.(4) Animal studies showed 
alterations in the renin angiotensin system in experimentally induced intrauterine 
growth restricted rats at adult age. These differences were not present at younger age.
(39) Several markers of the renin angiotensin system were increased in intrauterine 
growth restricted subjects with hypertension.(39) An accumulating body of evidence 
suggests that an adverse intra-uterine environment might cause epigenetic alterations 
which in turn influence kidney growth and function.(4) Finally, a mismatch between 
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fetal and postnatal growth may also lead to insufficient kidney function for an individual 
metabolic load. Future studies are needed to identify possible underlying mechanisms.
 The main strength of this study is the population-based prospective design from fetal life 
onwards. Follow-up measurements at the age of 6 years were obtained in 75% of the children. 
If the associations of fetal characteristics with childhood kidney outcomes would differ 
between those with and without follow-up measurements, the results would be biased. This 
seems unlikely, but cannot be excluded. Children without kidney measurements were on 
average smaller at birth, which might have led to an underestimation of our associations. We 
evaluated fetal blood flow and fetal kidney volume at one time point during late pregnancy. 
Although the intra- and interobserver variability are adequate and mean values are in line 
with previous studies, misclassification due to measurement error cannot be excluded. 
However, this would most likely have to random error, which reduces power of the study and 
may have led to an underestimation of the evaluated associations. Fetal kidney volume was 
evaluated around 30 weeks of gestational age. Since nephrogenesis continues until 36 weeks 
gestational age, our measurements did not reflect final nephron number.(2) Evaluation of 
fetal kidney size until 36 weeks of gestational age, might have been more representative for 
final nephron number. When we used gestational age adjusted birth weight as a surrogate 
for final nephron number instead of third trimester kidney volume, we observed similar 
results. It is not known whether birth weight is a better proxy for fetal nephron number 
than fetal kidney size.(40) We used kidney size as a measure of kidney development, since 
nephron number cannot be studied in vivo. Kidney size is correlated with the number of 
glomeruli and can be used in epidemiological studies as measure of kidney development.
(40) However, glomerular enlargement due to hyperfiltration may attenuate the differences 
in childhood kidney volume and may lead to an underestimation of the associations of 
interest.(41) We estimated the glomerular filtration using blood creatinine levels. Blood 
cystatin C levels might be more accurate in estimating glomerular filtration. As compared 
to creatinine, cystatin C is freely filtered, produced more constantly and less dependent 
from children’s body weight, height and sex.(42) In the current study, we observed similar 
results for creatinine and cystatin C levels. We used the urine albumin-creatinine ratio to 
evaluate albuminuria in a random urine sample.(43) Since the within subject variation in 
urinary albumin excretion is large, the variability would probably be lower if we collected 
first morning void samples instead of random during the day.(44) This was not possible in 
the current study. In the present study we evaluated multiple associations, this might have 
led to chance findings due to multiple testing. However, since the kidney related outcomes 
were correlated we did not adjust for multiple testing. Finally, although we had information 
about a large number of confounders, the influence of residual confounding should be 
considered, as in any observational study.
 The findings from the present study are important from a developmental perspective. 
They strongly suggest that suboptimal third trimester fetal kidney development influences 
childhood kidney function. The observed small differences in kidney function are without 
direct clinical consequences in childhood, but may lead to impaired kidney function in 
later life.
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Conclusion and perspectives
In conclusion, fetal blood redistribution at expense of the intra-abdominal organs and 
impaired fetal kidney growth have persistent consequences for kidney function in 
childhood. The observed associations suggest that fetal kidney developmental adaptations 
have affect kidney function throughout the life-course, and predispose individuals for 
kidney diseases in later life. Further studies are needed to identify the underlying biological 
mechanisms and the long-term consequences of the observed associations.
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Imputation procedure
To reduce the possibility of potential bias associated with missing data (less than 17%), 
missing values were imputed using the multiple imputations procedure.(1) For the 
multiple imputations, we used Fully Conditional Specification, an iterative of the Markov 
Chain Monte Carlo approach. For each variable, the fully conditional specification 
method fits a model using all other available variables in the model as predictors, and 
then imputes missing values for the specific variable being fit. In the imputation model, 
we included all covariates plus maternal pre-pregnancy weight, birth weight, height 
and weight of the child aged 6. Furthermore, we added the determinants and outcomes 
studied in the imputation model as prediction variables only; they were not imputed 
themselves. Five imputed datasets were created and analyzed together.
1. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for 
missing data in epidemiological and clinical research: potential and pitfalls. BMJ (Clinical research 
ed. 2009;338:b2393.
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Table S1. Subject characteristics in tertiles of U/C ratio (N=879)
High tertile
U/C ratio 
(N=297)
Middle tertile 
U/C ratio 
(N=285)
Low tertile
U/C ratio 
(N=297)
P-value for 
trend
Maternal characteristics
Age, (y)
Height, (cm) 
Pre-pregnancy weight, (kg) 
Pre-pregnancy body mass index, (kg/m2)
Parity ≥1, (%)
Educational level, (%)
 Primary/secondary
 Secondary or higher
Smoking during pregnancy, (%) 
 Yes
 No
Folic acid supplement use, (%)
31.8 (24.1, 39.5)
170.9 (6.2)
68.0 (12.7)
23.4 (4.1)
32.0 (95)
28.6 (85)
71.4 (212)
19.9 (59)
80.1 (238)
32.3 (23.6, 40.6)
171.4 (6.3)
69.5 (13.6)
23.6 (4.2)
40.7 (116)
36.1 (103)
63.9 (182)
21.8 (62)
78.2 (223)
32.2 (21.9, 39.0)
170.8 (6.1)
69.6 (13.3)
23.9 (4.4)
41.8 (124)
35.7 (106)
64.6 (191)
22.2 (66)
77.8 (231)
P=0.43
P=0.53
P=0.39
P=0.35
P<0.05
P=0.12
P=0.74
 Yes 89.9 (267) 93.3 (266) 87.9 (261) P=0.10
 No 10.1 (30) 6.7 (19) 12.1 (36)
Pregnancy induced hypertension, (%)
 Yes 6.1 (18) 5.6 (16) 4.7 (14) P=0.74
 No 93.9 (279) 94.4 (269) 96.3 (283)
Preeclampsia, (%)
 Yes 3.4 (10) 3.2 (9) 2.2 (6) P=0.69
 No 96.6 (287) 96.8 (276) 97.8 (291)
Fetal characteristics
Gestational age at measurement, (wk) 30.2 (28.5, 32.5) 30.4 (28.6, 32.5) 30.4 (28.4, 33.1) P<0.05
Estimated fetal weight, (g)
Umbilical artery PI
Middle cerebral artery PI
U/C ratio middle cerebral artery
1580 (237)
1.08 (0.16)
1.73 (0.28)
0.63 (0.08)
1647 (259)
0.97 (0.12) 
1.98 (0.26)
0.49 (0.03)
1675 (279)
0.86 (0.12) 
2.21 (0.28)
0.39 (0.04)
P<0.01
P<0.01
P<0.01
P<0.01
Right kidney volume, (cm3) 10.3 (3.1) 10.7 (2.9) 11.0 (3.2) P<0.05
Left kidney volume, (cm3) 9.5 (2.7) 10.1 (2.7) 10.4 (2.8) P<0.01
Combined kidney volume, (cm3) 19.8 (5.5) 20.8 (5.2) 21.3 (5.7) P<0.01
Birth and infant characteristics
Gestational age at birth, (wk) 40.4 (35.6, 42.6) 40.3 (37.0, 42.6) 40.3 (36.9, 42.1) P=0.36
Birth weight, (g) 3450 (506) 3568 (510) 3601 (474) P<0.01
Sex boys, (cm3) 47.1 (140) 52.3 (149) 52.5 (156) P=0.34
Childhood characteristics
Height, (cm) 118.3 (5.2) 119.4 (5.1) 119.4 (5.1) P<0.05
Weight, (kg) 22.1 (3.1) 22.9 (3.6) 22.8 (3.0) P<0.01
Age at follow up, (y) 5.9 (5.6, 6.8) 5.9 (5.7, 6.5) 5.9 (5.7, 6.8) P=0.69
Body mass index, (kg/m2) 15.8 (1.37) 16.0 (1.62) 15.9 (1.28) P=0.12
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Body surface area, (m2) 0.85 (0.07) 0.87 (0.08) 0.87 (0.07) P<0.01
Kidney volume left, (cm3) 59.2 (11.5) 61.7 (12.7) 63.4 (13.2) P<0.01
Kidney volume right, (cm3) 56.8 (11.4) 60.5 (12.0) 61.3 (11.5) P<0.01
Kidney volume combined, (cm3) 115.9 (20.8) 122.1 (22.5) 124.8 (22.6) P<0.01
Creatinine, (µmol/l) 36.8 (5.2) 36.8 (4.6) 37.0 (5.0) P=0.91
Cystatin C, (µg/l) 793 (77) 794 (77) 784 (70) P=0.32
Estimated glomerular filtration rate ml/
min per 1.73m²
119.4 (15.5) 120.4 (15.2) 120.4 (16.8) P=0.75
Estimated glomerular filtration rate/cm3 
kidney volume
1.06 (0.19) 1.01 (0.18) 0.97 (0.17) P<0.01
Microalbuminuriaa, (%) 4.0 (12) 9.1 (26) 7.1 (21) P=0.05
Systolic blood pressure, (mmHg) 101.9 (8.5) 102.7 (7.4) 101.8 (7.1) P=0.28
Diastolic blood pressure, (mmHg) 59.8 (6.9) 60.3 (5.7) 60.0 (6.3) P=0.64
Means were compared using ANOVA for continuous variables and chi-square test for 
categorical variables. 
aDefined as levels between 2.5-25.0 mg/mmol (boys) and 3.5-25.0 mg/mmol (girls)
Table S1. Continued
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Table S2. Subject characteristics in tertiles of fetal kidney volume (N=870)
Low tertile kidney 
volume 
(N=302)
Middle tertile  
kidney volume  
(N=292)
High tertile kidney 
volume 
(N=276)
P-value for 
trend
Maternal characteristics
Age, (y)
Height, (cm)
Pre-pregnancy weight, (kg) 
Pre-pregnancy body mass index, (kg/m2)
Parity ≥1, (%)
Educational level, (%)
 Primary/secondary
 Secondary or higher
Smoking during pregnancy,  (%)
 Yes
 No
Folic acid supplement use, (%)
31.8 (22.5, 39.6)
170.5 (6.1)
67.7 (12.0)
23.3 (3.9)
35.4 (107)
35.1 (106)
64.9 (196)
23.2 (70)
76.8 (232)
32.5 (23.8, 39.4)
170.9 (6.2)
64.2 (12.3)
23.5 (4.1)
43.5 (127)
31.2 (91)
68.8 (201)
21.5 (63) 
78.5 (229)
31.9 (23.4, 39.5)
171.9 (6.3)
70.8 (14.0)
24.0 (4.6)
32.2 (89)
34.1 (94)
65.9 (182)
21.0 (58) 
79.0 (218)
P=0.17
P<0.05
P<0.05
P=0.17
P=0.30
P=0.63
P=0.74
 Yes 90.1 (272) 90.8 (265) 90.6 (251) P=0.59
 No 9.9 (30) 9.2 (27) 9.4 (25)
Pregnancy induced hypertension, (%)
 Yes 7.0 (21) 4.5 (13) 5.4 (15) P=0.84
 No 93.0 (281) 96.5 (279) 94.6 (261)
Preeclampsia, %
 Yes 3.6 (11) 2.1 (6) 2.5 (7) P=0.76
 No 96.4 (291) 97.9 (286) 97.5 (269)
Fetal characteristics
Gestational age at measurement, (wk) 30.1 (28.1, 32.0) 30.4 (28.6, 32.5) 30.7 (28.9, 33.1) P<0.01
Estimated fetal weight, (g)
Umbilical artery PI
1511 (230)
1.00 (0.17)
1635 (232)
0.97 (0.16)
1768 (264)
0.94 (0.16)
P<0.01
P<0.01
Middle cerebral artery PI
U/C ratio middle cerebral artery 
1.96 (0.36)
0.52 (0.12)
1.99 (0.33)
0.49 (0.10)
1.95 (0.31)
0.49 (0.11)
P=0.20
P<0.01
Right kidney volume, (cm3) 7.9 (1.3) 10.4 (1.1) 13.9 (2.7) P<0.01
Left kidney volume, (cm3) 7.4 (1.2) 9.7 (1.1) 12.9 (2.3) P<0.01
Combined kidney volume, (cm3) 15.3 (2.0) 20.1 (1.3) 26.8 (4.2) P<0.01
Birth and infant characteristics
Gestational age at birth, (wk) 40.1 (37.0, 42.3) 40.4 (35.7, 42.6) 40.4 (36.8, 42.3) P=0.52
Birth weight, (g) 3384 (489) 3561 (478) 3682 (502) P<0.01
Sex boys, (%) 54.3 (164) 52.1 (152) 55.1 (152) P=0.37
Childhood characteristics
Age at follow up, (y) 5.9 (5.7, 6.7) 5.9 (5.7, 6.6) 6.0 (5.7, 6.7) P=0.19
Height, (cm) 118.3 (5.4) 118.7 (5.1) 120.2 (4.9) P<0.01
Weight, (kg) 22.2 (3.4) 22.3 (2.9) 23.3 (3.4) P<0.01
Body mass index, (kg/m2) 15.8 (1.5) 15.8 (1.2) 16.1 (1.5) P<0.05
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Body surface area, (m2) 0.85 (0.08) 0.86 (0.07) 0.88 (0.07) P<0.01
Kidney volume left, (cm3) 58.9 (11.9) 61.4 (12.6) 63.9 (12.6) P<0.01
Kidney volume right, (cm3) 56.5 (11.1) 59.3 (11.2) 62.8 (12.1) P<0.01
Kidney volume combined, (cm3) 115.4 (21.0) 120.7 (21.6) 126.7 (22.4) P<0.01
Creatinine, (µmol/l) 37.8 (4.7) 36.4 (4.8) 36.1 (5.1) P<0.01
Cystatin C, (µg/l) 812 (74) 780 (75) 776 (71) P<0.01
Estimated glomerular filtration rate ml/
min per 1.73m²
116.0 (14.0) 121.3 (15.2) 124.0 (17.1) P<0.01
Estimated glomerular filtration rate/cm3 
kidney volume
1.04 (0.01) 1.02 (0.01) 1.00 (0.01) P=0.16
Microalbuminuriaa, (%) 6.6 (20) 5.1 (15) 8.3 (23) P=0.62
Systolic blood pressure, (mmHg) 102.2 (8.2) 101.9 (7.7) 102.4 (7.2) P=0.88
Diastolic blood pressure, (mmHg) 60.3 (6.2) 60.2 (6.5) 59.8 (6.0) P=0.70
Means were compared using ANOVA for continuous variables and chi-square test for 
categorical variables.
 aDefined as levels between 2.5-25.0 mg/mmol (boys) and 3.5-25.0 mg/mmol (girls)
Table S2. Continued
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Table S5. Associations of third trimester umbilical/cerebral artery resistance ratio with 
childhood kidney volume at the age of 6 years (N=834)
Combined kidney volume difference (95%CI) (cm3) R square
U/C ratio (SD = 0.11)
Basic model -2.46 
(-3.89, -1.04)a
0.221
Confounder model -2.58
(-4.01, -1.14)a
0.223
Values are regression coefficients (95% Confidence interval (CI)) based on multiple regression 
models and reflect the difference for kidney volume for fetal blood flow characteristics. 
Basic model is adjusted for gestational age at third trimester measurement, third trimester 
estimated fetal weight, child sex, current age and body surface area. Confounder model is 
additionally adjusted for maternal age, parity, educational level, pre-pregnancy body mass 
index, smoking status during pregnancy, maternal pregnancy complications (hypertension, 
preeclampsia), folic acid use during pregnancy, gestational age and gestational age adjusted 
birth weight.
ap<0.01
Table S6. Associations of third trimester fetal kidney volume with childhood kidney 
volume at the age of 6 years (N=799)
Combined kidney volume difference (95%CI) (cm3) R square
Combined fetal kidney volume (SD = 5.48)
Basic model 3.89  
(3.61, 4.16)a
0.246
Confounder model 3.96
(2.43, 5.49)a
0.247
Values are regression coefficients (95% Confidence interval (CI)) based on multiple regression 
models and reflect the difference for kidney volume for fetal kidney volume. Basic model 
is adjusted for gestational age at third trimester measurement, third trimester estimated 
fetal weight, child sex, current age and body surface area. Confounder model is additionally 
adjusted for maternal age, parity, educational level, pre-pregnancy body mass index, smoking 
status during pregnancy, maternal pregnancy complications (hypertension, preeclampsia), 
folic acid use during pregnancy, gestational age and gestational age adjusted birth weight. 
ap<0.01
| Childhood kidney outcomes in relation to fetal blood
| 79
Table S7. Subject characteristics of participants with and without follow-up data
(N=1,201)
Childhood data available
(N=923)
Childhood data unavailable
(N=278)
Maternal characteristics
Age, (y) 32.2 (23.4 – 39.4) 31.1 (19.2 – 38.2)a
Height, (cm) 171 (6.3) 170 (6.4)
Pre-pregnancy weight, (kg) 69.3 (13.0) 67.1 (11.3)
Pre-pregnancy body mass index, (kg/m2)) 23.6 (4.2) 23.1 (3.7)
Parity ≥1, (%) 37.7 (348) 44.2 (123)a
 Missing 0.2 (2) 0.7 (2)
Educational level, (%)
 Primary/secondary 33.7 (311) 45.3 (126)b
 Secondary or higher 65.3 (603) 51.1 (142)
 Missing 1 (9) 3.6 (10)
Smoking during pregnancy, (%) 
 Yes 19.4 (179) 35.3 (89)b
 No 70.7 (653) 58.2 (171)
 Missing 9.9  (91) 6.5 (18)
Folic acid, (%)
 Yes 76.6 (707) 69.4 (193)b
 No 6.5 (60) 11.9 (33)
 Missing 16.9 (156) 18.7 (52)
Pregnancy induced hypertension, (%) 
 Yes 4.9 (45) 4.0 (11)
 No 89.7 (828) 89.5 (249)
 Missing 5.4 (50) 6.5 (18)
Preeclampsia, (%) 
 Yes 2.5 (23) 1.8 (5)
 No 89.7 (828) 89.5 (249)
 Missing 7.8 (72) 8.7 (24)
Gestational age at measurement, (wk) 30.3 (28.5 – 32.7) 30.4 (28.1 – 32.5)
Estimated fetal weight, (g) 
Blood flow distribution
1634 (263) 1616 (285)
Umbilical artery PI 0.97 (0.16) 0.99 (0.18)
Middle cerebral artery PI 1.97 (0.33) 1.99 (0.33)
U/C ratio, middle cerebral artery 0.50 (0.11) 0.51 (0.12)
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Fetal kidney biometrics
Right kidney volume, (cm3) 10.64 (3.07) 10.84 (3.13)
Left kidney volume, (cm3) 9.94 (2.76) 10.01 (2.86)
Combined kidney volume, (cm3) 20.56 (5.48) 20.85 (5.61)
Birth and infant characteristics
Gestational age at birth, (wk) 40.3 (36.4 – 42.4) 40.0 (34.7 – 42.4)b
Birth weight, (g) 3534 (509) 3446 (628)a
Sex boys, (%) 50.3 (464) 57.6 (160)a
 Missing 0
Childhood characteristics
Age at follow up, (y) 5.9 (5.7 – 6.6) N.A.
Height, (cm) 119 (5.2) N.A.
Weight, (kg) 22.6 (3.2) N.A.
Body mass index, (kg/m2) 15.9 (1.4) N.A.
Body surface area, (m2) 0.86 (0.07) N.A.
Kidney volume left, (cm3) 61.4 (12.6) N.A.
Kidney volume  right, (cm3) 59.5 (11.7) N.A.
Kidney volume combined, (cm3) 120.9 (22.1) N.A.
Creatinine, (µmol/l) 36.8 (4.9) N.A.
Cystatin C, (µg/l) 790 (74) N.A.
Estimated glomerular filtration rate ml/min per 1.73m² 120.2 (15.8) N.A.
Estimated glomerular filtration rate/cm3 kidney volume 1.02 (0.19)
Micro albuminuriac, (%) 7.1 (62) N.A.
Systolic blood pressure, (mmHg) 102.2 (7.7) N.A.
Diastolic blood pressure, (mmHg) 60.1 (6.3) N.A.
Values are means (SD), medians (95% range), or % (numbers). Participants were 
compared using independent samples t-test for continuous variables and chi-square 
test for categorical variables. 
cDefined as levels between 2.5-25.0 mg/mmol (boys) and 3.5-25.0 mg/mmol (girls) 
N.A. not applicable
ap<0.05, bp<0.01
Table S7. Continued
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Table S8. Subject characteristics of observed and imputed data (N=923)
Observed data Imputed data
Maternal characteristics
Age, (y) 32.2 (23.4 – 39.4) 32.2 (23.4 – 39.4)
Height, (cm) 171 (6.3) 171 (6.3)
Pre-pregnancy weight, (kg ) 69.3 (13.0) 69.0 (13.0)
Pre-pregnancy body mass index, (kg/m2) 23.6 (4.2) 23.6 (4.2)
Parity ≥1,  (%) 37.7 (348) 37.7 (348)
 Missing 0.2 (2)
Educational level, (%)
 Primary/secondary 33.7 (311) 34.1(315)
 Secondary or higher 65.3 (603) 65.9 (608)
 Missing 1 (9)
Smoking during pregnancy, (%)
 Yes 19.4 (179) 21.5 (198)
 No 70.7 (653) 78.5 (745)
 Missing 9.9  (91)
Folic acid, (%)
 Yes 76.6 (707) 90.9 (839)
 No 6.5 (60) 9.1 (84)
 Missing 16.9 (156)
Pregnancy induced hypertension, (%) 
 Yes 4.9 (45) 5.6 (52)
 No 89.7 (828) 94.4 (871)
 Missing 5.4 (50)
Preeclampsia, (%)
 Yes 2.5 (23) 3.1 (29)
 No 89.7 (828) 96.9 (894)
 Missing 7.8 (72)
Fetal characteristics
General
Gestational age at measurement, (wk) 30.3 (28.5 – 32.7) 30.3 (28.5 – 32.7)
Estimated fetal weight, (g) 1634 (263) 1634 (263)
Blood flow distribution
Umbilical artery PI 0.97 (0.16) Not imputed
Middle cerebral artery PI 1.97 (0.33) Not imputed
U/C ratio, middle cerebral artery 0.50 (0.11) Not imputed
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Fetal kidney biometrics
Right kidney volume, (cm3) 10.64 (3.07) Not imputed
Left kidney volume, (cm3) 9.94 (2.76) Not imputed
Combined kidney volume, (cm3) 20.56 (5.48) Not imputed
Birth and infant characteristics
Gestational age at birth, (wk) 40.3 (36.4 – 42.4) 40.3 (36.4 – 42.4)
Birth weight, (g) 3534 (509) 3534 (509)
Sex boys, (%) 50.3 (464) 50.3 (464)
 Missing 0
Childhood characteristics
Age at follow up, (y) 5.9 (5.7 – 6.6) 5.9 (5.7 – 6.6)
Height, (cm) 119 (5.2) 119 (5.2)
Weight, (kg) 22.6 (3.2) 22.6 (3.2)
Body mass index, (kg/m2) 15.9 (1.4) 15.9 (1.4)
Body surface area, (m2) 0.86 (0.07) 0.86 (0.07)
Kidney volume left, (cm3) 61.4 (12.6) Not imputed
Kidney volume  right, (cm3) 59.5 (11.7) Not imputed
Kidney volume combined, (cm3) 120.9 (22.1) Not imputed
Creatinine, (µmol/l) 36.8 (4.9) Not imputed
Cystatin C,( µg/l) 790 (74) Not imputed
Estimated glomerular filtration rate ml/min per 1.73m² 120.2 (15.8) Not imputed
Estimated glomerular filtration rate/cm3 kidney volume 1.02 (0.19) Not imputed
Micro albuminuriaa, (%) 7.1 (62) Not imputed
Systolic blood pressure, (mmHg) 102.2 (7.7) Not imputed
Diastolic blood pressure, (mmHg) 60.1 (6.3) Not imputed
Values are means (SD), medians (95% range), or % (numbers) 
aDefined as levels between 2.5-25.0 mg/mmol (boys) and 3.5-25.0 mg/mmol (girls)
Missing values for continuous maternal characteristics are: age (N=0), height (N=0), 
pre-pregnancy weight (N=138), pre-pregnancy body mass index (N=138), for fetal 
characteristics: gestational age at measurement (N=0), estimated fetal weight (N=6), for 
infant characteristics: gestational age at birth (N=0), birth weight (N=0), for childhood 
characteristics: age (N=0), height (N=1), weight (N=1), body mass index (N=1), body 
surface area (N=1).
Table S8. Continued
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Figure S1. Scatterplots: gestational age, estimated fetal weight and fetal kidney 
outcomes (N=879)  
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Figure S2. Scatterplots: gestational age, estimated fetal weight and fetal kidney volume/
estimated fetal weight (N=870)
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Figure S3. Scatterplots: third trimester umbilical/cerebral resistance ratio, fetal kidney 
volume and childhood kidney volume (N=923)
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Figure S4. Scatterplots: third trimester umbilical/cerebral resistance ratio and childhood 
kidney outcomes (N=879) 
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Figure S5. Scatterplots: fetal kidney volume and kidney outcomes (N=870)
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Figure S6. Associations of gestational age adjusted birth weight with childhood 
estimated glomerular filtration rate (N=613)
Bars represent regression coefficients (95% Confidence interval (CI)) based on multiple 
regression models and reflect the associations of gestational age adjusted birth weight 
with kidney outcomes in tertiles of U/C ratio. Models are adjusted for maternal age, parity, 
educational level, pre-pregnancy body mass index, smoking status during pregnancy, folic 
acid use during pregnancy, maternal pregnancy complications (hypertension, preeclampsia), 
gestational age at third trimester measurement, third trimester estimated fetal weight, child 
sex, gestational age, current age and body surface are. P-value not significant for interaction 
of fetal blood flow and birth weight with all childhood kidney outcomes.
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Figure S7. Flow chart of participants included in the analysis  
Live births in full study
N = 9,749
N = 8,503 Excluded, no subgroup
Live births in subgroup
N = 1,246
Singleton live births in focus cohort
N = 1,216
N = 30 Excluded, due to twin births
Data on placental haemodynamics and fetal 
kidney dimensions
Data on 6 year visit
N= 925
Participation in 6 years visit: N = 923
Kidney dimensions: N = 923
Blood samples: N = 616
Urine samples: N = 884
N = 15 Excluded, due to missing placental 
haemodynamics or fetal kidney dimension 
measurements
N = 2 Excluded, due to missing measurements 
of kidney size or function (N = 1) or evidence of 
heart disease (N = 1)
N = 276 Excluded, due to withdrawal of 
consent (N = 35), loss to follow-up (N = 15), 
or not visiting the research center at age 6 years 
(N = 226)
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Chapter 2.2
Fetal first trimester growth 
is not associated with kidney 
outcomes in childhood
Adapted from Pediatr Nephrol. 2017;32(4):651-658
Hanneke Bakker 
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Abstract
Background Impaired fetal growth is associated with increased risks of kidney diseases 
in later life. Because of the high development rates, the first trimester might be a specific 
critical period for kidney outcomes. We examined the associations of fetal first trimester 
growth with kidney outcomes in childhood. 
Methods This study was embedded in a prospective population-based cohort study 
among 1,176  pregnant women and their children. We measured fetal first trimester 
crown to rump length as growth measure among mothers with a regular menstrual cycle 
and a known first day of the last menstrual period. At the age of 6 years (median 5.7-6.8), 
we measured combined kidney volume, microalbuminuria and estimated glomerular 
filtration rate based on serum creatinine and cystatin C concentrations.  
Results We did not observe consistent associations of fetal first trimester crown to 
rump length with childhood combined kidney volume, estimated glomerular filtration 
rate and microalbuminuria. As compared to children with a fetal first trimester crown to 
rump length in the highest quintile, those in the lowest quintile had a larger childhood 
combined kidney volume (difference 5.32 cm³, 95% confidence interval 1.06 to 9.57), but 
no differences in kidney function. 
Conclusion Our results do not support the hypothesis that fetal first trimester growth 
restriction affects kidney size and function in childhood. Further studies are needed to 
focus on critical periods in early life for kidney function and disease in later life.
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Introduction
Chronic kidney disease may originate in the earliest phase of life.(1) It has been 
hypothesized that adverse environmental exposures in utero may lead to kidney 
developmental adaptations, including lower nephron numbers leading to glomerular 
hyperfiltration.(2-4) These adaptations may subsequently lead to glomerulosclerosis, 
impaired kidney function and increased risks of chronic kidney disease in adulthood.(5,6) 
This hypothesis is supported by observational studies showing associations of preterm 
birth or small-size for gestational age at birth with smaller kidneys and increased risk 
of kidney disease later in life.(7-9) Previously, we have shown that decreased second 
and third trimester fetal growth and lower infant growth rates are associated with 
smaller kidneys in childhood. Also, decreased second and third trimester fetal weight 
growth was associated with lower kidney function in childhood.(8) Not much is known 
about the influence of first trimester fetal development on later life kidney outcomes. 
Nephrogenesis starts around the 8th week of gestation and ceases around 36 weeks 
of gestation.(10) Because of the relatively high developmental rates, first trimester 
might also be a critical period for kidney development. Fetal first trimester crown to 
rump measurement is often used for determination of gestational age in obstetric care 
practices which suggests there is no variation in early fetal growth.(11) However, we 
have previously shown that in women with a regular cycle and a known first day of 
their menstrual period, fetal first trimester crown to rump length can be used to assess 
differences in embryonic growth rate.(11,12) 
 We assessed, in a population-based prospective cohort study among 1,176 mothers 
and their children, the associations of fetal first trimester crown to rump length with 
kidney outcomes in childhood. Kidney outcomes included combined kidney volume, 
estimated glomerular filtration rate (eGFR) based on creatinine and cystatin C blood 
levels, and microalbuminuria. Since kidney function tracks from childhood into 
adulthood, subclinical variations at young age might already be associated with renal 
impairment in later life.(7,8) 
Methods
Design and study population
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from fetal life onwards in Rotterdam, the Netherlands.(13) Written informed 
consent was obtained from all parents. The study has been approved by the Medical 
Ethics Committee of the Erasmus University Medical Center, Rotterdam. As previously 
described, inclusion in the study was aimed at early pregnancy but enrollment was 
allowed until birth.(14) Of the total cohort of 9,901 mothers, 1,630 mothers had an 
available fetal first trimester crown to rump measurement within the range of 10 weeks 
0 days to 13 weeks 6 days and had a reliable gestational age based on the last menstrual 
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period and a regular menstrual cycle, and were therefore eligible for this study.(12) We 
included only mothers who gave birth to singleton live born child (N=1,619). In total, 
1,176 mothers and children were included in the detailed follow-up measurements 
at age of 6 years. Blood and urine samples for kidney function measurements were 
available in 793 (67%) and 1,141 (98%) children, respectively. Missing blood samples 
were mainly because of lack of consent. A flow chart is given in Figure 1. Differences in 
subject characteristics between children with and without blood samples are shown in 
Supplemental Table 1. There were no differences in fetal first trimester crown to rump 
length between children with and without blood sample measurements. 
Fetal first trimester crown to rump length
As previously described, fetal first trimester crown to rump length measurements were 
carried out in the gestational age range of 10 week 0 days to 13 weeks 6 days in a true 
mid-sagittal plane with genital tubercle and the fetal spine longitudinally in view.(12) 
Intraclass correlation coefficients were 0.995 and higher.(15) Information about the first 
day of the last menstrual cycle was obtained from the referring letter from the midwife 
or hospital and was confirmed at enrollment.(12) Mothers gave additional information 
on the regularity and duration of the menstrual cycle at the ultrasound visit. Gestational 
age adjusted standard deviation scores for first trimester crow to rump length were 
constructed, as described before.(12)
Childhood kidney outcomes
We measured left and right kidney biometrics at the median age of 6 years (90% range 
5.7-6.8). Measurements were conducted as described previously.(8,16) The child was 
awake and calm in a standardized prone position during the ultrasound measurements. 
Maximal bipolar kidney length, width and depth were measured. We measured kidney 
width and depth at the level of the hilum. The cross-sectional area in which the kidney 
appeared symmetrically round at its maximum width was used. We calculated the kidney 
volume as the equation of an ellipsoid: volume (cm3) = 0.523 x length (cm) x width (cm) 
x depth (cm).(17) Combined kidney volume was calculated by summing right and left 
kidney volume. We previously reported intra-observer and inter-observer correlation 
coefficients.(18)
 Blood samples were drawn by antecubital venipuncture. Serum creatinine levels 
were measured by an enzymatic method on a Cobas c 502 analyzer (Roche Diagnostics, 
Germany), and serum cystatin C levels were measured using a particle-enhanced 
immunoturbidimetric assay on Cobas c 702 analyzer. Intra- and interassay coefficients 
were used a described previously.(19) eGFR was calculated according to the revised 
Schwartz 2009 formula(20): eGFRcreat = 36.5 * (height (cm)/creatinine (µmol/l).(20) 
Additionally, eGFR based on cystatin C levels according to the Zappitelli’s formula(21): 
eGFRCyst = 75.94 / [CysC
1.17].(16)  Urine creatinine (mmol/l) and urine albumin (mg/l) levels 
were determined on Beckman Coulter AU analyser, creatinine levels were measured 
according to the Jaffe method. The albumin-creatinine ratio was calculated. We defined 
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microalbuminuria as an albumin-creatinine ratio between 2.5 and 25 mg/mmol for boys, 
and for girls we used a ratio between 3.5 and 25 mg/mmol.(22)
Covariates
We obtained information on maternal age, pre-pregnancy weight, parity, ethnicity, 
educational level, smoking during pregnancy, alcohol consumption during pregnancy, 
folic acid supplementation during pregnancy, and breastfeeding by questionnaires and 
registries. Maternal height was measured without shoes and pre-pregnancy body mass 
index (BMI) was calculated. Date of birth, infant sex and birth weight were obtained 
from midwife and hospital registries. At the age of 6 years, child height and weight were 
measured without shoes and heavy clothing, and body surface area (BSA) was calculated 
using the DuBois formula (BSA = weight (kg) 0.425 x height (cm) 0.725 x 0.007184).(23)
Statistical analyses 
First, we analysed the associations of fetal first trimester crown to rump length with 
childhood kidney outcomes (kidney volume, eGFR based on creatinine and cystatin C 
levels and microalbuminuria) by using multiple linear and logistic regression models. 
We used first trimester crown to rump length standard deviation scores as continuous 
variables and as quintiles to explore non-linear associations. We performed sensitivity 
analyses using tertiles of fetal first trimester growth. To explore the associations of lower 
and higher growth as compared to average growth, we compared the lowest and the 
highest tertile with the middle tertile. The fully adjusted model was adjusted for maternal 
age, educational level, ethnicity, parity, pre-pregnancy body mass index, smoking 
during pregnancy, alcohol consumption during pregnancy, folic acid supplement use, 
breastfeeding and current body surface area. To take into account body composition, 
analyses focussed on total kidney volume were indexed for body surface area. Analyses 
focused on eGFR were not adjusted for childhood body surface area (BSA) since height 
is included in the Schwartz 2009 formula. Potential confounders were based on their 
associations with kidney outcomes or a change in effect estimate of more than 10%. To 
reduce the possibility of potential bias due to missing data, we imputed missing data 
of the fetal, child and maternal covariates with five imputations and analysed these 
datasets together.(24) Additional information on the imputation procedure is given 
in the Supplementary material. All statistical analyses were performed using the 
Statistical Package for the Social Sciences version 21.0 for Windows (SPSS Inc, Chicago, 
IL, USA).
Results
Subject characteristics
Maternal, fetal and child characteristics are shown in Table 1. Mean fetal first trimester 
crown to rump length was 61.1 (SD 11.4) mm at a median gestational age of 12.4 (90% 
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range 11.0-13.7) weeks.  At the median age of 6.0 (90% range 5.7-6.8) years, mean 
combined kidney volume was 119.7 (SD 22.0) cm3, creatinine based eGFR was 119.4 (SD 
15.4) ml/min per 1.73m2 and cystatin C based eGFR was 102.8 (SD15.9) ml/min/1.73m2. 
Microalbuminuria was present in 7.0 % of all children. Correlations of total kidney 
volume and BSA-related kidney volume with estimated glomerular filtration rate based 
on creatinine and cystatin levels are given in Supplemental Tables 4 and 5. In total 
N=117 children were born with a small size for gestational age at birth (<10%) and N 54 
(4.6%) children were born preterm (<37 weeks). 
Fetal first trimester crown to rump length and kidney outcomes in childhood
Table 2 presents the analyses focused on the associations between fetal first trimester 
crown to rump length and kidney volume and function. Fetal first trimester crown 
to rump length SDS was not associated with kidney volume and eGFR. Also, there 
was no association of fetal first trimester crown to rump length SDS with the risk of 
microalbuminuria (all p-values > 0.05).
 To investigate non-linearity, we created quintiles of fetal first trimester growth. 
Table 2 shows that as compared to the highest quintile of fetal first trimester crown to 
rump length, the lowest quintile was associated with a larger childhood combined kidney 
volume  (difference 5.32cm³, 95% confidence interval 1.06 to 9.57), but not with eGFR 
and microalbuminuria. Sensitivity analyses using tertiles of fetal first trimester crown to 
rump length showed no associations with childhood kidney outcomes. Results of this 
sensitivity analyses are presented in Supplementary table 3. Observed data before 
multiple imputations are presented in Supplementary Table 2. The association of fetal 
first trimester crown to rump length with childhood kidney volume was not observed in 
non-imputed data. Also, analyses of non-imputed data showed no associations with other 
kidney outcomes in childhood. The lack of significant associations in non-imputed datasets 
may be due to smaller numbers. Analyses in imputed data were based on N=1,176, whereas 
analyses in the non-imputed data were based on N=934. 
Table 1. Maternal and child characteristics (N=1,176)
Values
Maternal characteristics
Age, median (90% range), (yr) 31.8 (22.8-38.1)
Height, mean (SD,) (cm) 168.8 (7.1)
Pre-pregnancy weight, mean (SD), (kg) 67.0 (11.8)
Pre-pregnancy body mass index, (kg/m2) 23.5 (3.9)
Parity, nulliparous, No. (%) 715 (60.8)
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Ethnicity,  No. (%)
  European 853 (72.5)
  Non -European 323 (27.5)
Educational level,  No. (%)
     No higher education 525 (44.6)
    Higher education 651 (55.4)
Smoking,  No. (%)
             Non-smoking 881 (74.9)
             Continued smoking 295 (25.1)
Folic acid supplement use,  No. (%)
 No use 156 (13.3)
 First 10 weeks use 376 (32.0)
 Preconception use 644 (54.8)
Fetal characteristics
Gestational age at fetal crown to rump length, median (90% range), weeks 12.4 (11.0-13.7)
First trimester fetal crown to rump length, mean (SD), (mm) 61.1 (11.4)
Birth and infant characteristics
Males, No. (%) 570 (48.5)
Gestational age, median, (90% range) weeks 40.1 (37.1-42.0)
Birth weight, (g) 3,459.2 (549.9)
Breastfeeding, (%)
 No 92 (7.8)
 Yes 1,084 (92.2)
Child characteristics
Age, (median 990% range), (yr) 6.0 (5.7-6.8)
Height, mean (SD), (cm) 119.0 (5.5)
Weight,  mean (SD), (kg) 22.9 (3.7)
Body mass index,  mean (SD), (kg/m2) 16.1 (1.7)
Kidney volume combined, (cm3) 119.7 (22.0)
eGFR, (Schwartz, creatinine based) (ml/min per 1.73m²) 119.4 (15.4)
eGFR, (Zappitelli, cystatin C based), (ml/min per 1.73m²) 102.8 (15.9)
Microalbuminuria, No.  (%) 82 (7)
Values are means (standard deviation), median (90% range) or number of subjects (valid %).
eGFR,  estimated glomerular filtration rate
Table 1. Continued
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Table 2. Fetal First Trimester Growth Quintiles and Childhood Kidney Volume and 
Function (N=1,176)1
CRL quintiles
in SDS
BSA-adjusted
Combined kidney 
volume (cm3)
GFRcreat
(ml/min per 1.73m²)
GFR cys C
(ml/min per 1.73m²)
Micro albuminuria
(mg/mmol) (OR)
1 N=238 5.32 (1.06, 9.57)* 0.24 (-3.33, 3.80) -0.67 (-4.47, 3.14) 0.60 (0.25, 1.44)
2 N=234 -0.88 (-5.14, 3.38) -0.34 (-3.93, 3.26) -2.69 (-6.53, 1.15) 0.92 (0.42, 2.02)
3 N=234 0.42 (-0.85, 4.68) -0.26 (-3.83, 3.31) 0.33 (-3.48, 4.14) 1.13 (0.52, 2.44)
4 N=237 0.54 (-3.75, 4.83)  1.04 (-2.54, 4.64) -1.11 (-4.96, 2.73) 1.41 (0.66, 2.96)
5 N=233 reference reference reference reference
p-value for trend 0.10 0.58 0.83 0.51
1Values are regression coefficients (95% confidence interval) that reflect the difference in 
childhood kidney outcomes between first-trimester crown to rump length fifths, highest 
fifth is reference group. Model is adjusted for duration of last menstrual cycle, and child 
sex and age at outcome measurements, maternal age, educational level, ethnicity, parity, 
pre-pregnancy body mass index, smoking during pregnancy, alcohol consumption 
during pregnancy and folic acid supplement use, breastfeeding and current childhood 
body surface area. 
* P value < 0.05
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Figure 1. Flow chart: inclusion of participants in analyses
N = 1,630
Children with accurate fetal rst trimester crown to 
rump
N = 11 Excluded, 
only included singleton live births
N = 1,619
Children participating postnatal
N = 1,178
Children with successful kidney size or function 
measurements
N = 441 Excluded,
no visit to the research center or no successful 
measurements of kidney size and function
N= 1,176
Childhood measurements
- Kidney volume N = 1,070
- Estimated glomerular ltration rate N = 793
- Microalbuminuria N= 1,141
N = 2 Excluded,
congenital kidney abnormalities
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Discussion 
In this population-based prospective cohort study, we evaluated the associations of 
fetal first trimester crown to rump length with kidney growth and function in childhood. 
We did not observe consistent associations of fetal first trimester growth with kidney 
outcomes in childhood. 
 Some methodological issues need to be addressed. We used a subgroup of a large 
population based prospective cohort study to examine the kidney consequences of 
fetal first trimester growth restriction. Only mothers with a first trimester crown to rump 
measurement and a reliable first day of their last period were eligible, which was only 
a small subgroup of the full study. We used the first day of the last menstrual period in 
women with a regular menstrual cycle to date gestational age. Since we could not measure 
timing of ovulation and implantation, misclassification of gestational age could have 
occurred.(25) Of the eligible subgroup, 67% of all children had blood sample collections. 
Our results would be biased if results would differ between children with and without 
follow up measurements at the age of 6 years. This seems unlikely, but we cannot exclude 
it. Children without blood samples had lower mean birth weight as compared to children 
with blood samples. Our results would be biased if the associations of first trimester 
growth with childhood kidney function differ between children with and without 
blood samples. Since smaller numbers of blood samples were available in children with 
lower birth weight, our observed effect estimates may be underestimated. Glomerular 
number cannot be evaluated in vivo but kidney size and glomerular number correlate 
in pathological studies in childhood and adulthood.(26-28) We estimated glomerular 
filtration rate based on the Schwartz formula (20) which is based on serum creatinine levels 
and based on the Zappitelli formula (21) which is based on serum cystatin C levels, both 
are validated in pediatric populations. Estimated glomerular filtration rate was higher 
when calculated based on creatinine concentrations than on cystatin C concentrations. 
This difference is in line with previous studies.(29) However, no difference in results were 
observed when we used eGFR based on creatinine concentrations compared to cystatin 
C concentrations. In the present study we did not find differences in outcomes between 
those formulas. It has been suggested that serum cystatin C levels might be superior in 
evaluating kidney function to serum creatinine levels.(30) However, to date it is not clear 
which formula provides the best estimation of the eGFR.(30) We used a random urine 
sample to determine the albumin to creatinine ratio to evaluate microalbuminuria. Since 
intra-individual variation in urinary albumin secretion might be large, the variability 
would probably have been lower if we collected first morning void samples.(31) Finally, 
although we adjusted for several potential confounders, residual confounding might still 
be a problem because of the observational design of the study.
 Growth and development rates are  higher in fetal life than in childhood. Human 
organogenesis has the highest development rates in the first trimester. The first trimester 
might be a critical period for developing risk factors for diseases in later life. Similar as in 
previous studies focused on fetal first trimester growth in relation to birth outcomes and 
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cardiovascular outcomes, we used quintiles for fetal first trimester growth.(12,14) No major 
differences in results were observed when we used tertiles of fetal first trimester growth 
instead of quintiles. Longitudinal studies, including studies from the same cohort as the 
present study, showed associations of impaired first trimester growth with increased 
risks of premature birth, low birth weight and being small for gestational age at 
birth.(12,32,33) Also, results from this cohort study have previously shown that fetal first 
trimester growth restriction was associated with cardiovascular risk factors in childhood.
(14) The analyses in this study were performed in a healthy population with the majority 
born at term and normal weight for gestational age. To the best of our knowledge, no 
other human studies evaluated the associations of first trimester growth with kidney 
function in later life. Nephrogenesis starts around week 5 of gestation, at approximately 
week 9 formation of the first nephrons begins.(34) Nephrogenesis continues during 
gestation and stops around week 34-36.(10) Against this background, we aimed to 
identify the role of first trimester fetal development for kidney development.
 Using data from the same cohort as the present study, we have previously reported 
that lower fetal growth from second trimester onwards was associated with lower 
combined kidney volume and eGFR in childhood.(8) Also, a previous study among 
children born preterm showed that size for gestational age was correlated with kidney 
volume at the ages of 0, 3 and 18 months which implies that impaired fetal growth  has 
consequences for kidney growth in infancy.(35) Some studies on fetal growth impairment 
showed slight catch up kidney growth postnatally in small for gestational age infants but 
results are inconclusive.(35,36) The current study extends these previous findings since 
it is focused on first trimester of pregnancy, a period of which little is known in relation 
to kidney outcomes. We did not observe consistent associations of fetal first trimester 
growth with kidney outcomes in childhood.
 Smaller kidneys with fewer nephrons will lead to compensatory glomerular 
hyperfiltration, which might be beneficial in the short term but can lead to 
glomerulosclerosis and impaired kidney function in later life.(1) Hyperfiltration might 
increase renal mass while glomerular number is relatively low.(37) However, it is not 
possible to distinguish hypertrophy or normal growth by ultrasound. Also, it is not known 
when hypertrophy exactly occurs and it is difficult to determine whether glomerular 
enlargement is caused by glomerular hyperfiltration.(38,39) In the present study, we 
observed an inverse association of fetal first trimester crown to rump length and kidney 
volume in childhood, we cannot fully explain this finding. This finding is in line with a 
previous study from the same cohort which showed that the lowest tertile of gestational 
age-adjusted abdominal circumference in third trimester was associated with a larger 
relative fetal kidney volume.(40) Renal hypertrophy might be an explanation for this 
inverse association. More studies are needed to replicate our findings and to identify the 
underlying mechanisms. 
 We performed multiple statistical tests. However, since the kidney outcomes are 
highly correlated, we did not adjust analyses for multiple testing. Therefore, the observed 
association of the lowest of first trimester crown to rump length with kidney volume 
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should be interpreted carefully and may be a chance finding. Decreased fetal growth 
might lead to impaired kidney function by other mechanisms than smaller kidneys. For 
example, multiple studies suggested that epigenetic changes in response to adverse 
fetal exposures lead to developmental adaptations.(6,41,42)
 In conclusion, we did not observe associations of fetal first trimester growth restriction 
with kidney size and function in childhood. These findings do not support the hypothesis 
that first trimester is a critical period for kidney function in later life, further studies on 
this hypothesis are needed. 
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Imputation procedure
To reduce the possibility of potential bias associated with missing data and to maintain 
statistical power, missing values were imputed using the multiple imputations procedure.
(1) For the multiple imputations, we used Fully Conditional Specification, an iterative 
of the Markov Chain Monte Carlo approach. For each variable, the fully conditional 
specification method fits a model using all other available variables in the model as 
predictors, and then imputes missing values for the specific variable being fit. In the 
imputation model for the analyses focused on the associations of early growth outcomes 
with kidney outcomes in childhood, we included all covariates except childhood body 
surface area plus maternal weight gain during pregnancy and height and weight of 
the child aged 6. Furthermore, we added the determinants and outcomes studied in 
the imputation model as prediction variables only. Determinants and outcomes were 
not imputed themselves. Five imputed datasets were created and analyzed together. 
For the conditional analyses only, we additionally imputed fetal and childhood growth 
characteristics using a similar imputation model.
1. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for 
missing data in epidemiological and clinical research: potential and pitfalls. BMJ (Clinical 
research ed. 2009;338:b2393.
Table S1. Maternal and child characteristics in subjects with and without blood samples 
(N=1,176)
Subjects with
 blood samples 
N=794
Subjects without 
blood samples
N=382
Maternal characteristics
Age, median (90% range), (yr) 31.8 (23.1-38.4) 31.6 (22.0-37.6)
Height, mean (SD,) (cm) 168.8 (7.1) 168.3 (6.8)
Pre-pregnancy weight, mean (SD), (kg) 66.9 (11.8) 67.2 (12.0)
Pre-pregnancy body mass index, (kg/m2) 23.4 (3.8) 23.7 (4.1)
Parity, nulliparous, No. (%) 467 (58.9) 247 (64.7)
Ethnicity,  No. (%)
  European 584 (73.6) 268 (70.2)
  Non -European 209 (26.4) 111 (29.3)
Educational level,  No. (%)
     No higher education 344 (43.4) 182 (47.6)
    Higher education 449 (56.6) 200 (52.4)
Smoking,  No. (%)
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             Non-smoking 590 (74.4) 292 (76.4)
             Continued smoking 206 (26.6) 90 (23.6)
Folic acid supplement use,  No. (%)
 No use 103 (13.0) 42 (13.5)
 First 10 weeks use 239 (30.1) 99 (31.8)
 Preconception use 451 (56.9) 170 (54.70
Fetal characteristics
Gestational age at fetal crown to rump length, median  
(90% range), weeks
12.4 (10.6-13.9) 12.4 (10.9-13.6)
First trimester fetal crown to rump length, mean (SD), (mm) 61.3 (11.4) 60.7 (11.7)
Birth and infant characteristics
Males, No. (%) 392 (49.4) 178 (46.6)
Gestational age, median, (90% range) weeks 40.1 (37.1-42.0) 40.2 (37.0-42.1)
Birth weight, (g) 3,490.6 (536.8) 3,394.8 (572.0)**
Ever breastfeeding, (%)
 No 61 (7.7) 27 (7.1)
 Yes 732 (92.3) 355 (92.9)
Child characteristics
Age, (median 90% range), (yr) 6.0 (5.7-7.0) 6.0 (5.7-6.5)**
Height, mean (SD), (cm) 119.2 (5.5) 1.19 (5.6)
Weight,  mean (SD),  (kg) 22.9 (3.6) 22.7 (3.8)
Body mass index, mean (SD), (kg/m2) 16.0 (1.3) 16.1 (1.8)
Kidney volume combined, (cm3) 120.1 (22.3) N.A.
eGFR, (Schwartz, creatinine based) (ml/min per 1.73m²) 119.4 (15.4) N.A.
eGFR, (Zapitelli, cystatin C based), (ml/min per 1.73m²) 102.8 (15.9) N.A.
Microalbuminuria, No.  (%) 52 (6.7) 30 (8.2)
Values are means (standard deviation), median (90% range) or number of subjects (valid %).
T-tests were used for continuous variables, chi-square tests for categorical variables 
eGFR,  estimated glomerular filtration rate, N.A. not applicable
* p-value < 0.05, ** p-value < 0.01 
Table S1. Continued
| Chapter 2.2
| 108
Table S2. Fetal First Trimester Growth Quintiles and Childhood Kidney Volume and 
Function (N=934)1 non-imputed analyses
CRL quintiles
in SDS
Combined kidney 
volume  (cm3)
GFRcreat
(ml/min per 1.73m²)
GFR cys C
(ml/min per 1.73m²)
Micro albuminuria
(mg/mmol) (OR)
1 3.28 (-0.91, 7.47) -0.32 (-4.63, 4.00) 0.08 (-4.89, 5.04) 0.53 (0.18, 1.54)
2 -3.52 (-7.70, 0.66) -2.06 (-6.36, 2.25) -3.43 (-8.39, 1.52) 0.94 (0.38, 2.34)
3 0.51 (-3.73, 4.76) -0.80 (-5.08, 3.49) 0.85 (-4.07, 5.77) 0.99 (0.39, 2.52)
4 1.80 (-2.47, 6.06)  0.12 (-4.33, 4.57) -0.84 (-5.97, 4.28) 1.12 (0.44, 2.85)
5 reference reference reference reference
p-value  for trend 0.69 0.38 0.79 0.45
1Values are regression coefficients (95% confidence interval) that reflect the difference in 
childhood kidney outcomes between first-trimester crown to rump length fifths, highest 
fifth is reference group. Model is adjusted for duration of last menstrual cycle, and child 
sex and age at outcome measurements, maternal age, educational level, ethnicity, parity, 
pre-pregnancy body mass index, smoking during pregnancy, alcohol consumption 
during pregnancy and folic acid supplement use, breastfeeding and current childhood 
body surface area.
Table S3. Fetal First Trimester Growth Tertiles and Childhood Kidney Volume and 
Function (N=1,176)1 non-imputed analyses
CRL quintiles
in SDS
Combined kidney 
volume (cm3)
GFRcreat
(ml/min per 1.73m²)
GFR cys C
(ml/min per 1.73m²)
Micro albuminuria
(mg/mmol) (OR)
1 2.28 (-0.55, 5.10) -0.45 (-3.20, 2.30) -1.58 (-4.52, 1.36) 0.80 (0.43, 1.48)
2 Reference Reference Reference reference
3 0.02 (-2.85, 2.89) 0.24 (-2.51, 2.99) 0.03 (-2.91, 2.98) 1.15 (0.64, 2.07)
p-value  for trend 0.11 0.58 0.83 0.51
1Values are regression coefficients (95% confidence interval) that reflect the difference in 
childhood kidney outcomes between first-trimester crown to rump length fifths, highest 
fifth is reference group. Model is adjusted for duration of last menstrual cycle, and child 
sex and age at outcome measurements, maternal age, educational level, ethnicity, parity, 
pre-pregnancy body mass index, smoking during pregnancy, alcohol consumption 
during pregnancy and folic acid supplement use, breastfeeding and current childhood 
body surface area.
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Table S4. Correlations between kidney volume and kidney function
Combined kidney volume
(cm3)
eGFRcreat 
(ml/min per 1.73m²)
eGFRcys C 
(ml/min per 1.73m²)
Combined kidney volume (cm3) 1 - -
eGFRcreat (ml/min per 1.73m²) 0.23** 1 -
eGFRcys C (ml/min per 1.73m²) 0.10** 0.29** 1
Table S5. Correlations between body surface area-related kidney volume and kidney 
function
BSA-related kidney 
volume (cm3)
eGFRcreat 
(ml/min per 1.73m²)
eGFRcys C 
(ml/min per 1.73m²)
BSA-related kidney volume (cm3) 1 - -
eGFRcreat (ml/min per 1.73m²) 0.28** 1 -
eGFRcys C (ml/min per 1.73m²) 0.13** 0.29** 1
Figure S1. Normal distribution of of BSA-related renal volume
BSARV in cm3/m2
| 110
| 111
Chapter 2.3
Fetal and infant growth 
patterns and kidney function 
at school-age
Adapted from J Am Soc Nephrol. 2014;25(11):2607-15
Hanneke Bakker
Romy Gaillard 
Oscar H. Franco  
Albert Hofman 
Albert J. van der Heijden
Eric A.P. Steegers 
H. Rob Taal 
Vincent W.V. Jaddoe
 
| Chapter 2.3
| 112
Abstract 
Background Low birth weight is associated with end-stage kidney disease. To identify 
specific growth patterns in early life, we examined the associations of longitudinally 
measured fetal and infant growth with kidney function in school-age children.
Methods This study was embedded in a population-based prospective cohort study 
among 6,482 children followed from fetal life onwards. Fetal and childhood growth was 
measured during second and third trimester of pregnancy, at birth, and at 6, 12, 24, 
36 and 48 months postnatally. At the age of 6 years, we measured kidney volume by 
ultrasound.  The glomerular filtration rate was estimated using blood creatinine levels.  
Results Higher gestational age adjusted birth weight was associated with higher 
combined kidney volume and higher estimated  glomerular filtration rate (per 1 Standard 
deviation score (SDS) increase in birth weight 1.27 cm3 (95 % Confidence Interval (CI) 0.61 
to 1.93), and 0.78 ml/min per 1.73m² (95 % CI 0.16 to 1.39), respectively). Fetal weight, 
birth weight and weight at 6 months were positively associated with childhood kidney 
volume, whereas higher second trimester fetal weight was  positively associated with 
higher glomerular filtration rate (all p-values < 0.05). Fetal and childhood length were 
not consistently associated with kidney function. 
Conclusion Lower fetal and early infant  weight growth is associated with smaller 
kidney volume in childhood, whereas only lower fetal weight growth is associated with 
lower kidney function in childhood, independent of childhood growth. Whether these 
associations lead to an increased risk of kidney disease needs to be further studied. 
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Introduction
Low birth weight is associated with higher risks of end-stage renal disease and hypertension 
in later life.(1-3) Clearly, low birth weight is not the causal factor per se leading to kidney 
diseases in later life. Birth weight is the result of various exposures and growth patterns in 
fetal life and the starting point of childhood growth. It has been hypothesized that especially 
third trimester fetal growth restriction lead to persistently smaller kidneys with a reduced 
number of nephrons, which may predispose the individual to kidney disease in adulthood.
(4-6) This hypothesis is supported by both animal and human studies showing that kidney 
volume and nephron number are reduced in fetal growth restricted subjects and hypertensive 
subjects.(7-9) Although nephrogenesis is known to continue until 36 weeks of gestation, and 
to cease thereafter, not much is known about the specific critical periods and early growth 
patterns related to kidney function in later life.(10) Also, whether and to what extend the 
associations of low birth weight with chronic kidney disease are explained by preterm birth 
is not known.(1) Longitudinal studies suggested that the associations of low birth weight 
with hypertension were stronger in subjects with rapid weight gain in childhood, but results 
are inconclusive.(11,12) A similar growth pattern has not been identified as risk factor for 
kidney diseases yet. Prospective studies linking fetal and early childhood growth patterns to 
kidney outcomes in later life might help to identify critical periods in later life. 
 Prospective studies linking fetal and early childhood growth patterns to kidney outcomes 
in later life might help to identify early critical periods for developing impaired kidney 
function in later life. 
 Therefore, we examined, in a population-based prospective cohort study among 6,482 
children followed from early fetal life onwards, the associations of birth weight, gestational 
age and birth weight for gestational age, and longitudinally measured fetal and early 
childhood growth patterns with kidney size and function at school-age. We used subclinical 
variation of kidney function in childhood as outcome, since they relate to kidney disease in 
later life.(13)
Methods
Design and study population
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from fetal life onwards in Rotterdam, the Netherlands.(14) All children were 
born between April 2002 and January 2006. Written informed consent was obtained 
from all parents. The study has been approved by the Medical Ethics Committee of the 
Erasmus Medical Center, Rotterdam. In total 8,305 children participated in the follow-up 
measurements at the age of 6 years, of whom 6,494 (78%) visited the research center with 
successful measurements of kidney size. We excluded children with kidney abnormalities 
(N=12). Blood samples for kidney function measurements were successfully obtained in 
4,336 (67%) children (Figure 1). Missing blood samples were mainly due to non-consent.
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Fetal and childhood growth measurements
Gestational age was established by first trimester ultrasound measurements.(15) 
Second and trimester fetal growth examinations were performed at median (90% range) 
gestational ages of 20.6 (18.9 – 22.9) weeks, and 30.4 (29.0 – 33.1) weeks, respectively. 
Fetal head circumference, abdominal circumference, and femur length were measured 
and estimated fetal weight was calculated using the formula by Hadlock et al (log10 
EFW=1.5662-0.0108 (HC) +0.0468 (AC) +0.171 (FL) +0.00034 (HC) 2-0.003685 (AC x FL)).
(16) At birth, gestational age, length and weight were obtained from community midwife 
and hospital registries. Small and large size for gestational age was defined as the lower 
and the upper 5% of birth weight standard deviation score (SDS).
 We measured childhood length and weight using standardized methods at the 
median (90% range) ages of 6.2 (5.4 to 7.5) months, 11.1 (10.2 to 12.3) months, 24.8 
(23.5 to 27.6) months, 36.7 (35.6 to 39.7) months, 45.8 (44.8 to 48.0) months and 72.6 
(68 to 95.5) months. All growth characteristics were converted into SDS using fetal,(15) 
birth weight(17) and childhood(18) reference growth charts (Growth Analyzer 3.5, Dutch 
Growth Research Foundation, Rotterdam, the Netherlands).
Childhood kidney outcomes 
Left and right kidney biometrics were measured at the median age of 6.0 (90% range 
5.7 – 7.5) years. We identified the left and right kidney in the sagittal plane along its 
longitudinal axis. We performed measurements of maximal bipolar kidney length, width 
and depth. Kidney width and depth were measured at the level of the hilum. The cross-
sectional area in which the kidney appeared symmetrically round at its maximum width 
was used. The cross-sectional area in which the kidney appeared symmetrically round at 
its maximum width was used. Kidney volume was calculated using the equation of an 
ellipsoid: volume (cm3) = 0.523 x length (mm) x width (mm) x depth (mm).(19) Combined 
kidney volume was calculated by summing right and left kidney volume. We previously 
reported good intra-observer and inter-observer correlation coefficients.(20) 
 Blood creatinine levels were measured with an enzymatic method on a Cobas c 502 
analyzer (Roche Diagnostics, Germany). Quality control samples demonstrated intra- and 
inter-assay coefficients of variation ranging from 0.51% to 1.37% . Estimated glomerular 
filtration rate (eGFR) was calculated according to the revised Schwartz 2009 formula21; 
eGFR = 36.5 * (height (cm)/creatinine (µmol/l).(21) Urine creatinine (mmol/l) and urine 
albumin (mg/l) levels were determined on Beckman Coulter AU analyser, creatinine levels 
were measured according to the Jaffe method. We calculated the albumin-creatinine 
ratio. For boys microalbuminuria was defined as an albumin-creatinine ratio between 2.5 
and 25 mg/mmol, for girls we used a ratio between 3.5 and 25 mg/mmol.(22) 
Covariates
Information on maternal age, pre-pregnancy weight, parity, ethnicity, educational 
level, smoking during pregnancy, folic acid supplementation during pregnancy, and 
breastfeeding was obtained by questionnaires.(14) Maternal height was measured 
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without shoes and pre-pregnancy body mass index (BMI) was calculated (kg/m2). Infant 
sex was obtained from midwife and hospital registries. At the age of 6 years, child height 
and weight were measured without shoes and heavy clothing, and body surface area 
was calculated. 
Statistical analyses
First, we explored differences in characteristics between boys and girls by t-tests 
for continuous variables and chi-square tests for categorical variables. Second, we 
performed multiple linear or logistic regression models to explore the associations of 
birth outcomes (gestational age at birth; birth weight; gestational age adjusted birth 
weight) with childhood combined kidney volume, estimated glomerular filtration 
rate and microalbuminuria. These models were adjusted for sex and age only, and 
additionally for potential confounders. Potential confounders were based on their 
associations with kidney outcomes or a change in effect estimate of more than 10%. 
The associations with kidney function outcomes were additionally adjusted for kidney 
volume to explore whether any association was explained by kidney growth. We 
performed a sensitivity analysis using the lower and upper 10% as definition for small 
and large size for gestational age at children. Third, we assessed the associations of 
fetal (second and third trimester, birth) and childhood (6, 12, 24, 36, 48 and 72 months) 
weight and length measures with kidney outcomes at the age of 6 years using multiple 
linear regression models. Since fetal and childhood growth measurements at different 
ages are strongly correlated, we additionally performed conditional regression analyses 
to explore the independent associations of fetal and early childhood growth with kidney 
outcomes, taking account for their correlation.(23) For these analyses, we constructed 
length and weight variables for each timepoint, which are statistically independent 
from each other, by using standardized residuals obtained from regression of growth 
measures at a specific time point on prior growth measures.(23) As conditional growth 
measures are statistically independent of each other, this approach allows inclusion of 
growth measures simultaneously in one linear regression model. Thus, the associations 
of fetal and childhood growth measures at specific ages with kidney outcomes can be 
assessed adjusted for, and compared, with fetal and childhood growth measures at other 
ages.(24,25) Results from these datasets were pooled and presented in the conditional 
growth results. All statistical analyses were performed using the Statistical Package for 
the Social Sciences version 20.0 for Windows (SPSS Inc, Chicago, IL, USA).
Results
Subject characteristics
Maternal and child characteristics are shown in Table 1. At the age of 6.0 years 
(90 % range 5.7 to 7.4 years), mean (SD) total kidney volume was 120.3 (23.5) cm3 and 
estimated glomerular filtration rate was 118.8 (16.4) ml/min per 1.73m², respectively. 
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Microalbuminuria was present in 7.6 % of all children. In Table 2 all fetal, birth and childhood 
growth characteristics are presented. Observed data before multiple imputation are 
presented in Supplementary Table S1. Differences in subject characteristics between 
children with and without blood samples are shown in Supplementary Table S2. 
Birth outcomes and childhood kidney outcomes 
Figure 2  shows that 1 SD longer duration of gestational age at birth was associated with 
a larger combined kidney volume in childhood (p-value for trend < 0.05). As compared 
to term born children (38.0-39,9 weeks), children born very preterm ( < 34 weeks) had a 
smaller kidney volume (difference: -10.48 cm3, 95 % CI -17.74 to -3.22). Post term birth 
( > 42 weeks) was associated with higher estimated glomerular filtration rate in childhood 
(difference: 3.80 ml/min per 1.73m², 95 % 1.39 to 6.21). Gestational age at birth was 
not associated with the risk of childhood microalbuminuria. Birth weight not adjusted 
for gestational age was positively associated with combined kidney volume and  with 
estimated glomerular filtration rate (p values for trend < 0.01) in childhood. Gestational 
age adjusted birth weight was positively associated with childhood combined kidney 
volume and estimated glomerular filtration rate (p values for trend < 0.05).  As compared 
to children appropriate for gestational age, children born small for gestational age had 
smaller kidney volume (-3.74 cm3 (95 % CI -6.89 to -0.89)). We performed a sensitivity 
analysis using the lower and upper 10% as definition for small and large size for gestational 
age at children. These analyses showed the same results as compared to 5% cut off 
(Figure S1). Birth weight was not associated with risk of microalbuminuria. Results from 
models adjusted for sex and age only were similar with some stronger effect estimates 
(Supplementary Table S3). Results from analyses on the data before imputation are 
shown in Supplementary Table S4.  After additional adjustment for childhood kidney 
volume, the associations of birth outcomes with kidney function attenuated towards 
non-significant (results presented in Supplementary Table S5).
Fetal and early childhood growth and kidney outcomes
We explored whether the associations of fetal and early childhood growth characteristics 
with childhood kidney function outcomes were independent from growth measures 
at other ages using conditional growth analyses. Figure 3 shows that higher second 
and third trimester fetal weight, birth weight and weight at the age of 6 months were 
all, independently associated with a larger combined kidney volume in childhood (all 
p values < 0.05). Also, higher second trimester and third trimester fetal weight tended to 
be independently from weight at other ages, associated with higher estimated glomerular 
filtration rate (p value < 0.05 and 0.05 respectively). When we additionally adjusted the 
models focused on estimated glomerular filtration rate for childhood kidney volume, we 
observed that these associations attenuated towards non-significant (Results shown in 
Supplementary Figure S3). Conditional analyses for fetal and childhood length growth 
did not show consistent associations with childhood kidney volume and function 
outcomes (Results shown in Supplementary Figure S2).
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Results from the normal multivariate regression models, which do not take into account 
growth measures at other ages, showed that larger length at different ages is associated 
with higher estimated glomerular filtration rate and an increased risk of microalbuminuria 
(all p values < 0.05). Higher weight at different ages is associated with larger kidney 
volume and higher estimated glomerular filtration rate (all p values < 0.05), but with 
the risk of microalbuminuria (basic and adjusted models are shown in Supplementary 
Tables S6 and S7). 
Table 1.
Boys N=3,257 Girls N=3,235 P value
Maternal characteristics
 Age, (yr) 31.1 (21.2 to 38.8) 31.0 (21.2 to 38.5) 0.284
 Height, (cm) 167.6 (7.2) 167.5 (7.6) 0.129
 Pre-pregnancy body mass index, (kg/m2) 23.6 (4.2) 23.8 (4.3) 0.075
 Parity ≥1, (%) 44.6 (1452) 43.1 (1390) 0.304
 Ethnicity, (%) 0.104
  European 61.2 (3964) 62.1 (2001
  Non -European 38.8 (2518) 37.9 (1224)
 Educational level, (%) 0.188
     No higher education 53.9 (1756) 55.4 (1788)
    Higher education 46.1 (1501) 44.6 (1437)
 Smoking, (%) 0.222
             Non-smoking 73.5 (2066) 75.9 (2133)
             Continued smoking 26.5 (745) 24.1 (678)
Folic acid supplement use, (%) 0.086
 No 25.7 (570) 24.5 (552)
 Preconceptional 42.0 (929) 44.5  (1001)
 Postconceptional 32.3 (715) 30.9 (696)
Infant characteristics
 Gestational age, (week) 40.1 (37.0 to 42.1) 40.1 (36.9 to 42.0) 0.069
 Birth weight, (g) 3488 (569) 3362 (534) <0.001
 Breastfeeding, (%) 0.805
 No 7.5 (188) 7.8 (252)
 Yes 92.5 (2325) 92.2 (2973)
Child characteristics
 Age, (years) 6.0 (5.7 to 7.5) 6.02 (5.7 to 7.2) 0.013
 Height, (cm) 119.9 (6.1) 119.0 (6.0) <0.001
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 Weight, kg 23.4 (4.1) 23.2 (4.5) 0.011
 Body mass index, (kg/m2) 16.2 (1.8) 16.3 (2.0) 0.381
 Kidney volume combined, (cm3) 122.3 (24.2) 118.3 (22.6) <0.001
 eGFR, ml/min per 1.73m² 118.7 (16.2) 118.9 (16.7) 0.611
 Microalbuminuria (%) 6.8 (217) 8.3 (256) 0.204
Values are means (standard deviation), median (90% range) or percentage (number).
T-tests were used for continuous variables, chi-square tests for categorical variables. 
eGFR,  estimated glomerular filtration rate
Table 2. Fetal and early childhood growth characteristics (N=6,482)
Growth characteristics Boys N=3,257 Girls N=3,235 P value
Fetal growth
Second trimester 
Gestational age (weeks) 20.6 (18.9 to 22.9) 20.5 (18.9 to 22.7) < 0.001
Femur length (mm) 33.5 (3.6) 33.5 (3.6) 0.824
Estimated fetal weight (g) 387 (98) 378 (91) 0.000
Third trimester
Gestational age (weeks) 30.4 (29.0 to 32.4) 30.3 (28.8 to 32.3) 0.001
Femur length (mm) 57.4 (3.1) 57.6 (3.1) 0.002
Estimated fetal weight (g) 1633 (260) 1618 (268) 0.033
Birth
Gestational age (weeks) 40.1 (37.0 to 42.1) 40.1 (36.9 to 42.0) 0.075
Length (cm) 50.6 (2.4) 49.9 (2.3) <0.001
Weight (g) 3488 (569) 3362 (534) <0.001
Early childhood growth
6 months
Age (months) 6.2 (5.4 to 7.5) 6.2 (5.5 to 7.5) 0.650
Length (cm) 68.5 (2.5) 66.7 (2.4) <0.001
Weight (g) 8176 (903) 7590 (832) <0.001
12 months
Age (months) 11.1 (10.2 to 12.3) 11.1 (10.2 to 12.3) 0.621
Length (cm) 75.1 (2.5) 73.5 (2.5) <0.001
Weight (g) 9970 (1061) 9326 (991) <0.001
24 months
Age (months) 24.8 (23.5 to 27.6) 24.8 (23.6 to 27.4) 0.347
Length (cm) 88.9 (3.3) 87.7 (3.4) <0.001
Table 1. Continued
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Weight (kg) 13.2 (1.5) 12.7 (1.5) <0.001
36 months
Age (months) 36.7 (35.6 to 39.8) 36.7 (35.5 to 39.6) 0.174
Length (cm) 97.9 (3.8) 96.8 (3.8) <0.001
Weight (kg) 15.4 (1.8) 15.0 (1.9) <0.001
48 months
Age (months) 45.8 (44.8 to 48.0) 45.8 (44.7 to 47.9) 0.334
Length (cm) 103.7 (4.1) 102.8 (4.2) <0.001
Weight (kg) 17.1 (2.2) 16.7 (2.3) <0.001
72 months
Age (months) 72.6 (44.7 to 48.0) 72.6 (69.0 to 87.3) 0.013
Length (cm) 119.9 (6.1) 119.0 (6.0) <0.001
Weight (kg) 23.4 (4.1) 23.1 (4.5) 0.011
Values are means (standard deviation), median (90% range) or percentage (number).
T-tests were used for comparison between boys and girls.
Table 2. Continued
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Figure 1. Flow chart: inclusion of participants in analyses
N = 8,305
Children participating at age 6 years
N = 208 Excluded, 
Only included singleton live births
N = 8,097
Children participating at age 6 years
N = 6,494
Children with successful kidney size or function 
measurements
N = 1,868 Excluded,
No visit to the research center or no successful 
measurements of kidney size and function
N= 6,482
Childhood measurements
- Kidney volume N = 5,965
- Creatinine N = 4,336
- Microalbuminuria N= 6,263
N = 12 Excluded,
Congenital kidney abnormalities
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Figure 2. Birth outcomes are associated with kidney outcomes (N=6,482)
Bars represent regression coefficients (95% CI) based on multiple regression models and 
reflect the difference for each outcome for the birth weight or gestational age group, 
as compared to the reference group. Models are adjusted for maternal age, body mass 
index, parity, ethnicity, educational level, folic acid supplementation and smoking 
during pregnancy, and child sex, breastfeeding, current age and body surface area. 
eGFR,  estimated glomerular filtration rate. β for trend (95% confidence interval) Results 
from models adjusted for sex and age only are given in Table S3. Results for models 
additionally adjusted for kidney volume are given in Table S5.
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Figure 2. Continued
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Figure 3. Fetal and childhood weight are associated with kidney outcomes at the age of 
6 years (N=6,482) 
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Effect estimates ((95% Confidence Interval) represent regression coefficients based on 
multiple regression models and reflect the difference per 1 SD increase in standardized 
residual score for (estimated) weight measures at different time points (see details 
for conditional regression models in Supplementary material). Models are adjusted 
for maternal age, body mass index, parity, ethnicity, educational level, folic acid 
supplementation and smoking during pregnancy, and child sex, breastfeeding, current 
age and body surface area. eGFR, estimated glomerular filtration rate. Results for models 
additionally adjusted for kidney volume are given Figure S3.
Discussion
In this population-based prospective cohort study, we aimed to identify critical periods 
during fetal life and childhood for development of impaired kidney function. We 
observed that preterm birth was associated with smaller kidney volume, and smaller size 
for gestational at birth was associated with a smaller kidney volume and lower estimated 
glomerular filtration rate. Higher fetal weight, birth weight and weight at 6 months were 
independently positively associated with childhood kidney volume, whereas only higher 
fetal weight was independently positively associated with higher estimated glomerular 
filtration rate. Fetal life and early infancy may be critical periods for kidney function in 
later life.
Strengths and limitations 
A major strength of our study is its prospective design from fetal life onwards within a 
large population-based cohort. Our analyses were based on more than 6,000 children with 
kidney volume and function measurements available. The study population comprised 
a multi-ethnic group, comprising almost 40% of non-Western children. The largest non-
Western groups were Moroccan, Surinamese, and Turkish children, which are the largest 
ethnic minority groups in the Netherlands.(14) Whether these results are generalizable 
to other populations should be further studied. Repeated fetal and childhood growth 
measures were available, which enabled us to identify critical growth periods that might 
influence kidney volume and function. We did take account for the repeated growth 
measures by performing conditional growth analyses. Of all children, more than 80% did 
participate in the kidney follow up studies. Since not all participants in the study gave 
consent for collecting blood samples, 67% of all children provided useful blood samples 
for measurements of creatinine levels. There were no differences in birth outcomes, 
fetal and early childhood growth measures between children with and without blood 
samples. However, children without blood samples had smaller kidney dimensions at the 
age of six years. These differences might have led to an underestimation of the observed 
associations. Furthermore, statistical power might have been reduced due to the missing 
data. We used kidney size as a measure of kidney development, since nephron number 
cannot be studied in vivo. Kidney size is correlated with the number of glomeruli and 
can be used in epidemiological studies as measure of kidney development.(4) However, 
glomerular enlargement due to hyperfiltration may attenuate the differences in 
| Fetal and infant growth patterns and kidney function at school-age
| 125
childhood kidney volume and may lead to an underestimation of the associations of 
interest.(26) In the present study, estimated glomerular filtration rate was based on one 
random creatinine value. This is a limitation to the study. However, measurement error 
due to only one creatinine value is likely to be random and might have underestimated 
the observed differences. Mean values for estimated glomerular filtration rate and 
overall prevalence of microalbuminuria are in line with results of previous population 
based-studies in children of the same age range.(27,28) We used the urine albumin-
creatinine ratio to evaluate albuminuria in a random urine sample.(29) Since the within 
subject variation in urinary albumin excretion is large, the variability would probably be 
lower if we collected first morning void samples instead of random during the day.(30) 
Finally, although we had information about a large number of confounders, residual 
confounding might still be an issue due to the observational design of the study.
Fetal and early childhood growth and childhood kidney 
To the best of our knowledge, the current study is the largest population-based 
prospective cohort study from fetal life onwards focused on the associations of early 
growth with kidney function at school-age. Several studies showed associations of 
low birth weight with renal disease and hypertension in later life.(1-3) Results from a 
systematic review based on 31 studies among 49,387 subjects showed that low birth 
weight is associated with a 1,73 higher risk of kidney disease.(1) Studies focused on the 
associations of birth weight with predictors of renal disease at younger ages are scarce. A 
Norwegian study among 7,457 subjects showed that young adults born with a small size 
for gestational age had an increased risk of low-normal creatinine clearance compared 
with children with appropriate birth weight for gestational age.(31) In contrast, a Dutch 
study among 82 severely growth restricted children, did not show associations of birth 
weight with renal function in young adulthood.(8) A study among 86 children aged 9 to 
12-year-old found no differences in kidney volume or function between preterm born 
term children, children born small for gestational age and children born appropriate 
for gestational age.(32) A study among 73 9.5 year-old children reported a positive 
association of birth weight with estimated glomerular filtration rate.(33) An observational 
cohort study among 426 children with congenital kidney disease showed that low birth 
weight and being small for gestational age are risk factors for poor growth outcomes 
in children with mild and moderate chronic kidney disease.(34) We observed that that 
younger gestational age and lower gestational age adjusted birth weight are associated 
with both a lower kidney volume and a lower estimated glomerular filtration rate in 
school-age children. These findings are in line with previous studies showing that low 
birth weight for gestational age are associated with kidney function in childhood.(13) 
We are not aware of other large population-based studies focused on the associations 
of birth weight, taking into account gestational age, with kidney function at young age.
 Since birth weight is the result of various exposures and growth patterns in fetal 
life and the starting point of childhood growth, longitudinal fetal and early childhood 
growth patterns might be stronger associated with increased risk of renal disease in 
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later life.(13) Longitudinal studies linking fetal and early childhood growth patterns to 
kidney outcomes in later life might help to identify critical periods in later life. A study 
among 50 children aged 7.6 years, showed that children with low birth weight and slow 
growth rates had slightly lower glomerular filtration rate as compared to children with 
appropriate growth.(35) It has been postulated that rapid weight gain and obesity in 
childhood are associated with an increased risk of hypertension and type 2 diabetes 
in adulthood, which are risk factors for kidney disease.(11,12) In a retrospective cohort 
study among 80 children with proteinuric kidney disease, obese children who were 
born preterm had an increased risk of progression of kidney disease as compared to 
obese who were born at term, suggesting an additive risk of obesity and prematurity in 
the risks for progression of kidney disease.(36)  Experimental studies have shown that 
adequate feeding of low birth weight rats could restore nephron numbers to normal and 
overfeeding of these rats led to low nephron numbers, hypertension and renal injury. 
Overfeeding of normal birth weight rats had also adverse effects.(37-39) In line with 
these findings we observed that lower fetal weight gain and lower early infancy weight 
gain lead to an impaired kidney growth, whereas only lower fetal weight gain leads to 
impaired kidney function. The results from our present study suggest that both fetal 
life and early infancy may be critical periods for the development of kidney diseases in 
later life. To our knowledge, this is the first population-based study, which shows that 
fetal and early growth are associated with kidney function in childhood. The present 
study was focused on the associations of fetal and childhood growth in relation to 
kidney outcomes. Previous studies, including those from the same cohort as the present 
study, suggested that children with fetal growth restriction, followed by infant growth 
acceleration have higher blood pressure.(40,41) Both fetal growth in later pregnancy and 
growth in early infancy seem to be critical periods for childhood blood pressure.  
 The underlying mechanisms for the associations between early growth and kidney 
function are not known. An adverse fetal growth may lead to a persistently reduced 
congenital nephron number and smaller kidney volume, with glomerular hyperfiltration 
and subsequent glomerulosclerosis. These adaptations may predispose individuals to 
impaired renal function and hypertension.(4,5) Specifically third trimester growth is 
important in kidney development, since approximately 60 % of the total nephron number 
develops during the third trimester of gestation.(42) In line with this hypothesis, we 
observed that fetal growth was positively associated with kidney growth and estimated 
glomerular filtration rate. We also observed that after additional adjustment for kidney 
volume, most associations of birth outcomes focused on kidney function outcomes 
attenuated. Other mechanisms may also be involved. Experimental studies showed 
alterations in the renin angiotensin system in experimentally induced intrauterine 
growth restricted individuals at adult age, these differences were not present at younger 
age.(43) Several markers of the renin angiotensin system were increased in intrauterine 
growth restricted subjects with hypertension.(43) Future studies are needed to identify 
possible underlying mechanisms. The observed effect estimates in the present study 
are small and without clinical significance at young age. However, they are important 
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from a etiological developmental perspective. The presented results suggest that birth 
characteristics, fetal and early childhood growth influence kidney function throughout 
the life course. Whether and to what extend the observed variations in kidney function 
relate with kidney disease in later life is not known yet. Tracking of blood pressure from 
childhood to adulthood has been described previously,(44) but is less clear for kidney 
function. Studies showing that lower estimated glomerular filtration  rate relates with 
renal disease development many decades later, suggest that subclinical variation in 
kidney function precede the developmental of renal disease.(13)
Conclusion and perspectives
In conclusion, lower fetal and lower early infant weight gain lead to smaller kidneys, 
whereas and only lower fetal weight gain led to a lower estimated glomerular filtration 
rate. Although the observed effect estimates are small, and without direct individual 
clinical consequence, they suggest that suboptimal early growth affects kidney function 
in later life. Future studies are needed to evaluate the long-term consequences of the 
observed associations. 
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Imputation procedure
To reduce the possibility of potential bias associated with missing data and to 
maintain statistical power, missing values were imputed using the multiple imputations 
procedure.(1) For the multiple imputations, we used Fully Conditional Specification, 
an iterative of the Markov Chain Monte Carlo approach. For each variable, the fully 
conditional specification method fits a model using all other available variables in the 
model as predictors, and then imputes missing values for the specific variable being 
fit. In the imputation model for the analyses focused on the associations of early 
growth outcomes with kidney outcomes in childhood, we included all covariates 
except childhood body surface area plus maternal weight gain during pregnancy and 
height and weight of the child aged 6. Furthermore, we added the determinants and 
outcomes studied in the imputation model as prediction variables only. Determinants 
and outcomes were not imputed themselves. Five imputed datasets were created and 
analyzed together. For the conditional analyses only, we additionally imputed fetal and 
childhood growth characteristics using a similar imputation model.
1. Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and 
clinical research: potential and pitfalls. BMJ (Clinical research ed. 2009;338:b2393.
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Table S1. Maternal and child characteristics for non-imputed and imputed data
Non-imputed Imputed
Maternal characteristics
Age, (yr) 31.1 (21.2 to 38.8) -
Height, (cm) 167.5 (7.4) 167.6 (7.4)
Pre-pregnancy body mass index, (kg/m2) 23.6 (4.2) 23.6 (4.3)
 Parity ≥1, (%) 43.6 (2730) 44.0 (2852)
 Ethnicity, (%)
  European 61.5 (3882) 61.2 (3964)
  Non -European 38.5 (2428) 38.8 (2518)
 Educational level, (%)
     No higher education 53.3 (3142) 54.5 (3534)
    Higher education 46.7 (2750) 45.5 (2948)
 Smoking, (%)
    No 74.7 (4199) 74.9 (4855)
    Yes 25.3 (1423) 25.1 (1627)
Folic acid supplement use, (%)
 No 25.7 (1122) 23.4 (1601)
 Preconceptional 43.2 (1930)  38.8 (2515)
 Postconceptional 31.6 (1411) 37.8 (2189)
Infant characteristics
 Gestational age, (weeks) 40.1 (37.0 to 42.1) -
 Birth weight, (g) 3425 (558) -
 Breastfeeding, (%)
 No 7.6 (382) 7.9 (511)
 Yes 92.4 (4662) 92.1 (5971)
Child characteristics
 Age, (years) 6.0 (5.7 to 7.5) -
 Height,(cm) 119.5 (6.1) -
 Weight, (kg) 23.3 (4.3) -
 Body mass index, (kg/m2) 16.2 (1.9) -
 Kidney volume combined, (cm3) 120.3 (23.5) -
 eGFR, ml/min per (1.73m²) 118.8 (16.4) -
 Microalbuminuria (%) 6.8 (217) -
Values are means (standard deviation), median (90% range) or percentage (number).
eGFR, estimated glomerular filtration rate
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Table S2. Subject characteristics of subjects with and without childhood blood samples 
With blood sample
(N=4,336)
Without blood sample
(N=2,146)
P value
Maternal characteristics
Age, (yr) 31.2 (21.4 to 38.7) 30.8 (20.9 to 38.4) <0.001
Height, (cm) 167.7 (7.5) 167.1 (7.3) 0.002
Pre-pregnancy body mass index, (kg/m2) 23.6 (4.2) 23.6 (4.4) 0.969
 Parity ≥1, (%) 44.9 (1875) 41.0 (855) 0.003
 Ethnicity, (%) 0.409
  European 60.2 (2610) 60.8 (1272)
  Non -European 38.1 (1608) 39.2 (820)
 Educational level, (%) 0.007
     No higher education 52.1 (2053) 55.8 (1089)
    Higher education 47.9 (1888) 44.2 (862)
 Smoking, (%) 0.763
     No 75.0 (2820) 74.0 (1379)
     Yes 24.9 (336) 8.7 (162)
Folic acid supplement use, (%) 0.432
 No 24.8 (739) 25.8 (383)
 Preconceptional 31.2 (930) 32.4 (481)
 Postconceptional 44.0 (1309) 41.8 (621)
Infant characteristics
 Gestational age, (weeks) 40.1 (36.9 to 42.0) 40.1 (36.9 to 42.0) 0.685
 Birth weight, (g) 3439 (548) 3397 (566) 0.004
 Breastfeeding, (%) 0.705
 No 7.5 (255) 7.8 (127)
 Yes 92.5 (3156) 92.2 (1506)
Child characteristics
 Age, (years) 6.0 (5.7 to 7.5) 6.0 (5.7 to 7.1) <0.001
 Height, (cm) 119.7 (6.0) 118.9 (6.0) <0.001
 Weight, (kg) 23.4 (4.3) 23.1 (4.3) 0.009
 Body mass index, (kg/m2) 16.2 (1.9) 16.2 (2.0) 0.838
 Kidney volume combined, (cm3) 120.8 (23.6) 119.3 (23.1) 0.021
 eGFR, ml/min per 1.73m² 118.8 (16.4) - -
 Microalbuminuria (%) 7.7 (324) 7.3 (149) 0.585
Values are means (standard deviation), median (90% range) or percentage (number)
T-tests were used for continuous variables, chi-square tests for categorical variables. 
eGFR, estimated glomerular filtration rate 
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Table S3. Associations of birth outcomes with kidney volume and function at the age of 
6 years: basic model
Birth characteristics Difference (95% CI) 
in combined kidney 
volume (cm3)
Difference (95% CI) in 
eGFR (ml/min per 1.73m²)
Risk (Odds Ratio 
(95%CI)) of micro 
albuminuria
Gestational age N=6,482
< 34 weeks
N=98
-6.36**
(-11.15 to -1.56)
-2.12
(-6.24 to 1.99)
0.81
(0.35 to 1.88)
34.0 – 35.9 weeks 
N=102
-9.08**
(-13.68 to -4.48)
2.85
(-1.06 to 6.76)
0.64 
(0.26 to 1.60)
36.0 – 37.9 weeks
N=514
-3.58**
(-5.83 to -1.32)
0.92
(-1.01 to 2.85)
0.93
(0.64 to 1.36)
38.0 - 39.9 weeks
N=2,199
Reference Reference Reference
40.0-41.9 weeks
N=3,131
0.11
(-1.17 to 1.39)
1.62**
(0.54 to 2.71)
1.01
(0.82 to 1.24)
≥ 42.0 weeks
N=438
0.64
(-1.76 to 3.04)
3.82**
(1.77 to 5.88)
1.02
(0.69 to 1.52)
Trend (SDS)
P value
1.60
(1.02 to 2.17)
< 0.001
0.86
(0.36 to 1.36)
0.001
1.02
(0.93 to 1.13)
0.656
Birth weight N=6,482
<2,000 grams
N=79
-10.85**
(-16.07 to -5.63)
-7.21**
(-11.95 to -2.48)
0.65
(0.24 to 1.80)
2,000-2,499 grams
N=213
-8.74**
(-11.97 to -5.50)
0.39
(-2.49 to 3.27)
0.79
(0.44 to 1.42)
2,500-2,999 grams
N=958
-4.57**
(-6.31 to -2.83)
-1.98*
(-3.51 to -0.45)
1.17
(0.89 to 1.54)
3,000-3,499 grams
N=2,241
Reference Reference Reference
3,500-3,999 grams
N=2,072
4.14**
(2.77 to 5.55)
1.28*
(0.09 to 2.47)
0.85
(0.67 to 1.07)
4,000-4,499 grams
N=756
7.46**
(5.55 to 9.37)
1.81*
(0.19 to 3.43)
1.02
(0.75 to 1.40)
≥ 4,500 grams
N=163
11.69**
(8.01 to 15.37)
2.14
(-1.07 to 5.34)
1.26
(0.71 to 2.23)
Trend (SDS)
P value
4.64
(4.07 to 5.20)
< 0.001
1.20
(0.71 to 1.70)
<0.001
0.98
(-0.89 to 1.08)
0.658
Birth weight for gestational age N=6,482
Small for gestational age
N=321
-9.05**
(-11.65 to -6.56)
-2.34
(-4.69 to 0.02)
0.79
(0.49 to 1.26)
Normal for gestational age
N=5,779
Reference Reference Reference
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Large for gestational age
N=321
9.05
(6.42 to 11.68))
2.26*
(0.05 to 4.47)
0.95
(0.61 to 1.49)
Trend (SDS)
P value
4.52
(3.96 to 5.08)
< 0.001
0.96
(0.47 to 1.45)
< 0.001
0.93
(0.85 to 1.03)
0.934
Values are regression coefficients (95% Confidence Interval) based on multiple regression 
models and reflect the difference for each outcome for the birth weight or gestational 
age group, as compared to the reference group. Values for analyses on microalbuminuria 
are Odds ratios (95% Confidence Interval) and reflect the Odds ratio for each outcome for 
the birth weight or gestational age group, as compared to the reference group. Models 
are adjusted for sex and current age. 
eGFR, estimated glomerular filtration rate 
*P<0.05, **P<0.01
Table S4. Associations of birth outcomes with kidney outcomes at the age of 6 years 
with non-imputed data 
Birth characteristics
Combined kidney 
volume (cm3)
eGFR
(ml/min per 1.73m²)
Micro albuminuria
(Odds Ratio)
Gestational age N=6,482
< 34 weeks
N=98
-21.84** 
(-34.52 to -9.16)
-4.82
(-16.70 to 7.05)
1.68
(0.20 to 13.91)
34.0 – 35.9 weeks 
N=102
-5.36
(-11.28 to 0.56)
3.44
(-2.29 to 9.18)
0.90
(0.27 to 3.00)
36.0 – 37.9 weeks
N=514
-2.52
(-5.50 to -0.46)
1.22
(-1.66 to 4.10)
1.06
(0.59 to 1.90)
38.0 - 39.9 weeks
N=2,199
Reference Reference Reference
40.0-41.9 weeks
N=3,131
-1.03
(-2.62 to 0.56)
1.12
(-0.41 to 2.66)
1.16
(0.85 to 1.59)
≥ 42.0 weeks
N=438
-0.64
(-3.51 to 2.24)
2.65
(-0.15 to 5.45)
1.39
(0.83 to 2.34)
Trend (SDS) 0.83
(0.03 to 1.63)
0.36
(-0.41 to 1.13)
1.03
(0.88 to 1.20)
P values 0.041 0.360 0.730
Birth weight N=6,482
Table S3. Continued
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<2,000 grams
N=79
-13.20**
(-21.76 to -4.64)
-8.09
(-17.18 to 0.99)
0.49
(0.07 to 3.78)
2,000-2,499 grams
N=213
-3.92
(-8.53 to 0.70)
2.49
(-2.07 to 7.06)
0.98
(0.41 to 2.36)
2,500-2,999 grams
N=958
-1.01
(-3.34 to 1.33)
-2.14
(-4.41 to 0.14)
0.97
(0.63 to 1.49)
3,000-3,499 grams
N=2,241
Reference Reference Reference
3,500-3,999 grams
N=2,072
0.55
(-1.18 to 2.28)
1.14
(-0.52 to 2.80)
0.80
(0.58 to 1.12)
4,000-4,499 grams
N=756
1.84
(-0.56 to 4.23)
1.14
(-1.10 to 3.37)
0.69
(0.42 to 1.12)
≥ 4,500 grams
N=163
3.31
(-1.46 to 8.12)
0.68
(-3.99 to 5.35)
1.09
(0.45 to 2.64)
Trend (SDS)
P value
1.58
(0.77 to 2.38)
<0.001
0.63
(-0.12 to 1.39)
0.099
0.94
(0.81 to 1.10)
0.441
Birth weight for gestational age N= 6,482
Small for gestational age
N=321
-4.60*
(-8.12 to -1.08)
-1.88
(-5.39 to 1.63)
0.66
(0.30 to 1.44)
Normal for gestational age
N=5,779
Reference Reference Reference
Large for gestational age
N=321
0.72
(-2.61 to 4.04)
2.31
(-0.69 to 5.31)
1.02
(0.53 to 1.93)
Trend (SDS)
P value
1.26
(0.48 to 2.05)
0.002
0.61
 (-0.11 to 1.34)
0.097
0.91
(0.79 to 1.06)
0.234
Values are regression coefficients (95% Confidence Interval) based on multiple regression 
models and reflect the difference for each outcome for the birth weight or gestational 
age group, as compared to the reference group. Values for analyses on microalbuminuria 
are Odds ratios (95% Confidence Interval) and reflect the Odds ratio for each outcome for 
the birth weight or gestational age group, as compared to the reference group. Models 
are adjusted for maternal age, body mass index, parity, ethnicity, educational level, folic 
acid supplementation and smoking during pregnancy, and child sex, breastfeeding, 
current age and body surface area. 
eGFR, estimated glomerular filtration rate
*P<0.05, **P<0.01
Table S4. Continued
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Table S5. Associations of birth outcomes with kidney outcomes at the age of 6 years 
adjusted for kidney volume
Birth characteristics Difference (95% CI) in eGFR
(ml/min per 1.73m²)
Risk (Odds Ratio (95%CI)) of 
micro albuminuria
Gestational age N=6,482
< 34 weeks
N=98
-1.22
(-8.63 to 6.19)
0.45
(0.06 to 3.36)
34.0 – 35.9 weeks 
N=102
3.72
(-0.79 to 8.22)
0.81
(0.25 to 1.98)
36.0 – 37.9 weeks
N=514
2.10
(-0.24 to 4.45)
1.03
(0.81 to 1.32)
38.0 - 39.9 weeks
N=2,199
Reference Reference
40.0-41.9 weeks
N=3,131
1.92**
(0.64 to 3.20)
0.92
(0.70 to 1.21)
≥ 42.0 weeks
N=438
4.08**
(1.70 to 6.46)
1.07
(0.65 to 1.77)
Trend (SDS)
P value
0.39
(-0.22 to 1.00)
0.205
0.99
 (0.87 to 1.12)
0.827
Birth weight N=6,482
<2,000 grams
N=79
-2.50
(-8.42 to 3.42)
0.76
(0.23 to 2.50)
2,000-2,499 grams
N=213
2.13
(-1.22 to 5.47)
0.87
(0.43 to 1.78)
2,500-2,999 grams
N=958
-1.61
(-3.72 to 0.25)
1.06
(0.73 to 1.52)
3,000-3,499 grams
N=2,241
Reference Reference
3,500-3,999 grams
N=2,072
0.36
(-1.06 to 1.78)
0.75
(0.55 to 1.03)
4,000-4,499 grams
N=756
-0.28
(-2.23 to 1.67)
0.71
(0.45 to 1.11)
≥ 4,500 grams
N=163
-1.05
(-5.04 to 2.95)
1.17
(0.52 to 2.65)
Trend (SDS)
P value
0.09
(-0.55 to 0.72)
0.789
0.93
(0.82 to 1.07)
0.311
Birth weight for gestational age N=6,482
Small for gestational age
N=321
-0.81
(-3.64 to 2.02)
0.60
(0.30 to 1.19)
Normal for gestational age
N=5,779
Reference Reference
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Large for gestational age
N=321
0.66
(-2.02 to 3.35)
1.18
(0.66 to 2.14)
Trend (SDS)
P values
-0.09
 (-0.72 to 0.53)
0.771
0.91
(0.79 to 1.04)
0.151
Values are regression coefficients (95% Confidence Interval) based on multiple regression 
models and reflect the difference for each outcome for the birth weight or gestational 
age group, as compared to the reference group. Values for analyses on microalbuminuria 
are Odds ratios (95% Confidence Interval) and reflect the Odds ratio for each outcome for 
the birth weight or gestational age group, as compared to the reference group. Models 
are adjusted for maternal age, body mass index, parity, ethnicity, educational level, folic 
acid supplementation and smoking during pregnancy, and child sex, breastfeeding, 
current age, body surface area and childhood kidney volume. 
eGFR, estimated glomerular filtration rate
*P<0.05, **P<0.01
Table S5. Continued
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Table S6. Associations of fetal and length and weight with kidney volume and function 
at the age of 6 years: basic model
Growth characteristics Difference (95% CI) in 
combined kidney volume (cm3)
Difference (95% CI) in eGFR
(ml/min per 1.73m²)
Risk (Odds Ratio (95%CI))  
of micro albuminuria
Length
Second trimester (SDS) 
N=5,553
0.84**
(0.23 to 1.46)
-0.15
(-0.67 to 0.37)
0.97
((0.88 to 1.08)
Third trimester (SDS) 
N=5,711
2.35**
(1.73 to 2.96)
0.37
(-0.16 to 0.89)
0.98
(0.89 to 1.08)
Birth (SDS) 
N=3,963
2.53**
(1.91 to 3.15)
0.49
(-0.06 to 1.04)
0.97
(0.87 to 1.08)
6 months (SDS)  
N=4,242
6.48**
(5.77)
2.09**
(1.45 to 2.73)
1.05
(0.93 to 1.19)
12 months (SDS)
N=4,369
6.98**
(6.28 to 7.68)
2.01**
(1.37 to 2.66)
1.10
(0.97 to 1.24)
24 months (SDS)
N=4,066
7.37**
(6.70 to 8.05)
2.08**
(1.46 to 2.69)
1.08
(0.96 to 1.21)
36 months (SDS)
N=3,890
8.47**
(7.80 to 9.13)
2.07**
(1.45 to 2.69)
1.05
(0.93 to 1.18)
48 months (SDS)
N=3,446
8.25**
(7.53 to 8.96)
1.85**
(1.19 to 2.51)
1.08
(0.96 to 1.23)
72 months (SDS)
N=6,473
9.40**
(8.88 to 9.91)
2.26**
(1.77 to 2.74)
1.02
(0.93 to 1.12)
Weight
Second trimester (SDS) 
N=5,523
2.03**
(1.40 to 2.66)
0.41
(-0.12 to 0.93)
0.91
(0.82 to 1.01)
Third trimester (SDS) 
N=5,692
3.58**
(2.99 to 4.18)
0.97**
(0.47 to 1.48)
0.97
(0.88 to 1.07)
Birth (SDS) 
N=6,421
4.52**
(3.96 to 5.08)
0.96**
(0.47 to 1.45)
0.93
(0.85 to 1.03)
6 months (SDS) 
N=4,734
6.53**
(5.86 to 7.20)
0.50
(-0.12 to 1.11)
0.98
(0.87 to 1.11)
12 months (SDS)
N=4,376
7.17**
(6.49 to 7.84)
0.71*
(0.07 to 1.35)
1.05
(0.93 to 1.18)
24 months (SDS)
N=4,124
8.63**
(7.97 to 9.29)
1.25**
(0.64 to 1.87)
0.97
(0.86 to 1.09)
36 months (SDS)
N=3,934
9.06**
(8.41 to 9.72)
1.18**
(0.55 to 1.80)
0.95
(0.85 to 1.07
48 months (SDS)
N=3,459
9.22**
(8.53 to 9.90)
0.91**
(0.25 to 1.57)
0.93
(0.82 to 1.05)
72 months (SDS)
N=,3473
10.47**
(9.98 to 10.95)
1.02**
(0.55 to 1.50)
0.88
(0.81 to 0.97)
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Values are regression coefficients (95% CI) based on multiple regression models and 
reflect the difference for each kidney volume and function outcome per change in SDS 
of fetal and early childhood length or weight. Values for analyses on microalbuminuria 
are Odds ratios (95% CI) and reflect the difference for each kidney volume and function 
outcome per change in SDS of fetal and early childhood length or weight. Models are 
adjusted for sex and current age. 
eGFR, estimated glomerular filtration rate 
*P<0.05, **P<0.01
Table S7. Associations of fetal and length and weight with kidney volume and function 
at the age of 6 years: confounder model 
Growth characteristics Difference (95% CI) in combined 
kidney volume (cm3)
Difference (95% CI) in eGFR
(ml/min per 1.73m²)
Risk (Odds Ratio (95%CI)) of 
micro albuminuria
Length
Second trimester (SDS) 
N=5,553
-0.42
(-1.14 to 0.04)
-0.30
(-0.86 to 0.27)
0.98
(0.88 to 1.10)
Third trimester (SDS) 
N=5,711
-0.39
(-0.98 to 0.21)
0.11
(-0.45 to 0.67)
0.94
(0.84 to 1.06)
Birth (SDS) 
N=3,963
-0.11
(-0.74 to 0.53)
0.39
(-0.23 to 0.99)
0.98
(0.87 to 1.10)
6 months (SDS)  
N=4,242
0.76
(-0.15 to 1.68)
1.85**
(1.09 to 2.61)
1.08
(0.90 to 1.28)
12 months (SDS)
N=4,369
0.23
(-0.72 to 1.17)
1.73**
(0.99 to 2.48)
1.25*
(1.05 to 1.50)
24 months (SDS)
N=4,066
-0.42
(-1.43 to 0.58)
1.83**
(1.13 to 2.53)
1.30**
(1.09 to 1.56)
36 months (SDS)
N=3,890
0.71
(-0.47 to 1.89)
1.88**
(1.16 to 2.59)
1.37**
(1.10 to 1.72)
48 months (SDS)
N=3,446
-0.91
(-2.20 to 0.38)
1.79**
(1.08 to 2.52)
1.27
(1.00 to 1.62)
72 months (SDS)
N=6,473
-1.00
(-2.14 to 0.14)
1.94**
(1.39 to 2.49)
1.45**
(1.16 to 1.81)
Weight
Second trimester (SDS) 
N=5,523
0.63*
(0.02 to 1.23)
0.37
(-0.21 to 0.94)
0.91
(0.81 to 1.02)
Third trimester (SDS) 
N=5,692
1.13**
(0.55 to 1.72)
0.71*
(0.16 to 1.26)
0.92
(0.82 to 1.03)
Birth (SDS) 
N=6,421
1.33**
(0.72 to 1.94)
0.84**
(0.27 to 1.42)
0.94
(0.83 to 1.05)
6 months (SDS) 
N=4,734
1.51**
(0.69 to 2.32)
0.25
(-0.48 to 0.97)
1.02
(0.88 to 1.19)
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12 months (SDS)
N=4,376
1.19*
(0.28 to 2.10)
0.56
(-0.17 to 1.29)
1..09
(0.92 to 1.30)
24 months (SDS)
N=4,124
1.28*
(0.19 to 2.36)
1.06**
(0.37 to 1.76)
1.01
(0.83 to 1.24)
36 months (SDS)
N=3,934
1.81**
(0.54 to 3.09)
1.02**
(0.31 to 1.73)
0.98
(0.78 to 1.24)
48 months (SDS)
N=3,459
0.95
(-0.53 to 2.44)
0.92*
(0.17 to 1.67)
0.84
(0.65 to 1.09)
72 months (SDS)
N=3,473
2.13*
(0.01 to 4.24)
0.83**
(0.29 to 1.38)
0.72
(0.48 to 1.07)
Values are regression coefficients (95% Confidence Interval) based on multiple regression 
models and reflect the difference for each kidney outcome per change in SDS of fetal 
and early childhood length or weight. Values for analyses on microalbuminuria are Odds 
ratios (95% Confidence Interval) and reflect the difference for each kidney volume and 
function outcome per change in SDS of fetal and early childhood length or weight. 
Models are adjusted for maternal age, body mass index, parity, ethnicity, educational 
level, smoking, total daily calorie intake and alcohol consumption during pregnancy, 
and gestational age, child sex, breastfeeding and current age and body surface area. 
eGFR, estimated glomerular filtration rate
*P<0.05, **P<0.01
Table S7. Continued
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Figure S1. Association of small and large size size for gestational age with kidney volume 
and function at the age of 6 years  
Bars represent regression coefficients (95% Confidence Interval) based on multiple 
regression models and reflect the difference for each kidney outcome between small 
(<10%), normal (10-90%) and large (>90%) size for gestational age born children. Models 
are adjusted for maternal age, body mass index, parity, ethnicity, educational level, folic 
acid supplementation and smoking during pregnancy, and child sex, breastfeeding, 
current age and body surface area. eGFR,  estimated glomerular filtration rate. β for trend 
(95% Confidence Interval).
| Fetal and infant growth patterns and kidney function at school-age
| 143
Figure S2. Associations of fetal and childhood length with kidney outcomes at the age 
of 6 years 
Effect estimates ((95% Confidence Interval) represent regression coefficients based on 
multiple regression models and reflect the difference per 1 SD increase in standardized 
residual score for (estimated) length measures at different time points (see details 
for conditional regression models in Supplementary Material). Models are adjusted 
for maternal age, body mass index, parity, ethnicity, educational level, folic acid 
supplementation and smoking during pregnancy, and child sex, breastfeeding and 
current age. Models focused on kidney volume were additionally adjusted for body 
surface area. eGFR, estimated glomerular filtration rate
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Figure S3. Associations of fetal and childhood weight and length with estimated 
glomerular filtration rate at the age of 6 years adjusted for kidney volume 
Effect estimates ((95% Confidence Interval) represent regression coefficients based on 
multiple regression models and reflect the difference per 1 SD increase in standardized 
residual score for (estimated) weight and length measures at different time points 
(see details for conditional regression models in Supplementary Material). Models are 
adjusted for maternal age, body mass index, parity, ethnicity, educational level, folic acid 
supplementation and smoking during pregnancy, and child sex, breastfeeding, current 
age and kidney volume at the age of 6 years. eGFR, estimated glomerular filtration rate 
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Abstract
Background Suboptimal kidney development in early life may be associated with an 
increased risk of kidney disease in later life. We aimed to identify specific kidney growth 
patterns during fetal life and infancy associated with impaired kidney function in 
childhood. 
Methods In a population-based prospective cohort study among 614 mothers and 
their children, combined kidney volume was measured by ultrasound at the ages of 30 
weeks of gestation, and 6, 24 and 72 months. At the age of 6 years, estimated glomerular 
filtration rate (eGFR) was calculated from blood creatinine and cystatin C concentrations. 
Results Children with small combined kidney volume during fetal life which persisted 
at 6 years had lower eGFRcreat, compared to children with persistent large combined 
kidney volume (differences eGFRcreat -0.64 SD (95% CI -0.95 to -0.33) and eGFRcyst -0.39 SD 
(95% CI -0.71 to -0.07), respectively). Longitudinal analyses showed that children in the 
lowest tertile of eGFRcreat and eGFRcyst had smaller combined kidney volume from fetal 
life onwards, compared to children in the highest tertile (all p values <0.01). Conditional 
regression analyses showed that early childhood kidney growth, independent from 
previous kidney growth, was positively associated with eGFRcreat  and eGFRcyst (all P values 
<0.05). 
Conclusion Smaller combined kidney growth during both fetal life and early childhood 
is associated with lower eGFR at school-age. 
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Introduction
The prevalence of chronic kidney disease (CKD) is increasing and has a growing impact 
on morbidity and mortality.(1) An accumulating body of evidence suggests that the 
susceptibility for CKD is established in early life.(2) Multiple studies have shown that 
low birth weight is associated with increased risks of CKD in later life.(3-5) It has been 
hypothesized that adverse exposures in utero lead to impaired fetal growth and smaller 
kidneys with a persistently reduced number of nephrons.(6-8) A persistently reduced 
nephron number in smaller kidneys may subsequently lead to glomerular hyperfiltration 
and hypertrophy, which in turn leads to glomerulosclerosis and CKD in later life.(8) This 
hypothesis is supported by our recent studies showing that reduced fetal and early 
postnatal growth are associated with smaller kidney volume and lower kidney function 
in childhood.(9,10) Also, impaired third trimester fetal blood flow to the abdominal 
organs was associated with lower eGFR in childhood.(11) To the best of our knowledge, 
no previous studies have examined the associations of directly longitudinally measured 
kidney volume with kidney function in later life. Nephron numbers cannot be assessed in 
vivo. Kidney volume can be used as proxy for kidney development and nephron number.
(6) Previous studies suggested that small kidney volume is associated with hypertension 
and renal disease.(9)
 We evaluated, in a population based prospective cohort study involving 614 pregnant 
mothers and their children, the associations of longitudinally measured fetal and early 
childhood kidney volumes with eGFR at school age. We used different approaches to 
identify longitudinal patterns and critical periods for fetal and early childhood kidney 
growth related to impaired kidney function at school-age. 
Methods
Design and study population
This study was nested in the Generation R Study, a population-based prospective cohort 
study from fetal life onwards in Rotterdam, the Netherlands.(10) All children were 
born between April 2002 and January 2006. Written informed consent was obtained 
from all parents. The study has been approved by the Medical Ethics Committee of the 
Erasmus University Medical Center, Rotterdam. More detailed growth and development 
evaluations were conducted in a subgroup of 1,232 Dutch mothers and their children, 
of which 1,218 had at least 1 kidney measurement in fetal life or early childhood. Only 
singleton life births were included in the current study. In total, combined kidney 
volume measures were available from 922 children the age of 6 years, of whom 614 
(67%) provided blood samples for creatinine and cystatin C measurements (Figure 1). 
Missing blood samples were mainly due to non-consent. No kidney abnormalities were 
present in these 614 children.
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Fetal and childhood combined kidney volume 
Left and right kidney biometrics were measured at the median (90% range) age of 30.4 
(28.8-32.3) weeks of gestational age, and 6.3 (5.5-7.8), 25.0 (23.8-27.5) and 71.5 (69.0-
76.6) months. As previously described, we identified the left and right kidney in the 
sagittal plane along its longitudinal axis.(11) We performed measurements of maximal 
bipolar kidney length, width and depth. Kidney width and depth were measured at the 
level of the hilum. The cross-sectional area in which the kidney appeared symmetrically 
round at its maximum width was used. The cross-sectional area in which the kidney 
appeared symmetrically round at its maximum width was used. Kidney volume was 
calculated using the equation of an ellipsoid: volume (cm3) = 0.523 x length (mm) x 
width (mm) x depth (mm).(12) Combined kidney volume was calculated by summing 
right and left kidney volume. We previously reported good intra-observer and inter-
observer correlation coefficients.(13) 
Childhood estimated glomerular filtration rate
Since creatinine concentrations might be influenced by muscle mass, ethnicity, age, sex 
and dietary factors, we calculated the eGFR based on creatinine and cystatin C blood 
concentrations.(14) Blood creatinine concentrations were measured with an enzymatic 
method and cystatin C concentrations with a particle enhanced immunoturbimetric 
assay on a Cobas c 502 analyzer (Roche Diagnostics, Germany). Quality control samples 
demonstrated intra-assay and inter-assay coefficients of variation of 0.51% for creatinine 
and 1.65% for cystatin C, and 1.37% for creatinine and 1.13% for cystatin C, respectively.(15) 
eGFR was calculated according to the revised Schwartz 2009 formula(16); eGFRcreat = 36.5 
* (height (cm)/creatinine (µmol/l).(16) We used the formula as proposed by Zappitelli in 
2006: eGFRcyst = 75.94 / [CysC(mg/L)
1.17].(17) 
Covariates
Information on parity, educational level, smoking during pregnancy and folic acid 
supplementation during pregnancy was obtained by questionnaires.(10) Infant sex, 
gestational age at birth and birth weight was obtained from midwife and hospital 
registries. At the age of 6 years, child height and weight were measured without shoes 
and heavy clothing, and body mass index (BMI) was calculated. 
Statistical analyses 
We performed a non-response analyses to compare characteristic between  included 
and not-included mother-child pairs. We used different approaches to identify 
longitudinal patterns and critical periods for fetal and early childhood kidney growth 
related to impaired kidney function at school-age. First, we assessed the correlations of 
combined kidney volume in fetal life and early childhood with eGFR in childhood and 
performed multiple linear regression models to explore the associations of combined 
kidney volume (at the ages of 30 weeks of gestation, and 6, 24 and 72 months) with 
childhood combined kidney volume and eGFR. Second, we created tertiles of fetal 
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and early childhood combined kidney volume to compare the associations in different 
combined strata. We used linear regression models to assess whether the associations 
of fetal combined kidney volume with eGFR were modified by childhood combined 
kidney volume at 6 years. Additionally, we also used linear regression models to assess 
whether the associations of fetal combined kidney volume with eGFR were modified by 
infants combined kidney volume at the of 24 months. Third, we compared fetal and early 
childhood longitudinal combined kidney volume growth patterns between children 
in different tertiles of eGFR. For these analyses we used mixed-effects models. These 
regression models take into account the correlation between repeated measurements 
within the same participant and allowing for incomplete data.(18) Finally, to identify 
independent critical periods for combined kidney volume in relation to eGFR at school-
age, we performed conditional regression taking account for the correlations between 
kidney volume measurements at different ages.(11,19) For these analyses, we constructed 
kidney volume variables for each time point, which are statistically independent from 
each other, by using standardized residuals obtained from regression of kidney volume 
measures at a specific time point on prior kidney volume measures.(19) As conditional 
kidney volume measures are statistically independent of each other, this approach 
allows inclusion of kidney volume measures simultaneously in one linear regression 
model. Thus, the associations of fetal and early childhood kidney volume measures at 
specific ages with kidney outcomes can be assessed adjusted for, and compared, with 
fetal and childhood kidney volume measures at other ages.(20,21) Results from these 
datasets were pooled and presented in the conditional kidney volume growth results. 
 The regression models were first adjusted for child sex and age and for potential 
confounders. Potential confounders were based on their associations with kidney 
outcomes or a change in effect estimate of more than 10% and included folic acid use, 
maternal smoking, parity, birth weight, gestational age at birth and body mass index at 6 
years. To reduce the possibility of potential bias due to missing data, we imputed missing 
data of the fetal, child and maternal covariates with five imputations and analysed these 
datasets together.(22) Additional information on the imputation procedure is given in 
the Supplementary material. The repeated measurement analyses, including the Prox 
Mixed module for unbalanced repeated measurements, were performed using SAS 
version 9.3 (SAS Institute Inc., Cary, North Carolina, USA). All other statistical analyses 
were performed using the Statistical Package for the Social Sciences version 21.0 for 
Windows (SPSS Inc, Chicago, IL, USA).
Results
Subject characteristics
Maternal and child characteristics are shown in Table 1. At the age of 71.5 months (90 
% range 69.0 to 76.6), and mean (SD) eGFRcreat was 119.98 (16.4) ml/min per 1.73m² 
and eGFRcyst was 102.0 (14.6) ml/min per 1.73m², respectively. Non–response analyses 
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showed no differences in combined kidney volume measures between children included 
and children not included in the study. Mothers of children included in the current study 
were higher educated than mothers of children who were not included. Also, included 
children were born at older gestational age and had a higher birth weight as compared 
to children not included in the study. (Supplementary Table S1). Observed data before 
multiple imputation are presented in Supplementary Table S2. 
 Correlations between combined kidney volumes and eGFRcreat and eGFRcyst are given 
in Supplementary Table S3 and showed that all kidney measures were correlated. Also 
Supplementary Table S4 shows that combined kidney volume at all fetal and early 
childhood ages was positively associated with eGFRcreat and eGFRcyst (all P values < 0.01), 
independent of combined kidney volume at the age of 6 years (all P values < 0.01). 
Early fetal and infant kidney growth and childhood eGFR 
Figure 2 shows the eGFR of children in strata of combined kidney volume in fetal life 
and early childhood. Early childhood combined kidney volume was positively associated 
with eGFRcreat in each tertile of fetal combined kidney volume, whereas no consistent 
associations of early childhood combined kidney volume with eGFRcyst were observed in 
different tertiles of fetal combined kidney volume. Children in the lowest tertile of both 
fetal and childhood combined kidney volume had the lowest eGFRcreat and eGFRcyst at the 
age of 6 years (difference compared with children with normal fetal and early childhood 
combined kidney: -0.64 SD (95% Confidence Interval (CI) -0.95 to -0.33) and -0.39 SD 
(95% CI -0.71 to -0.07), respectively). Additional analyses in strata of fetal kidney volume 
and kidney at 24 months showed similar results (Supplementary figure 1).
 Figure 3 gives the results from the longitudinal analyses and present the kidney 
growth patterns from fetal life into childhood for children with different tertiles of eGFR. 
Overall, analyses on eGFRcreat and eGFRcyst showed similar results. As compared to children 
within the highest tertile of eGFR, those in the middle and lowest tertile tended to have 
smaller combined kidney volume in early childhood (all p values < 0.01). 
 Figure 4 gives the results from the conditional regression analyses, which were 
performed to identify the at which age combined kidney volume is associated with eGFR, 
independent of combined kidney volume at other ages. We observed that independent 
from combined kidney volume at other ages, combined kidney volumes at 6 months, 24 
months and 72 months were positively associated eGFRcreat and eGFRcryst (all P values < 
0.05), except for combined kidney volume at 72 months and eGFRcyst. The associations 
were similar across ages for eGFRcreat, but stronger for combined kidney volume at 
younger ages  for eGFRcyst.
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Table 1. Maternal and child characteristics (N=614)1  
Values
Maternal characteristics
Age, (yr) 32.3 (25.1-37.9)
Height, (cm) 171.1 (6.2)
Pre-pregnancy body mass index, (kg/m2) 23.5 (4.2)
Parity, nulliparous, (%) 383 (62.5)
Educational level, (%)
     No higher education 210 (34.7)
    Higher education 396 (65.3)
Smoking, (%)
             No 427 (77.5)
             Yes 124 (22.5)
Folic acid supplement use, (%)
 No use 49 (8.0)
 First 10 weeks use 184 (30.0)
 Preconception use 381 (62.1)
Fetal and infant characteristics
Males, (%) 312 (50.8)
Gestational age, (weeks) 40.3 (37.3-42.1)
Birth weight, (g) 3549 (506)
Combined kidney volume 
 30 weeks, (cm3) 20.6 (5.5)
 6 months, (cm3) 46.1 (9.5)
 24 months, (cm3) 66.5 (13.2)
Child characteristics
Age, (months) 71.5 (69.0-76.6)
Height, (cm) 119.2 (5.0)
Weight, (kg) 22.7 (3.2)
Body mass index, (kg/m2) 15.9 (1.4)
Combined kidney volume at 72 months ,(cm3) 120.8 (22.1)
eGFR, (Schwartz, creatinine based) ml/min per 1.73m² 119.9 (16.1)
eGFR, (Zapitelli, cystatin C based) ml/min per 1.73m² 102.0 (14.6)
1Values are means (standard deviation), median (90% range) or number of subjects 
(valid %).
eGFR, estimated glomerular filtration rate
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Figure 1. Flow chart: inclusion of participants in analyses
Values are regression coefficients (95% confidence interval) based on multiple regression 
models and reflect the difference for standard deviation score of eGFR compared to with 
children with normal fetal and infant kidney volume. Tertiles of fetal kidney volume at 
30 weeks gestational age and early childhood kidney volume at the age of 6 years were 
created. Models are adjusted for child sex and age at outcome measurements, folic acid 
use, maternal smoking, parity, birth weight, gestational age at birth and BMI at 6 years.
N = 1,218
Children with ≥ 1 kidney volume measurement in 
fetal life or early childhood
N = 296 Excluded, 
Non singleton live births (N = 23)
No participation in follow up measurements at 6 
years (N = 273)N = 922
Children with kidney measurements at 6 years
N = 614
Children with estimated glomerular ltration rate 
measurements
N = 308 Excluded,
No successful measurements of kidney function at 
6 years
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Figure 2. Associations of fetal and early childhood combined kidney volume with eGFR 
at school-age (N=614)
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Figure 3. Combined kidney volume growth patterns during fetal life and infancy from 
children in  eGFRcreat tertiles (N=614)
A. eGFRcreat    B. eGFRcyst
Values are estimates based on repeated linear regression models and reflext the standard 
deviation score for each kidney growth measure in children who were in first and second 
tertile of eGFRcreat and eGFRcyst  compared to children in the third tertile of eGFRcreat 
and eGFRcyst  at the age of 6 years.
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Figure 4. Associations of independent early childhood kidney growth measures and 
eGFRcreat and eGFRcyst in childhood (N=614)
      
Values are regression coefficients (95% confidence interval) based on multiple regression 
models and reflect the difference for each kidney volume and function outcome per 
increase of 1 SDS of standardized residual score for kidney volume in a specific time 
period. 
Model is adjusted for child sex and age at outcome measurements, folic acid use, 
maternal smoking, parity, birth weight, gestational age at birth and BMI at 6 years.
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Discussion
In this low-risk population-based prospective cohort study, we aimed to identify 
longitudinal growth patterns and critical periods for kidney growth related to kidney 
function at school age. Smaller fetal kidney volume which persisted in childhood was 
associated with impaired eGFR at school age. Also, children with the lowest and the 
middle tertile of eGFR in childhood had smaller combined kidney volume growth from 
fetal life onwards. Furthermore, early life kidney growth, independent from previous 
kidney growth, is positively associated with eGFR in childhood.
Strengths and limitations 
A major strength of our study is its population-based prospective design from fetal life 
onward and the large number of repeated kidney volume measurements available. By 
performing repeated measurements analyses and conditional growth analyses, we were 
able to identify kidney growth patterns and critical periods that might influence kidney 
function in childhood. Not all participants at baseline participated in the follow-up studies 
at the age of 6 years. Mothers of children included in the current study were higher educated 
than mothers of children who were not included. Also, included children were born at older 
gestational age and had a higher birth weight as compared to children not included in the 
study. These differences might have led to bias if the associations between early kidney 
growth and childhood kidney function differ between the children with and without 
follow-up measurements. We consider this unlikely but cannot explore this in further 
detail. Since nephron number cannot be studied in vivo, we used combined kidney volume 
as a proxy for kidney development. Kidney size is correlated with glomerular number in 
childhood and adulthood, and can be used in epidemiological studies as measure of kidney 
development.(6) GFR was estimated based on the Schwartz formula,(16) which is based 
on serum creatinine concentrations and on the Zappitelli formula(17) which is based on 
serum cystatin C concentrations. Both have been  validated in pediatric populations. In line 
with previous studies, GFR estimations were higher when calculated based on creatinine 
concentrations than on cystatin C concentrations.(24) Overall, results for analyses on 
eGFRcreat were comparable with results from analyses on eGFRcyst. However, effect estimates 
were higher for eGFRcreat in the stratified and conditional analyses. We have recently 
shown that creatinine based eGFR is stronger influenced by body composition than cystatin 
C based eGFR(Miliku et al Submitted). Since body growth is strongly correlated with kidney 
growth, this might have influenced our results. The stronger associations with creatinine 
based eGFR might be explained by relatively lower creatinine levels in high body growth. 
Confounder models were adjusted for childhood BMI, this might limit the effect of body 
composition on the observed associations. Currently, it is not clear which formula estimates 
GFR the most accurate. Previous studies suggested that serum cystatin C concentrations 
might be superior in evaluating kidney function to serum creatinine concentrations.(25) 
Although we had information about a large number of confounders, residual confounding 
might still be an issue due to the observational design of the study.
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Fetal and early childhood kidney growth and childhood eGFR
To the best of our knowledge, this study is the first population-based prospective 
cohort study focused on the associations of fetal and early childhood kidney growth 
and kidney function in childhood. Kidney development starts in early fetal life and ends 
arounds the 36th week of gestation.(26) To date, it is not known whether early childhood 
kidney growth is associated with the risk of lower kidney function in childhood. The 
longitudinally measured kidney volumes in fetal life and early childhood in the current 
study provided the oppurtunity to identify specific periods and patterns of kidney 
growth which might be associated with childhood eGFR.
 Low birth weight is associated with an increased risk of chronic kidney disease in 
adulthood. Only a few studies evaluated nephron numbers and birth weight, since 
nephron number can only be counted post mortem. These studies showed a lower 
nephron number in infants with lower birth weight.(3,27-30) Results of studies focused 
on birth weight and kidney function in childhood are inconclusive.(31-34) We have 
previously shown that suboptimal fetal and infant body growth is associated with smaller 
kidney volume and lower eGFR in childhood.(11). A previous study in small groups of 9 
to 12-year-old children did not find a difference in kidney volume or kidney function 
between groups of children born preterm, born term but small for gestational age or 
born term appropriate for gestational age.(32) A recent study in 100 low birth weight 
(LBW) and 66 normal birth weight (NBW) children showed that combined kidney volume 
was lower in LBW children as compared to NBW children during infancy. However despite 
the lower kidney volumes there were no differences in eGFR at the end of infancy.(35) 
Impaired fetal growth and low birth weight might be associated with smaller kidney 
volume and lower kidney function. The present study showed that longitudinally 
impaired kidney growth patters in fetal life and in early childhood is associated with 
lower eGFR in childhood. 
 Nephron endowment takes place in fetal life, new nephrons are formed until 36 
weeks of gestation, thereafter nephrogenesis ceases.(28) Multiple factors are suggested 
to be important for nephron mass endowment, for example genetic and epigenetic 
factors, maternal nutritional status during pregnancy and maternal medication use.
(6,9,36) Also, multiple factor are identified which might be associated with maintaining 
or decreasing nephron number in postnatal life, for example breastfeeding, body 
growth and protein intake.(6,9) Normal nephron number in human varies widely, it might 
be around 1.000.000, but there is a 10-fold range in this spectrum.(37) However, people at 
the lower end of this nephron number might be at a higher risk for kidney disease in later 
life.(37) Chronic kidney disease occurs when there are too few nephrons to maintain kidney 
function. The hyperfiltration theory hypothesizes that a reduction in nephron number 
leads to compensatory hyperfiltration which in turn might lead to glomerulosclerosis 
and decreased kidney function.(8) Previous studies in rats showed that when the total 
nephron number is decreased, the volume and the glomerular filtration rate of a single 
nephron increases. This might be beneficial on the short term, but on the long term 
total glomerular filtration rate decreases and progressive renal injury develops.(38,39) In 
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contrast with this hypothesis, and with animal studies and studies focused on early life 
low nephron number, the loss of one kidney does not lead to impaired kidney function 
per se. Studies in living kidney donors show that this reduction in nephron number does 
not have to lead to hypertension and/or impaired kidney function.(40,41) The current 
study shows for the first time that in a low risk population, fetal and early childhood 
are critical periods for kidney volume and are associated with lower eGFR in childhood. 
These findings might support the hypothesis that a smaller nephron number, reflected 
by smaller kidney volume, may lead to lower eGFR. Since nephrogenisis ceases before 
birth in term born children, only a decrease in nephron number can occur postnatal. The 
smaller kidney volumes in early childhood associated with lower eGFR in childhood in 
the present study might reflect a decrease in nephron number.
 In conclusion, smaller kidney growth in fetal life and during infancy is associated 
with lower eGFR in childhood. Together with previous studies, this study supports 
the hypothesis that kidney development in the early phases of life has persistent 
consequences for kidney function in later life. Future studies are needed to identify 
factors that can optimize early kidney development to improve kidney function 
throughout the life course.
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Imputation procedure
To reduce the possibility of potential bias associated with missing data and to maintain 
statistical power, missing values were imputed using the multiple imputations 
procedure.(1) For the multiple imputations, we used Fully Conditional Specification, 
an iterative of the Markov Chain Monte Carlo approach. For each variable, the fully 
conditional specification method fits a model using all other available variables in the 
model as predictors, and then imputes missing values for the specific variable being fit. 
In the imputation model for the analyses focused on the associations of early growth 
outcomes with kidney outcomes in childhood, we included all covariates. Furthermore, 
we added the determinants and outcomes studied in the imputation model as prediction 
variables only. Determinants and outcomes were not imputed themselves. Five imputed 
datasets were created and analyzed together. 
1. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for 
missing data in epidemiological and clinical research: potential and pitfalls. BMJ (Clinical 
research ed. 2009;338:b2393.
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Supplementary Table 1. Maternal and child characteristics included and not included1
Included N=614 Not included N=604
Maternal characteristics
Age, (yr) 32.3 (25.1-37.9) 31.6 (22.4-37.9)
Height, (cm) 171.1 (6.2) 170.7 (6.3)
Pre-pregnancy body mass index, (kg/m2) 23.5 (4.2) 23.4 (4.0)
Parity, nulliparous, (%) 383 (62.5) 350 (58.2)
Educational level, (%)
     No higher education 210 (34.7) 240 (40.6)*
    Higher education 396 (65.3) 351 (59.4)
Smoking, (%)
             No 427 (77.5) 405 (72.8)
             Yes 124 (22.5) 151 (27.2)
Folic acid supplement use, (%)
 No use 49 (8.0) 57 (11.4)
 First 10 weeks use 184 (30.0) 140 (28.1)
 Preconception use 381 (62.1) 301 (60.4)
Fetal and infant characteristics
Males, (%) 312 (50.8) 323 (53.5)
Gestational age, (weeks) 40.3 (37.3-42.1) 40.1 (36.0-42.0)**
Birth weight, (g) 3549 (506) 3535.7 (507.8)**
Combined kidney volume 
 30 weeks, (cm3) 20.6 (5.5) 20.7 (5.3)
 6 months, (cm3) 46.1 (9.5) 46.6 (9.6)
 24 months, (cm3) 66.5 (13.2) 65.0 (12.4)
Child characteristics
Age, (months) 71.5 (69.0-76.6) 5.9 (5.7-6.4)
Height, (cm) 119.2 (5.0) 118.5 (5.4)
Weight, (kg) 22.7 (3.2) 22.2 (3.2)*
Body mass index, (kg/m2) 15.9 (1.4) 15.7 (1.3)
Combined kidney volume at 72 months ,(cm3) 120.8 (22.1) 120.3 (22.2)
eGFR, (Schwartz, creatinine based) ml/min per 1.73m² 119.9 (16.1) N.A.
eGFR, (Zapitelli, cystatin C based) ml/min per 1.73m² 102.0 (14.6) N.A.
1Values are means (standard deviation), median (90% range) or number of subjects 
(valid %). 
eGFR, estimated glomerular filtration rate, N.A. not applicable
*P<0.05 **P<0.01
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Supplementary Table 2. Maternal and child characteristics imputed vs non-imputed 
(N=614)1
Values
Non imputed
Values
imputed
Maternal characteristics
Age, (yr) 32.2 (24.9-38.0) 32.2 (24.9-38.0)
Height, (cm) 171.0 (6.2) 171.0 (6.2)
Pre-pregnancy body mass index, (kg/m2) 23.6 (4.2) 23.6 (4.3)
Parity, nulliparous, (%) 575 (62.5) 576 (62.5)
Educational level, (%)
     No higher education 311 (34.1) 314 (34.1)
    Higher education 602 (65.9) 608 (65.9)
Smoking, (%)
             No 654 (78.7) 726(78.7)
             Yes 177 (21.3) 196(21.3)
Folic acid supplement use,  (%)
 No use 61 (7.9) 79 (8.6)
 First 10 weeks use 218 (28.4) 268 (29.1)
 Preconception use 489 (63.7) 575 (62.4)
Fetal and infant characteristics
Males, (%) 464 (50.3) 464 (50.3)
Gestational age, (weeks) 40.3 (37.5-42.1) 40.3 (37.5-42.1)
Birth weight, (g) 3535.7 (507.8) 3535.7 (507.8)
Combined kidney volume 
 30 weeks, (cm3) 20.6 (5.5) 20.6 (5.5)
 6 months, (cm3) 46.1 (9.5) 46.1 (9.5)
 24 months, (cm3) 68.3 (27.2) 68.3 (27.2)
Child characteristics
Age, (months) 5.9 (5.7-6.4) 5.9 (5.7-6.4)
Height,( cm) 119.0 (5.2) 119.0 (5.2)
Weight, (kg) 22.6 (3.2) 22.6 (3.2)
Body mass index, (kg/m2) 15.9 (1.4) 15.9 (1.4)
Combined kidney volume at 72 months ,(cm3) 120.8 (22.1) 120.8 (22.1)
eGFR, (Schwartz, creatinine based) ml/min per 1.73m² 119.9 (16.1) 119.9 (16.1)
eGFR, (Zapitelli, cystatin C based) ml/min per 1.73m² 102.0 (14.6) 102.0 (14.6)
1Values are means (standard deviation), median (90% range) or number of subjects 
(valid %). 
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Supplementary Table 4. Combined kidney volume in fetal life and early childhood and 
childhood eGFR (N=614)1 
Change in GFR (ml/min per 1.73m²)
Confounder model Kidney volume model
Combined kidney volume (age) GFRcreat GFRcyst GFRcreat GFRcyst
30 weeks gestation 3.59 (2.30 - 4.88)** 2.74(1.54 - 3.95)** 2.33(1.06 – 3.61)** 2.74(1.53 - 3.94)**
6 months 4.53(2.97 – 6.10)** 3.21(1.71 - 4.71)** 2.99(1.34 – 4.65)** 2.73(1.17 - 4.29)**
24 months 6.14(4.58 – 7.69)** 2.90(1.68 – 4.12)** 4.14(2.42 – 5.87)** 2.69(1.26 – 4.12)**
72 months 5.87(4.59 – 7.15)** 1.83(0.64 – 3.02)** N.A. N.A.
1Values are regression coefficients (95% confidence interval) based on multiple regression 
models and reflect the difference for each kidney volume and function outcome per 
change in SDS of combined kidney volume. Confounder model is adjusted for child 
sex and age at outcome measurements, folic acid use, maternal smoking, parity, birth 
weight, gestational age at birth and BMI at 6 years.
Kidney volume model is additionally adjusted for combined kidney volume at the age 
of 6 years 
N.A. not applicable
*P<0.05, **P<0.01. 
Supplementary Table 5. Conditional analyses on Kidney growth patterns and childhood 
kidney function in childhood1  Crude model
Kidney volume
(age)
Combined kidney 
volume (cm3)
GFR creat
(ml/min per 1.73m²)
GFR cys C
(ml/min per 1.73m²)
30 weeks gestation to 6 months (N=560) 6.66(6.04 – 7.29)** 4.32(2.43 – 6.22)** 2.39(0.81 – 3.98)**
6 months to 24 months (N=365) 6.10(5.50 – 6.71)** 3.76(1.93 – 5.58)** 2.00(0.47 – 3.52)*
24 to 60 months (N=329) N.A. 3.98(2.15 – 5.81)** 0.07(-1.46 – 1.60)
1Values are regression coefficients (95% confidence interval) based on multiple regression 
models and reflect the difference for each kidney volume and function outcome per 
change in SDS of kidney volume in a specific time period. 
Model is adjusted for child sex and age at outcome measurements.
*P<0.05, **P<0.01
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Supplemental Figure 1. Associations of fetal and infant combined kidney volume with 
eGFR at school-age (N=614)
A. eGFRcreat
B. eGFRcyst
Values are regression coefficients (95% confidence interval) based on multiple regression 
models and reflect the difference for standard deviation score of eGFR compared to with 
children with normal fetal and infant kidney volume. Tertiles of fetal kidney volume at 30 
weeks gestational age and early childhood kidney volume at the age of 24 months were 
created. Models are adjusted for child sex and age at outcome measurements, folic acid 
use, maternal smoking, parity, birth weight, gestational age at birth and BMI at 6 years.
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Abstract
Background Fetal smoke exposure might lead to developmental adaptations that 
permanently affect the developing kidney. We assessed the associations of maternal and 
paternal smoking during pregnancy with childhood kidney size and function. 
Methods Prospective cohort study from fetal life onwards. This study was conducted in 
a group of 5,622 children in Rotterdam, the Netherlands. Maternal and paternal smoking 
were assessed during pregnancy by questionnaires. At a median age of 6.0 years (95% 
range 5.6 – 7.9), we measured childhood kidney volumes, estimated glomerular filtration 
rate (eGFR) and microalbuminuria. 
Results Compared to children from mothers who did not smoke during pregnancy, those 
from mothers who continued smoking during pregnancy had a smaller combined kidney 
volume at the age of 6 years. The strongest effect estimate was observed for mothers 
who smoked 5 or more cigarettes per day during pregnancy (difference for combined 
kidney volume -2.80 cm3 (95% CI: -5.15, -0.45)). Similarly, continued maternal smoking 
during pregnancy was also associated with a lower eGFR in childhood (difference -2.09 
ml/min per 1.73m² (95% CI: -3.55, -0.63)).  First trimester only smoking was associated 
with a higher risk of microalbuminuria (Odds Ratio 1.45, (95% CI: 1.05, 2.01)). Among 
mothers who did not smoke during pregnancy, paternal smoking was associated with 
smaller childhood combined kidney volume (difference -1.78 cm3 (95% (CI): -3.48, -0.07)), 
but not with childhood kidney function measures. Smoking behavior was measured with 
questionnaires. Follow-up measurements were only available in 70% of the children. 
Conclusions Continued maternal smoking during pregnancy is associated with smaller 
combined kidney volume and lower eGFR in school-age children. Stronger effect 
estimates for maternal smoking than paternal smoking suggest intra-uterine adaptive 
responses might be involved as underlying mechanisms. 
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Introduction
Fetal kidney development can be adversely affected by adverse exposures.  Since 
nephrogenesis continues until 36 weeks of gestation and largely ceases thereafter, 
adverse exposures during this critical period may lead to impaired kidney development.
(1,2) Impaired fetal kidney growth with a reduced number of nephrons might lead to 
glomerular hyperfiltration and sclerosis, subsequently predisposing the individual to 
impaired kidney function and chronic kidney disease in adulthood.(3,4) This hypothesis 
is supported by various studies showing associations of low birth weight, as a result of an 
adverse fetal environment, with chronic kidney disease in later life.(5) Thus far, not much 
is known about the specific adverse fetal exposures leading to impaired kidney function 
in later life. Maternal smoking during pregnancy is an important modifiable adverse fetal 
exposures, and strongly related with increased risks of low birth weight and preterm 
birth.(6-8) Maternal smoking during pregnancy may also have direct adverse effects 
on fetal kidney and vascular development.(9) Previously, we have shown that maternal 
smoking during pregnancy is associated with third trimester fetal kidney development.
(10) Other studies showed that fetal kidney growth, measured by ultrasound or MRI, 
was affected by prenatal cigarette exposure.(9,11) Also, several animal studies showed 
structural changes in kidney morphology after prenatal cigarette exposure.(12,13) 
Whether these changes in early life persist and affect kidney function in later life is not 
known. Although any observational association between maternal smoking and kidney 
development may be the result of direct intra-uterine effects of fetal smoke exposure 
on kidney development, they may also reflect family-, socioeconomic-based, or life 
style related characteristics. Comparing the strength of effects of maternal and paternal 
smoking could help in disentangling the underlying mechanisms. Stronger effects for 
maternal compared to paternal smoking during pregnancy would suggest direct intra-
uterine effects, whereas similar effects for paternal and maternal smoking are more likely 
to imply a role for shared family life style related characteristics or genetic factors.(14,15)
 We assessed in a large population-based prospective cohort study among 5,622 
children, the associations of maternal and paternal smoking during pregnancy with 
kidney size and function, measured in blood and urine samples, in school-age children. 
We used subclinical changes in kidney function as outcomes since they precede clinical 
disease at later life.(3)
Methods
Study design and population for analysis
The study was embedded in the Generation R Study, a population-based, prospective 
cohort study from fetal life onwards in Rotterdam, the Netherlands.(16) Enrolment in the 
study was aimed at early pregnancy, but was allowed until the birth of the child. The study 
has been approved by the Medical Ethics Committee of the Erasmus Medical Center, 
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Rotterdam. Written informed consent was obtained from all parents of participants. In 
total, 8,879 mothers were enrolled in the study during pregnancy, of whom 8,244 (84.3%) 
provided information about their smoking habits. For the present study, only singleton 
life births were included (N=8,024), of whom 5,658 (70.5%) children attended the follow-
up visit between March 2008 and January 2012. Children with evidence of congenital 
kidney abnormalities on ultrasound examination were excluded from the study (N=10). 
Kidney ultrasound, blood samples or urine samples were successfully obtained in 5,622 
(99.3%) children (Figure 1).
Maternal and paternal smoking during pregnancy
As we have described before,(17) we asked each mother at enrolment, whether she 
smoked during pregnancy (no smoking; smoking until pregnancy was acknowledged 
(first trimester only smoking); continued smoking during pregnancy). Mothers who were 
enrolled before a gestational age of 18 weeks and between 18 and 25 weeks of gestation, 
also received a second and third trimester questionnaire, respectively. Mothers who 
reported in the first questionnaire that they smoked during the first trimester only 
(N=921), but still reported to smoke in the second or third trimester questionnaire 
(N=312) were reclassified into the ‘continued smoking during pregnancy’ category. The 
same strategy was used for women who reported no smoking in the first questionnaire, 
but reported smoking in the second or third questionnaire (N=80). Paternal smoking 
was assessed in the first questionnaire by asking the mother whether the father 
smoked during pregnancy (yes, no, or do not know). Among mothers and fathers who 
smoked, the number of cigarettes smoked daily was categorized as: <5 cigarettes/day 
≥5 cigarettes/day. Similar information completed by the father was available in 3,558 
(64%) participants. Agreement between these assessments by the mother and the father 
was good (sensitivity: 91%; specificity: 95%).(17) Tobacco smoke exposure at the child’s 
home was assessed by questionnaire around the age of 6 (no, seldom or never; yes, but 
less than once a week; yes, more than once a week). 
 
Kidney outcomes in children 
Childhood kidney dimensions: Left and right kidney biometrics were at the median age 
of 6.0 (95% range 5.6 – 7.9) years. As we described earlier,(18,19) we identified the 
left and right kidney in the sagittal plane along its longitudinal axis. We performed 
measurements of maximal bipolar kidney length, width and depth. Kidney width and 
depth were measured at the level of the hilum. The cross-sectional area in which the 
kidney appeared symmetrically round at its maximum width was used. Kidney volume 
was calculated using the equation of an ellipsoid: volume (cm3) = 0.523 x length (mm) 
x width (mm) x depth (mm).(20) Combined kidney volume was calculated by summing 
right and left kidney volume. We previously reported good intra-observer and inter-
observer correlation coefficients.(21) 
 Childhood kidney function: Blood creatinine levels were measured with an enzymatic 
method on a Cobas c 502 analyzer (Roche Diagnostics, Germany), as previously 
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described.(18,19) Quality control samples demonstrated intra- and inter-assay co-
efficients of variation ranging from 0.51% to 1.37%. Estimated glomerular filtration 
rate (eGFR) was calculated according to the revised Schwartz 2009 formula(22); eGFR = 
36.5 * (height (cm)/creatinine (µmol/l).(22) Urine creatinine (mmol/l) and urine albumin 
(mg/l) levels were determined on Beckman Coulter AU analyser, creatinine levels were 
measured according to the Jaffe method. We calculated the albumin-creatinine ratio. For 
boys microalbuminuria was defined as an albumin-creatinine ratio between 2.5 and 25 
mg/mmol, for girls we used a ratio between 3.5 and 25 mg/mmol.(23)
Covariates
Information on maternal age, parity, educational level, pre-pregnancy body mass 
index (BMI) and maternal and paternal ethnicity was obtained from questionnaires.
(24) Maternal and paternal blood pressure at intake was measured with the validated 
Omron 907 automated digital oscillometric sphygmanometer (OMRON Healthcare B.V. 
Hoofddop, the Netherlands).(25) Child sex, gestational age at birth and birth weight 
were obtained from midwife and hospital registries. Breastfeeding (yes/no) was assessed 
using questionnaires. Current height and weight were measured without shoes and 
heavy clothing at the visit at 6 years, and body surface area (m2) (BSA) was calculated. 
We assessed the associations of the covariates with the outcome measurements in a 
univariate model including child age and sex. All covariates, except ethnicity, were 
associated (P<0.10) with one or more outcome measurements (Supplementary Material 
Table S1). 
Statistical analysis
We assessed differences in baseline characteristics between the categories of maternal 
smoking during pregnancy using independent samples t-tests and Chi Square tests. We 
used multiple linear regression models to assess the associations of maternal smoking 
with combined kidney volume and eGFR in childhood. For analyses on the risk of 
microalbuminuria, we used logistic regression models. We investigated the associations 
of the quantity of maternal cigarettes smoked with kidney outcomes using similar 
models. Tests for trend were performed using multiple linear regression models in 
which the categories of the number of cigarettes smoked were included as a continuous 
variable, using the non-smoking mothers as reference group. The models were first 
adjusted for sex and age of the child (basic model). These models were additionally 
adjusted for potential confounders including maternal age, ethnicity, parity, educational 
level, pre-pregnancy body mass index, blood pressure at intake, gestational age at 
birth, birth weight and childhood BSA (confounder model). Analyses focused on eGFR 
were not further adjusted for BSA since this is included in the Schwartz 2009 formula. 
In addition we adjusted the confounder model for smoke exposure at home around 
the age 6 (childhood smoke exposure model). We additionally adjusted the childhood 
smoke exposure model for childhood kidney volume (childhood kidney volume model). 
With the childhood models we try to explore whether any association was explained 
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by childhood smoke exposure or childhood kidney volume. The confounder model was 
considered as the main model. We used similar models to assess the associations of 
paternal smoking during pregnancy on childhood kidney outcomes. These analyses were 
performed among mothers who did not smoke during pregnancy only. Since maternal 
and paternal smoking were strongly correlated, investigating paternal smoking among 
all mothers would overestimate the effect of paternal smoking if direct intra-uterine 
mechanisms are present. In these analyses we adjusted for paternal ethnicity and blood 
pressure at intake. Furthermore, we tested potential combined effects and interactions 
between maternal smoking, size at birth, gestational age at birth for the associations 
with childhood kidney volume and eGFR by performing stratified regression analyses. 
The interactions between smoking of the mother and birth outcomes with childhood 
kidney outcomes were not significant and no further stratified analyses were performed. 
Missing values in covariates (ranging from 0 to 39%, see Supplementary Material 
Table S2), were multiple-imputed, to reduce potential bias associated with missing 
data.(26) We created five imputed datasets and each dataset was analyzed separately 
to obtain the effect sizes and standard errors. The results of all 5 imputed analyses were 
pooled and are presented in this paper. Measures of association are presented with their 
95% confidence intervals (CI). All P-values are 2-sided and considered a p-value of <0.05 
as statistically significant. All statistical analyses were performed using the Statistical 
Package of Social Sciences version 20.0 for Windows (SPSS Inc, Chicago, IL, USA).
Results
Subject characteristics
Subject characteristics are presented in Table 1. The mean estimated glomerular filtration 
rate (eGFR) was 118.7 ml/min per 1.73m² (SD 16.0) and 7.4 percent of our sample had 
microalbuminuria. The observed, non-imputed, baseline characteristics are given in the 
Supplementary Material (Table S2). Mothers who continued smoking during pregnancy 
were more often younger, lower educated, from a non-European ethnicity, and more often 
had partners who also smoked. Also, their children had a lower birth weight, were less often 
breastfed and had a higher body mass index (BMI) at the age of 6 than children of mothers 
who did not smoke. Non-response analysis (Table S3) showed that compared with mothers 
of children not included in the analysis, mothers of children included in the analysis were 
older, were more frequently higher educated and of the Dutch or European ethnicity.  
Maternal smoking during pregnancy and childhood kidney outcomes 
Table 2 shows that compared to children from mothers who did not smoke during 
pregnancy, those from mothers who continued smoking during pregnancy had a 
smaller combined kidney volume at the age of 6 years. The strongest effect estimate 
was observed for mothers who smoked 5 or more cigarettes per day during pregnancy 
(difference for combined kidney volume -2.80 cm3 (95% Confidence Interval (CI): -5.15, 
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-0.45)). Similarly, continued maternal smoking during pregnancy was also associated 
with a lower eGFR in childhood (difference -2.09 ml/min per 1.73m² (95% CI: -3.55, -0.63)). 
The association of maternal smoking during pregnancy with eGFR was stronger for a 
higher number of cigarettes (p-value for trend <0.05). First trimester only smoking was 
associated with a higher risk of microalbuminuria (Odds Ratio (OR) 1.45, (95% CI: 1.05, 
2.01)).  Additional adjustment for smoke exposure during childhood did not materially 
changed the effect estimates. The effects of maternal smoking on childhood eGFR were 
only slightly explained by childhood kidney volume. Models that were only adjusted for 
sex and age of the child (basic models) show slightly stronger effect estimates (Table 2).
Paternal smoking during pregnancy and childhood kidney outcomes
Table 3 shows that among children of mothers who did not smoke during pregnancy, 
paternal smoking tended to be associated with a smaller childhood combined kidney 
volume. Similarly to maternal smoking during pregnancy, the strongest association 
was observed for fathers who smoked 5 or more cigarettes per day (difference -1.77 
cm3 (95% CI: -3.47, -0.07)). Paternal smoking was not associated with childhood eGFR 
and microalbuminuria. Additional adjustment for smoke exposure during childhood 
and childhood kidney volume did not materially change the associations between 
paternal smoking during pregnancy and measures of childhood kidney volume and 
function. Models that were only adjusted for sex and age of the child show similar results 
(Table 3). The effect estimates for maternal smoking on childhood kidney volume were 
not significantly stronger compared with paternal smoking. 
Figure 1. Flowchart
 
N = 8,024
Singleton life births with maternal smoking data 
available
N = 248 Excluded, 
due to withdrawal of consent, N = 800 due to loss 
follow-up and N = 1,318 did not visit research 
centerN = 5,658
Participation in visit at the age of six years
Information about kidney outcomes N = 5,622
Combined kidney volume N = 5,164
Estimated glomerular ltration rate N = 3,745
N = 10 Excluded,
due to kidney abnormalities, and N = 26 due to 
missing data on all outcome measurements
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Table 1. Subject characteristics (N=5,622)
Maternal smoking during pregnancy
Non smoking  
N=4,199 (74.7%)
Stopped when pregnancy 
was known N=498 (8.9%)
Continued smoking
N=925 (16.4%)
Maternal characteristics
Age, (y) 31.4 (20.4, 39.9) 30.7 (19.4, 39.5)† 29.6 (18.7, 39.2)†
Gestational age at enrollment (wks) 13.9 (9.8, 24.4) 13.4 (9.8, 22.3)† 14.1 (9.5, 23.8)
Height, (cm) 167.7 (7.4) 168.8 (7.0)† 166.9 (7.1)†
Pre-pregnancy weight, (kg) 66.5 (12.4) 66.1 (11.5) 67.1 (9.6)
Pre-pregnancy body mass index, (kg/m2) 23.6 (3.9) 23.2 (4.0)* 23.8 (4.8)
Parity ≥1, (%) 44.2 (1855) 29.3 (146)† 44.2 (409)
Systolic blood pressure (mmHg) 115.8 (12.3) 116.0 (12.1) 115.9 (12.1)
Diastolic blood pressure (mmHg) 68.6 (9.4) 67.7 (9.5) 67.1 (9.7)†
Education, (%)
Primary/secondary 48.8 (2051) 54.0 (269)* 77.6 (718)†
Secondary or higher 51.2 (2148) 46.0 (228)* 22.4 (207)†
Ethnicity, (%)
Dutch or European 63.7 (2673) 66.9 (333) 55.7 (515)†
Non-European 36.3 (1526) 33.1 (165) 44.3 (410)†
Paternal characteristics
Age, (y) 33.6 (22.8, 46.7) 32.4 (22.1, 46.8)† 31.9 (19.8, 44.6)†
Height, (cm) 182.0 (7.6) 182.6 (8.1) 180.5 (7.9)†
Weight, (kg) 83.8 (11.2) 83.6 (13.0) 82.8 (11.8)
Body mass index, (kg/m2) 25.3 (3.1) 25.1 (3.2) 25.4 (3.6)
Ethnicity, (%)
Dutch or European 64.6 (2714) 68.5 (341)* 56.2 (520)†
Non-European 35.4 (1485) 31.5 (157)* 43.8 (405)†
Systolic blood pressure (mmHg) 130.0 (13.5) 130.1 (13.6) 129.7 (13.4)
Diastolic blood pressure (mmHg) 73.6 (10.6) 72.9 (10.3) 72.7 (10.7)*
Smoking, (%)
Yes 35.5 (1350) 65.3 (301)† 77.1 (608)†
No 64.5 (2454) 34.7 (160)† 23.0 (180)†
Birth characteristics
Sex boys, (%) 49.2 (2066) 47.4 (236) 55.0 (509)†
Gestational age, (wk) 40.1 (36.0, 42.3) 40.1 (35.9, 42.2) 40.0 (34.7, 42.3)†
Preterm, (%) (n) 4.5 (191) 4.2 (21) 6.1 (56)
Birth weight, (g) 3457 (545) 3453 (551) 3282 (556)†
Small for gestational age, (%) (n) 5.1 (216) 5.8 (29) 11.6 (107)†
Breastfed yes, (%) 93.4 (3922) 92.6 (461) 84.4 (781)†
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Child characteristics
Age, (y) 6.0 (5.6, 7.8) 6.0 (5.6, 8.1) 6.1 (5.6, 8.1)†
Height, (cm) 119.4 (5.9) 119.8 (6.2) 119.5 (6.4)
Weight, (kg) 23.1 (4.1) 23.3 (4.2) 24.0 (5.1)†
Body mass index, (kg/m2) 16.1 (1.8) 16.1 (1.9) 16.7 (2.2)†
Body surface area, (m2) 0.87 (0.09) 0.88 (0.09) 0.89 (0.11) †
Smoke at home, (%)
              No, seldom or never 91.0 (3821) 80.5 (401) 46.8 (433)
              Yes, but less than once a week 3.0 (127) 6.2 (31) 9.7 (90)
              Yes, more than once a week 6.0 (251) 13.3 (66) 43.5 (402)
Combined kidney volume, (cm3) 120.1 (23.2) 119.8 (21.4) 119.9 (25.0)
Creatinine, (µmol/l) 37.3 (5.3) 37.5 (5.5) 38.5 (5.7)†
eGFR, ml/min 1.73 m2 119.3 (16.0) 119.3 (15.3) 116.0 (16.3)†
Microalbuminuriaǂ, (%) 7.2 (291) 9.9 (48)* 7.1 (63)
Values are means (SD) or medians (95% range) or % (numbers). Differences between 
categories of maternal smoking were compared using T-test and chi-square, non-
smoking category was used as reference. 
ǂDefined as levels between 2.5-25.0 mg/mmol (boys) and 3.5-25.0 mg/mmol (girls).
eGFR, estimated glomerular filtration rate
*P<0.05, †P<0.01
Table 2. Maternal smoking during pregnancy and kidney size and function in 6 year old 
children (N=5,622)
Combined kidney volume 
difference (95% CI) (cm3)
eGFR difference (95% CI)
(ml/min per 1.73m²)
Microalbuminuria 
Odds Ratio (95% CI)
Maternal smoking during pregnancy
Basic model1 
Non smoking during pregnancy (N=4,199) Reference Reference Reference
Stopped when pregnancy was known (N=498) -0.27 (-2.46, 1.91) 0.10 (-1.71, 1.91) 1.41 (1.02, 1.95)*
Continued smoking during pregnancy (N=925) -1.91 (-3.59, -0.22)* -2.94 (-4.35, -1.54)† 0.99 (0.74, 1.31)
< 5 cigarettes per day (N=355) -0.73 (-3.28, 1.82) -2.29 (-4.44, -0.13)* 1.08 (0.71, 1.65)
Table 1. Continued
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≥5 cigarettes per day (N=334) -4.28 (-6.91, -1.65)† -3.36 (-5.51, -1.20)† 1.01 (0.71, 1.67)
P-value for trend P<0.01 P<0.01 P=0.64
Confounder model2
Non smoking during pregnancy (N=4,199) Reference Reference Reference
Stopped when pregnancy was known (N=498) -1.08 (-2.99, 0.83) -0.06 (-1.88, 1.76) 1.45 (1.05, 2.01)*
Continued smoking during pregnancy (N=925) -0.89 (-2.41, 0.63) -2.09 (-3.55, -0.63)† 1.08 (0.80, 1.44)
< 5 cigarettes per day (N=355) 0.22 (-2.02, 2.45) -1.68 (-3.85, 0.49) 1.16 (0.76, 1.77)
≥5 cigarettes per day (N=334) -2.80 (-5.15, -0.45)* -2.22 (-4.42, -0.02)* 1.21 (0.78, 1.88)
P-value for trend P<0.05 P<0.05 P=0.33
Childhood smoke exposure model3 
Non smoking during pregnancy (N=4,199) Reference Reference Reference
Stopped when pregnancy was known (N=498) -1.02 (-2.94, 0.90) -0.11 (-1.94, 1.72) 1.44 (1.04, 2.00)*
Continued smoking during pregnancy (N=925) -0.70 (-2.37, 0.96) -2.04 (-3.71, -0.38)* 1.03 (0.74, 1.43)
             < 5 cigarettes per day (N=355) 0.30 (-2.01, 2.60) -1.79 (-4.05, 0.48) 1.14 (0.74, 1.77)
             ≥5 cigarettes per day (N=334) -2.72 (-5.22, -0.21)* -1.92 (-4.33, 0.50) 1.17 (0.73, 1.88)
P-value for trend P=0.11 P<0.05 P=0.53
Childhood kidney volume model4 
Non smoking during pregnancy (N=4,197) NA Reference Reference
Stopped when pregnancy was known (N=498) NA 0.65 (-1.17, 2.47) 1.43 (1.01, 2.02)*
Continued smoking during pregnancy (N=925) NA -1.90 (-3.57, 0.22)* 1.04 (0.74, 1.47)
< 5 cigarettes per day (N=355) NA -1.28 (-3.54, 0.97) 1.20 (0.76, 1.90)
≥5 cigarettes per day (N=334) NA -1.52 (-3.95, 0.91) 1.36 (0.84, 2.20)
P-value for trend NA P=0.11 P=0.26
Values are based on multiple linear and logistic regression models and reflect regression 
coefficients (95% Confidence interval (CI)) and Odds Ratio’s (95% CI) for microalbuminuria. 
1Model is adjusted for child sex and current age. 2Model is additionally adjusted for 
maternal age, parity, educational level, ethnicity, pre-pregnancy body mass index, blood 
pressure at intake, child’s gestational age at birth, birth weight, breastfeeding status and 
childhood body surface area. 3Model is additionally adjusted for child smoke exposure. 
4Model is additionally adjusted for combined childhood kidney volume. Children of non-
smoking mothers were used as reference group. 
eGFR, estimated glomerular filtration rate
*P<0.05, †P<0.01
Table 2. Continued
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Table 3. Paternal Smoking during pregnancy and kidney size and function in 6 year old 
children (N=3,804)
Combined kidney volume 
difference (95% CI, cm3)
eGFR difference  
(95% CI, ml/min per 1.73m²)
Microalbuminuria Odds Ratio
 (95%CI)
Paternal smoking
Basic model1
No (N=2,454) Reference Reference Reference
Yes (N=1,350) -0.15 (-1.72, 1.42) -0.45 (-1.74, 0.85) 0.92 (0.71, 1.20)
< 5 cigarettes per day (N=590) 0.89 (-1.22, 2.99) -1.16 (-2.91, 0.59) 0.90 (0.62, 1.29)
≥5 cigarettes per day (N=731) -1.40 (-3.33, 0.54) 0.20 (-1.43, 1.83) 0.96 (0.70, 1.33)
P-value for trend P=0.28 P=0.92 P=0.72
Confounder model2 
No (N=2,454) Reference Reference Reference
Yes (N=1,350) -0.77 (-2.16, 0.61) -0.36 (-1.66, 0.94) 0.95 (0.73, 1.24)
< 5 cigarettes per day (N=590) 0.06 (-1.80, 1.92) -1.24 (-2.99, 0.52) 0.89 (0.62, 1.29)
≥5 cigarettes per day (N=731) -1.78 (-3.48, -0.07)* 0.31 (-1.33, 1.95) 1.01 (0.73, 1.40)
P-value for trend P=0.06 P=0.96 P=0.92
Childhood smoke exposure model3 
No (N=2,454) Reference Reference Reference
Yes (N=1,350) -0.77 (-2.24, 0.70) -0.30 (-1.67, 1.08) 0.94 (0.70, 1.25)
< 5 cigarettes per day (N=590) 0.05 (-1.83, 1.92) -1.22 (-3.00, 0.55) 0.89 (0.61, 1.29)
≥5 cigarettes per day (N=731) -1.80 (-3.62, 0.02) 0.46 (-1.30, 2.21) 1.00 (0.70, 1.43)
P-value for trend P=0.08 P=0.79 P=0.85
Childhood kidney volume model4
No (N=2,454) NA Reference Reference
Yes (N=1,350) NA -0.26 (-1.63, 1.11) 1.08 (0.80, 1.46)
< 5 cigarettes per day (N=590) NA -1.44 (-3.21, 0.33) 1.03 (0.71, 1.51)
≥5 cigarettes per day (N=731) NA 0.67 (-1.04, 2.46) 1.14 (0.79, 1.66)
P-value for trend NA P=0.64 P=0.49
Values are based on multiple linear and logistic regression models and reflect regression 
coefficients (95% Confidence interval (CI)) and Odds Ratio’s (95% CI) for microalbuminuria. 
The associations of paternal smoking were assessed among children of mothers who did 
not smoke during pregnancy. 1Model is adjusted for child sex and current age. 2Model is 
additionally adjusted for maternal age, parity, educational level, pre-pregnancy body mass 
index, paternal ethnicity and blood pressure at intake, child’s gestational age at birth, 
birth weight, breastfeeding status and childhood body surface area. 3Model is additionally 
adjusted for child smoke exposure. 4Model is additionally adjusted for combined childhood 
kidney volume. Children of non-smoking fathers were used as reference group. 
eGFR, estimated glomerular filtration rate
*P<0.05
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Discussion 
The results of this study suggest that continued  maternal smoking during pregnancy 
is associated with a smaller childhood kidney size and a lower eGFR. A higher risk of 
microalbuminuria was found in children of mothers who smoked only in first trimester. Among 
mothers who did not smoke during pregnancy, paternal smoking was associated with smaller 
childhood combined kidney volume, but not with childhood kidney function measures. 
 Adverse fetal exposures, such as exposure to cigarette smoking, may influence fetal 
kidney development. Since nephrogenesis continues until 36 weeks of gestation and 
largely ceases thereafter, adverse exposures during this critical period may lead to impaired 
kidney development.(1,2) It has been hypothesized that impaired fetal kidney growth with a 
reduced number of nephrons leads to glomerular hyperfiltration and sclerosis, subsequently 
predisposing the individual to impaired kidney function and chronic kidney disease in 
adulthood.(3,4) Several studies, both in animals and in humans, have investigated the 
association of cigarette exposure during pregnancy with short-term kidney development 
outcomes in early life. We have previously shown in 1,072 pregnant mothers and their 
unborn children that maternal smoking during pregnancy was associated with an altered 
kidney development in third trimester of pregnancy in a time- and dose-dependent manner.
(10) Two human studies using ultrasound or MRI during fetal life showed diminished kidney 
growth in fetuses of mothers who smoked during pregnancy compared to non-smoking 
mothers.(9,11) 
 To the best of our knowledge the present study is the first that examines the associations 
of parental smoking during pregnancy with childhood kidney outcomes. We observed 
associations of maternal smoking with smaller childhood kidney volume and a lower eGFR. 
These associations were not explained by childhood smoke exposure. Our results suggest 
that the changes observed in fetal life, persist in childhood and may have effect on kidney 
function. Animal studies showed changes in kidney morphology after prenatal exposure 
to maternal cigarette smoking.(12,13) Our results are in line with an earlier study from the 
same cohort as the present study, which showed that maternal smoking during pregnancy 
is associated with an increase in diastolic blood pressure and fractional shortening in 6 
year old children, with stronger effects for maternal smoking than paternal smoking.(17) 
Another study showed an effect of maternal smoking during pregnancy on childhood 
systolic blood pressure, dependent of birth weight.(27) Surprisingly, we observed that first 
trimester smoking only was associated with a higher risk of microalbuminuria, independent 
of potential confounders, childhood smoke exposure and kidney size. Continued smoking 
was not associated with a higher risk of microalbuminuria. We could not explain why only 
first-trimester maternal smoking would be related with childhood microalbuminuria. 
 In the current study, we tried to disentangle the causality for the association of maternal 
smoking during pregnancy with childhood kidney outcomes. Next to adjusting for multiple 
potential confounders, we assessed the association of both maternal and paternal smoking 
during pregnancy with kidney outcomes to further explore the role of confounding. 
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Adjustment for potential confounders did not fully explain the associations. The adverse 
effects of maternal smoking on the fetus are likely to be much larger than the effects of 
paternal smoking. Stronger effects on kidney outcomes for maternal compared to paternal 
smoking during pregnancy would suggest direct intra-uterine effects, whereas similar effects 
for paternal and maternal smoking are more likely to imply a role for shared family-based 
and life style related factors.(14,15) Earlier we showed continued maternal smoking during 
pregnancy leads to a 100-200 grams lower birth weight, whereas only paternal smoking 
leads to a 29-44 grams lower birth weight.(6) Although the differences in effect estimates 
of maternal and paternal smoking were not significant, we observed stronger effect sizes 
for the associations of maternal smoking than for paternal smoking with childhood kidney 
volume. Maternal smoking was related to kidney function, but paternal smoking was not. 
These results suggest a role of direct intra-uterine mechanisms following tobacco exposure. 
However, we should be careful with concluding intrauterine causal mechanisms since the 
effect estimates were small, and of borderline significance.
 The biological mechanisms underlying the association of fetal smoke exposure with 
childhood kidney development are unknown. It might be explained by various smoking 
substances, such as teratogen and toxins, which involve nicotine, carbon monoxide and 
cadmium. Nicotine induces vasoconstriction, which leads to reduced placental blood flow 
and lower oxygen levels during fetal life,(28) which may result in a decreased hemodynamic 
stimulus for fetal vascular development.(29,30) Carbon monoxide and cadmium exposure 
lead to lower placental and fetal perfusion.(17,18) Subsequently, these vascular changes 
might lead to kidney developmental adaptations. The possible mechanism underlying 
the associations between fetal smoke exposure and kidney function in later life need to 
be studied in further research. 
 The results of this study are important from an etiological perspective. Fetal exposure 
to maternal smoking have persistent subclinical consequences on kidney outcomes. The 
associations of smoking with childhood eGFR were independent of childhood kidney size. 
This might imply that fetal smoke exposure has a permanent subclinical effect, independent 
of later kidney growth, on kidney function in later life. Longitudinal studies report the 
risks factors for kidney diseases track from childhood to adulthood.(31,32) We did not find 
associations of maternal smoking with a higher risk of childhood microalbuminuria. The 
effects of impaired kidney growth on microalbuminuria may not be detectable during 
childhood, but may become more evident later in life. For example, it also has been suggested 
that fetal adverse exposures can be compensated for many years before high levels of blood 
pressure are present.(33)
 The main strength of our study is the prospective data collection from early fetal life 
onwards and the size of the population-based cohort. Our analyses were based on more than 
5,600 children with kidney outcome measurements. The detailed information on maternal 
and paternal smoking during pregnancy enabled us to assess both trimester specific and 
dose-response relationships. We used ultrasound measurements to calculate kidney volume 
and measured kidney function using blood and urine samples. Also, we had information 
about a large number of potential confounders. We also need to address some limitations. 
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Information about smoking during pregnancy was missing for 16% of all mothers. This non-
response would lead to biased effect estimates if associations of maternal smoking during 
pregnancy with kidney outcomes would be different between those mothers included and 
not included in the analyses. This seems unlikely, but cannot be excluded. Biased estimates 
in large cohort studies mainly arise from loss to follow-up rather than from a non-response at 
baseline.(34) Of all children with available data on maternal smoking during pregnancy, 70% 
participated in the follow-up measurements at the age of six years. Overall, mothers who did 
not visit the research center for follow-up measurements were younger, did more frequently 
smoke during pregnancy, were less educated and did less often breastfed their child than 
the total sample. Their children had also a lower birth weight. This selective loss to follow-up 
might have led to an underestimation of the effect estimates observed. Furthermore, the 
selection towards a healthier group of mothers might affect the generalizability of the results 
towards more high-risk populations. Smoking behavior was measured with questionnaires. 
This might have resulted in an underreporting of smoking behavior in some individuals. 
Because nephron number cannot be studied in vivo, kidney size was used as a measure of 
kidney development. Kidney size is correlated with the number of glomeruli and can, in 
epidemiology studies, be used as a measure of kidney development.(35) The glomerular 
filtration rate was calculated using blood creatinine levels. More accurate might be the 
use of Cystatin C blood levels,  Cystatin C is produced more constantly and less dependent 
on children’s body weight, height, and sex.(36) However, when using Cystatin C instead of 
eGFR, we observed quite similar results. The albumin/creatinine ratio was used to assess 
albuminuria in a random urine sample.(37) For urinary albumin excretion the within subject 
variation is large, variability will be lower if we collected first morning void samples instead 
of random samples during the day;(38) unfortunately this was not possible in the current 
study. Finally, although we have performed adjustment for various potential confounders, 
residual confounding should be considered due to the observational design of the study. 
Conclusion and perspectives
In conclusion, we observed that maternal smoking during pregnancy is associated with 
smaller childhood kidney volume and lower eGFR. Maternal smoking during pregnancy is 
modifiable and could present an opportunity for prevention of chronic kidney disease in 
later life. Further research is needed to assess whether the associations between fetal smoke 
exposure and kidney function persist during later life and to establish whether reduction 
of maternal smoking during pregnancy might lead to a better kidney development and 
improved kidney function during the life course.
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Table S1. Univariate associations of covariates with kidney size and function in six year 
old children
Combined kidney volume 
difference (95% CI) (cm3)
eGFR difference (95% CI)
(ml/min per 1.73m²)
Microalbuminuria 
Odds Ratio (95% CI)
Covariates, maternal characteristics 
Maternal age, (y) -0.00 (-0.12, 0.12) 0.09 (-0.01, 0.19)# 1.02 (1.00 , 1.04)
Pre-pregnancy body mass index, (kg/m2) 0.43 (0.28, 0.59)† 0.07 (-0.07, 0.21) 0.99 (0.97 , 1.02)
Parity (multiparous vs primiparous) -1.21 (-2.45, 0.04)# -1.37 (-2.41, -0.34)† 0.97 (0.79 , 1.19)
Systolic blood pressure (mmHg) 0.12 (0.07, 0.18)† -0.01 (-0.05, 0.04) 1.01 (1.00, 1.02)
Diastolic blood pressure (mmHg) 0.04 (-0.03, 0.11) 0.02 (-0.04, 0.08) 1.01 (1.00, 1.02)#
Educational level (higher versus primary/secondary) 2.36 (1.10, 3.62)† 1.75 (0.69 , 2.82)† 1.22 (0.99 , 1.50)#
Ethnicity (European vs Non-European) -0.91 (-2.20, 0.38) 0.18 (-0.90, 1.26) 0.95 (0.77, 1.17)
Covariates, paternal characteristics
Ethnicity (European vs Non-European) 0.40 (-1.09, 1.89) -0.04 (-1.25, 1.17) 1.15 (0.92, 1.44)
Systolic blood pressure (mmHg) -0.01 (-0.08, 0.05) -0.04 (-0.10, 0.02) 1.00 (0.99, 1.01)
Diastolic blood pressure (mmHg) -0.10 (-0.18, -0.01)* -0.06 (-0.12, 0.01) 1.00 (0.99, 1.01)
Covariates, birth characteristics
Gestational age, (wk) 0.76 (0.41, 1.12)† 0.33 (0.03, 0.62)* 1.01 (0.98, 1.04)
Birth weight, (kg ) 8.16 (7.06, 9.27)† 1.85 (0.90, 2.79)† 0.95 (0.79, 1.14)
Breastfed (yes vs no) 3.98 (1.14, 6.82)† 2.90 (0.77, 5.04)† 1.41 (0.76, 2.62)
Covariates, child characteristics
Body mass index, (kg/m2) 4.21 (3.88, 4.53)† -0.20 (-0.48, 0.08) 0.90 (0.85, 0.96)†
Body surface area, (m2) 139.17 (132.33, 146.02)† 18.64 (12.20, 25.08)† 0.24 (0.06, 0.88)* 
Values are regression coefficients (95% Confidence interval (CI)) based on multiple 
regression models and Odds Ratio’s (95% CI) for microalbuminuria based on logistic 
regression models and reflect the difference in kidney size and function at the age of 
six years for different categories of maternal smoking during pregnancy. All regression 
analyses were adjusted for child sex and current age.
#<p<0.10, *P<0.05, †P<0.01
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Abstract
Background High protein intake has been linked to kidney growth and function. 
Whether protein intake is related to kidney outcomes in healthy children is unclear. 
Methods We examined the associations of protein intake in infancy with kidney 
outcomes at 6 years in 2,908 children participating in a population-based cohort study. 
Protein intake at 1 year was assessed with a food-frequency questionnaire and was 
adjusted for energy intake. At the children’s age of 6 years we measured kidney volume 
and urinary albumin/creatinine ratio (ACR), and we estimated glomerular filtration rate 
(eGFR) using serum creatinine and cystatin C levels. 
Results In models adjusted for age, sex, body surface area, and sociodemographic 
factors, a higher protein intake was associated with a lower ACR and a higher eGFR but 
not consistently with kidney volume. However, after further adjustment for children’s 
other dietary and lifestyle factors, such as sodium intake, diet quality, and television 
watching, higher protein intake was no longer associated with kidney function. No 
differences in associations were observed between animal and vegetable protein intake. 
Conclusions Protein intake in early childhood is not associated kidney size or function 
at the age of 6 years. Further study is needed on other early life predictors of later kidney 
size and function. 
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Introduction
Kidney function has been shown to track from childhood into adulthood.(1) Subclinical 
variations in kidney function are already present in childhood and have been shown 
to relate to kidney disease in later life.(2) This implicates that it is important to study 
determinants of kidney function already in childhood. We have recently observed that 
reduced infant weight growth is associated with smaller kidney volume in childhood,(3) 
and that longer breastfeeding duration is associated with larger kidney volume and an 
increased estimated glomerular filtration rate (eGFR).(4) These observations suggest 
that exposures in infancy are important for later kidney development. 
 Dietary protein intake during infancy is a key factor for growth and development and 
may be associated to kidney growth and function.(5) In animal studies, increased protein 
intake leads to increased kidney growth and function.(6-8) and early postnatal dietary 
protein affects kidney function.(8,9) Also in healthy adults, a higher protein intake has 
been associated with increased GFR.(10-12) In patients with chronic kidney disease, high 
protein intake may further decline kidney function, because the kidneys can no longer 
handle the excretion of protein metabolites.(13-16) However, randomized controlled 
trials with low-protein diets in adults or children with renal disease have not consistently 
been able to slow progression of kidney disease.(17-19)
 Not much is known on the effects of protein intake on kidney function in children 
with a normal kidney function. Trials suggest that infants who receive additional dietary 
protein have larger kidneys(5) and a higher eGFR(20) in infancy than those who received 
no additional protein. Whether protein intake in infancy is associated with kidney size 
and function in later childhood is unknown. 
 Therefore, we examined the associations between protein intake at the age of 1 year 
and kidney outcomes at the age of 6 years in 2,908 children participating in a population-
based prospective cohort study. Kidney measures included combined kidney volume, 
creatinine-based eGFR (eGFRCreat), cystatin C-based eGFR (eGFRCysC), and urinary albumin/
creatinine ratio. In addition, we examined the association between protein intake at 2 years 
with kidney outcomes at 6 years in a subgroup of the children; and we aimed to evaluate 
whether the associations between protein intake and kidney health differed by protein 
source, child sex, birth weight, gestational age at birth, kidney volume, or ethnicity. 
Methods
Study design and population
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from fetal life onward in Rotterdam, the Netherlands.(21) All children were 
born between April 2002 and January 2006. The study was conducted according to the 
guidelines of the Helsinki Declaration and approved by the Medical Ethics Committee of 
Erasmus Medical Center, Rotterdam (MEC 198.782/2001/31). Written informed consent was 
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given by all parents. A total of 7,893 children were available for follow-up studies in early 
childhood.(21) A questionnaire on child diet around the age of 1 year was sent to 5,088 
mothers who provided consent for follow-up and had sufficient mastery of the Dutch 
language (Figure 1). In total 3,650 (72%) of these mothers returned the questionnaire.
(22) After exclusion of subjects with invalid dietary data and withdrawn consent, 
information on infant diet was available for 3,629 children. From these 3,629 children, 
we excluded children with congenital kidney abnormalities or an albumin-creatinine 
ratio >25 mg/mmol (N=8).(23) Of the remaining children, 2,965 had one or more kidney 
measurements available at the age of 6 years (Figure 1).
Dietary assessment
Dietary intake was assessed at a median age of 12.9 months (95% range 12.2 to 18.9) 
using a semi-quantitative 211-item food frequency questionnaire (FFQ), as described 
previously in detail.(22,24) The FFQ was validated against three 24h-recalls in a 
representative sample of 32 Dutch children around the age of 1 year living in Rotterdam. 
The intraclass correlation coefficient was 0.7 for total protein intake.(22) Mothers of a 
subgroup of 899 Dutch children received an additional FFQ at their child’s median age of 
24.9 months (95% range 24.3 to 27.6).(24) Of these children, 715 had kidney measures at 
the age of 6 years available (Supplementary Figure S1).
Kidney outcome assessments
Children’s kidney outcomes were assessed at a median age of 5.9 years (95% range 5.6 
to 6.6) in a dedicated research center in the Sophia Children’s Hospital in Rotterdam 
by well-trained staff.(23) Kidney volume was measured with ultrasound, using an ATL-
Philips HDI 5000 instrument (Seattle, WA, USA), equipped with a 2.0-5.0 MHz curved 
array transducer, as described previously in detail.(25,23) Kidney volume was calculated 
using the equation for a prolate ellipsoid: volume (cm3) = 0.523 x length (cm) x width 
(cm) x depth (cm).(25) Combined kidney volume was calculated by summing right and 
left kidney volume. We previously reported good intra-observer and inter-observer 
correlation coefficients.(26) 
 Non-fasting blood samples were drawn by antecubital venipuncture. Creatinine 
concentrations were measured with enzymatic methods, and cystatin C levels were 
measured with a particle-enhanced immunoturbidimetric assay (using Cobas 8000 
analyzers, Roche, Almere, the Netherlands). Quality control samples demonstrated 
intra-assay coefficients of variation of 0.51% for creatinine and 1.65% for cystatin C, and 
inter-assay coefficients of 1.37% for creatinine and 1.13% for cystatin C.(23) Creatinine-
based estimated glomerular filtration rate (eGFR) was calculated according to the 
revised Schwartz 2009 formula, the most common pediatric equation: eGFRCreat = 36.5 x 
(height (cm)/ creatinine (µmol/L)).(27) Additionally, we evaluated eGFR calculated using 
a cystatin C-based and a combined creatinine and cystatin C formula as proposed by 
Zappitelli in 2006: eGFRCysC = 75.94 / (cystatin C (mg/L)
1.17) and eGFRCombined =507.76 x 
e0.003x height (cm)/ (cystatin C (mg/L)0.635 x creatinine (µmol/L)0.547).(28) 
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Urinary creatinine (mmol/L) and albumin (mg/L) levels were measured with a Beckman 
Coulter AU analyzer, and creatinine levels were determined using the Jaffe reaction. We 
calculated the urinary albumin/creatinine ratio (ACR). In addition to the continuous ACR, 
we defined microalbuminuria as an ACR ≥ 2.5 mg/mmol for boys, and ≥ 3.5 mg/mmol 
for girls.(29) 
Covariates
Information on maternal age, educational level, and folic acid supplement use was 
obtained with a questionnaire at enrollment in the study. Maternal height and weight 
were measured at the research center at enrollment and body mass index (BMI, kg/m2) 
was calculated. Maternal smoking during pregnancy was assessed using questionnaires 
in each trimester and was categorized into never; until pregnancy was known; or 
continued during pregnancy. Information on child’s sex, birth weight and gestational 
age was available from medical records and hospital registries. Sex and gestational age 
specific SD scores for birth weight were calculated using Swedish reference data.(30) 
Child’s ethnicity was defined according to Statistics Netherlands(31) and classified into 
eight categories (Western, Cape Verdean, Moroccan, Netherlands Antillean, Turkish, 
Surinamese Creole, Surinamese Hindustani, and other non-Western). 
 Information on breastfeeding was obtained from delivery reports and postnatal 
questionnaires, and breastfeeding was categorized as never; partial in the first 4 months; 
or exclusively in the first 4 months of life.(22) Total energy, fat and sodium intake from 
foods were estimated using the previously mentioned FFQs, and were adjusted for energy 
intake using the residual method.(32) A previously defined diet score was used to quantify 
overall diet quality using data obtained with the FFQ.(24) Information on child’s television 
watching around the age of 2 years was obtained using a questionnaire. At the child’s age of 
6 years, we measured height and weight at the research center and calculated BMI (kg/m2) 
and body surface area (BSA) (using the Du Bois formula: BSA (cm2) = weight (kg)0.425x height 
(cm)0.725x 0.007184).(33) Lean body mass was measured using whole body dual-energy 
X-ray absorptiometry scans (iDXA, GE-Lunar, 2008, Madison, WI, USA).
Statistical analysis 
We were interested in the effect of protein independent of its energy content and therefore 
we adjusted protein intake for total energy intake using the residual method.(32) Briefly, 
we used the residuals of a linear regression model with energy intake as independent 
variable and protein intake as dependent variable. These residuals provide a measure 
of protein intake uncorrelated with total energy intake. To enhance interpretability, 
predicted protein intake for the mean energy intake (1,311 kcal/d) was added to the 
residuals as a constant.(32) In line with recommendations for dietary exposures, protein 
intake was analyzed both as a continuous and as a categorical variable.(32) For the latter 
purpose we categorized protein intake into tertiles and used the lowest tertile as the 
reference category. 
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We used multivariable linear regression models to assess the associations of protein 
intake with combined kidney volume, eGFR, and ACR. We natural log-transformed ACR to 
obtain a normal distribution. For clinical interpretation, we also assessed the associations 
of protein intake with the risk of microalbuminuria, using multivariable logistic regression 
models. Model 1 was adjusted for child’s sex, age and BSA at kidney measurement. 
Model 2 was further controlled for the following prenatal and sociodemographic factors: 
maternal age, educational level, BMI, smoking during pregnancy, folic acid supplement 
use, and for child’s ethnicity and birth weight Z-score. The final model was additionally 
adjusted for childhood lifestyle factors: breastfeeding, children’s television watching, 
total energy, fat and sodium intake, and diet quality score (model 3). Covariates were 
included in the regression models based on previously shown associations with kidney 
outcomes(23,34,4) or a significant change (>5%) in effect estimates. Because both 
protein intake and kidney volume are strongly related to body size(35) and because 
creatinine levels are associated with muscle mass,(36) we adjusted all models for BSA 
and we performed sensitivity analyses in which we replaced BSA by height and weight, 
by BMI, or by lean body mass. In addition, we examined the association between protein 
intake and the ratio of kidney volume with either body weight, BMI, or BSA. 
 To assess whether the associations were different by sex, ethnicity, birth weight, 
gestational age at birth, or kidney volume at 6 years we evaluated statistical interactions 
by adding the product term of the covariate and protein intake to model 2. Stratified 
analyses were conducted in case the interaction term was significant (P < 0.05). Because 
the FFQ was developed and validated for Dutch children, we performed a sensitivity 
analysis in Dutch children only. Furthermore, since kidney size and function are different 
in low birth weight children,(25) we performed a sensitivity analysis in children born 
with a normal birth weight (≥ 2,500g) and among children born at term (≥ 37 weeks). 
 Missing values of covariates were multiple imputed (N=5 imputations) according to 
the Fully Conditional Specification method (predictive mean matching), assuming no 
monotone missing pattern.(37) We present results as pooled effect estimates after the 
multiple imputation procedure. Statistical analyses were performed using SPSS version 
21.0 (SPSS Inc., Chicago, IL, USA). 
Results
Subject characteristics
Characteristics of the children and their mothers, stratified by tertiles of protein intake, 
are presented in Table 1. Mean (±SD) total protein intake at the age of 1 year was 
41.2 g (±12.9), corresponding to 12.9% of total energy intake (E%). This is higher than 
recommended for this age group,(38) but similar to intakes observed in the general 
Dutch and other Western pediatric populations.(39,40) Children in the highest tertile 
of protein intake had more often been breastfed and were slightly heavier at the age of 
6 years. Protein intake at the age of 2 years (13.9 E%) was slightly higher than intake at 
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the age of 1 years (Supplementary Table S1). At the age of 6 years, mean (SD) combined 
kidney volume was 121 cm3 (±21) and mean eGFRCreat was 119 ml/min per 1.73m
2 (±16). 
Mean eGFRCysC was lower at 102 ml/min per 1.73m
2 (±13). Many children (34%) had urine 
albumin levels at or below the detection limit (≤ 2 mg/L) and microalbuminuria was 
present in 7.1% of the children. 
Protein intake in early childhood and kidney outcomes at school age
Table 2 presents the associations between protein intake and kidney outcomes. In 
model 1, adjusted for age, sex, and BSA, a higher protein intake at the age of 1 year 
was associated with a higher eGFR and lower ACR at the age of 6 years. Protein intake 
was not consistently associated with kidney volume. Results for eGFRCysC were similar to 
those for eGFRCreat (Table 2) and for eGFRCombined (Supplementary Table S2). After further 
adjustment for sociodemographic variables and maternal factors (model 2), the effect 
estimates hardly changed and a higher protein intake remained significantly associated 
with a higher eGFR and a lower ACR. However, after further adjustment for child lifestyle 
factor (model 3), all associations attenuated towards null (Table 2). Important lifestyle 
confounders in the associations with kidney outcomes were child’s television watching, 
overall diet quality, and sodium intake. 
Additional analyses
No clear differences were observed for the associations of animal versus vegetable 
protein intake on kidney outcomes (Supplementary Table S3). Replacement of BSA for 
either height and weight, BMI, or lean body mass; or replacement of absolute kidney 
volume by the ratio of kidney volume with weight, BMI, or BSA did not change the effect 
estimates (data not shown). Protein intake was not associated with urinary albumin or 
creatinine levels (data not shown). No significant interactions were observed of total 
protein intake with sex, birth weight, gestational age, ethnicity, or kidney volume on any 
of the kidney outcomes. Sensitivity analyses in Dutch children only (N=1,994) showed 
similar patterns of associations as in the whole group, but with slightly larger effect 
estimates and smaller P-values (Supplementary Table S4). Among children born with a 
normal birth weight (≥ 2,500g, N=2,802) and among children born at term (≥ 37 weeks, 
N= 2,781), effect estimates were similar to those observed in the whole group (data not 
shown). In line with the results for protein intake at the age of 1 year, higher total protein 
intake at the age of 2 years was associated with a higher eGFRCreat and a trend towards 
a lower ACR in crude models, and the associations attenuated to null after adjustment 
for other lifestyle factors (Supplementary Table S5). In contrast to protein intake at the 
age of 1 year, protein intake at 2 years was in crude models not associated with eGFRcysC 
and was associated with a higher kidney volume, which was explained by other lifestyle 
factors (Supplementary Table S5). 
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Table 1. Subject characteristics a
Tertiles of energy-adjusted total protein intake at 1 y
All
(N=2,968)
Tertile 1 (<37.5 g/d)
(N=989)
Tertile 2 (37.5-43.9 g/d)
(N=990)
Tertile 3 (>43.9 g/d)
(N=989)
P-value b
Maternal characteristics
Maternal age (y) 31.5 (21.7-39.9) 31.8 (22.5-41.4) 31.9 (22.4-39.6) 31.6 (20.6-39.4) 0.01
Maternal body mass index at 
enrolment (kg/m2)
23.4 (18.7-35.2) 23.4 (18.8-34.7) 23.6 (18.9-35.6) 24.5 (18.5-37.1) 0.50
Nulliparous (%) 60.4 59.5 59.8 61.6 0.09
Education level (%) 0.42
Primary 3.5 3.7 3.5 3.2
Secondary 33.9 33.2 32.8 35.6
Higher 62.7 63.1 63.7 61.2
Folic acid supplement use 
(%)
0.74
Never 15.8 17.0 14.8 15.4
In the first 10 weeks of 
pregnancy
30.2 28.5 30.9 31.3
Periconceptional 54.0 54.4 54.3 53.2
Smoking during pregnancy 
(%)
0.49
Never 78.1 78.7 78.6 77.0
Until pregnancy was known 10.0 9.2 9.4 11.5
Continued 11.8 12.1 11.9 11.5
Child characteristics
Girls (%) 50.9 51.6 52.6 48.5 0.17
Ethnicity (%) 0.24
Western 76.9 75.5 78.1 77.0
Cape Verdean 2.0 1.8 1.8 2.3
Moroccan 3.2 2.8 2.8 4.1
Netherlands Antillean 1.7 2.3 1.9 1.1
Turkish 4.5 4.5 4.0 4.9
Surinamese Creoles 2.3 3.0 2.5 1.3
Surinamese Hindustani 2.2 2.6 1.9 2.2
Other non-western 7.1 7.5 6.9 7.0
Gestational age at birth (wk) 40.0 (1.7) 39.9 (1.9) 39.9 (1.7) 40.0 (1.6) 0.79
Birth weight (g) 3,472 (551) 3,462 (562) 3,466 (557) 3,489 (532) 0.51
Breastfeeding (%) <0.01
Exclusive ≥ 4 months 29.5 34.8 26.9 27.2
Partial ≥ 4 months 62.5 58.1 65.5 63.7
Never or ≤ 4 months 8.0 7.1 7.5 9.1
Child characteristics at dietary measurement
Age at FFQ (mo) 12.9 (12.2-18.9) 12.8 (12.2-18.6) 12.9 (12.2-18.7) 13.0 (12.2-19.4) <0.01
Total energy intake (kcal/d) 1,266 (678-2212) 1,297 (619-2264) 1,238 (650-2093) 1,253 (765-2237) 0.02
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Protein intake (g/d) c
Total protein 41.2 (12.9) 34.9 (10.8) 39.7 (10.1) 48.0 (12.1) <0.01
Animal protein 25.7 (10.3) 20.8 (8.7) 25.0 (8.1) 33.1 (9.5) <0.01
Vegetable protein 14.9 (5.7) 13.5 (5.4) 14.8 (5.2) 16.6 (5.9) <0.01
Protein intake (E%)
Total protein 12.9 (2.4) 10.5 (1.1) 12.9 (1.0) 15.4 (1.7) <0.01
Animal protein 8.1 (2.4) 6.2 (1.7) 8.0 (1.6) 10.2 (2.1) <0.01
Vegetable protein 4.6 (1.4) 4.1 (1.3) 4.7 (1.3) 5.1 (1.3) <0.01
Total fat intake (g/d)c 42.3 (17.5) 43.1 (18.8) 40.8 (16.0) 42.7 (16.7) <0.01
Sodium intake from foods 
(g/d) c
1.02 (0.35) 0.88 (0.32) 0.98 (0.30) 1.17 (0.35) <0.01
Television watching (h/d) 0.9 (0.5) 0.9 (0.5) 0.9 (0.5) 0.9 (0.5) 0.19
Diet score 4.2 (1.3) 3.3 (1.1) 4.1 (1.1) 5.1 (1.2) <0.01
Child characteristics at 6 y visit
Age (y) 5.9 (5.6-6.6) 5.9 (5.6-6.5) 5.9 (5.6-6.6) 5.9 (5.6-6.6) 0.03
Height (cm) 118.2 (5.2) 117.8 (4.9) 118.2 (5.4) 118.5 (5.2) 0.02
Weight (kg) 22.4 (3.4) 22.1 (3.1) 22.4 (3.6) 22.7 (3.5) <0.01
Body mass index (kg/m2) 16.0 (1.6) 15.9 (1.5) 16.0 (1.6) 16.1 (1.7) <0.01
Body surface area (kg/m2) 0.86 (0.08) 0.85 (0.07) 0.86 (0.08) 0.86 (0.08) <0.01
Combined kidney volume 
(cm3)
121 (21) 119 (21) 122 (23) 122 (21) <0.01
Creatinine (µmol/l) 37.0 (5.2) 37.2 (5.0) 36.8 (5.4) 36.8 (5.2) 0.32
Cystatin C (mg/L) 0.79 (0.08) 0.79 (0.08) 0.78 (0.08) 0.78 (0.08) 0.02
eGFRCreat (Schwartz)  
(ml/min per 1.73m²) 
119 (16) 118 (15) 120 (17) 120 (16) 0.06
eGFRCysC (Zappitelli)  
(ml/min per 1.73m²) 
102 (13) 100 (13) 102 (14) 102 (13) <0.01
Urinary albumin/creatinine 
ratio
0.79 (0.20-5.70) 0.83 (0.20-7.33) 0.77 (0.190-5.56) 0.77 (0.20-5.00) 0.01
Microalbuminuria (%) 7.1 7.6 7.5 6.3 0.49
a Values are percentages for categorical variables, means (SD) for continuous variables 
with a normal distribution, or medians (95% range) for continuous variables with a 
skewed distribution. 
b P-values for differences of means between the tertiles of protein intake, assessed using 
ANOVA for continuous variables with a normal distribution, Kruskal-Wallis test for continuous 
variables with a skewed distribution, and chi-square tests for categorical variables.
c Not adjusted for energy intake. 
E%, energy percentage; eGFR, estimated glomerular filtration rate; FFQ, food frequency 
questionnaire
Table 1. Continued
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Table 2. Associations of protein intake at 1 y with childhood kidney volume and function 
at 6 y (N=2,968)a
Kidney volume
(mm3)
eGFRCreat
(Schwartz 2009)
(ml/min per 1.73m²)
eGFRCysC
(Zappitelli 2006)
(ml/min per 1.73m²)
ACR
(% change)c
Protein intake N=2,755 N=2,006 N=2,007 N=2,868
Model 1b
Tertile 1 Reference Reference Reference Reference
Tertile 2 2.31 (0.61, 4.02) 1.90 (0.17, 3.63) 1.84 (0.44, 3.25) -6.8 (-14.6, 1.0)
Tertile 3 1.16 (-0.54, 2.87) 2.46 (0.73, 4.19) 1.75 (0.35, 3.15) -7.8 (-15.7, -0.1)
Ptrend 
d 0.17 <0.01 0.01 0.04
Per 10 g 0.29 (-0.67, 1.25) 1.03 (0.04, 1.99) 0.66 (-0.12, 1.44) -5.4 (-9.8, -1.1)
Model 2b
Tertile 1 Reference Reference Reference Reference
Tertile 2 2.33 (0.64, 4.03) 1.85 (0.12, 3.58) 1.84 (0.43, 3.25) -6.7 (-14.5, 1.1)
Tertile 3 1.21 (-0.50, 2.91) 2.28 (0.56, 4.00) 1.70 (0.30, 3.11) -6.9 (-14.8, 0.0)
Ptrend 
d 0.16 <0.01 0.02 0.08
Per 10 g 0.31 (-0.65, 1.27) 0.91 (-0.05, 1.86) 0.64 (-0.14, 1.43) -4.9 (-9.3, -0.01)
Model 3b
Tertile 1 Reference Reference Reference Reference
Tertile 2 1.96 (0.10, 3.82) 1.21 (-0.69, 3.11) 1.58 (-0.21, 3.33) -3.1 (-11.7, 5.4)
Tertile 3 0.36 (-1.91, 2.63) 1.11 (-1.20, 3.42) 1.60 (-0.28, 3.49) -0.4 (-10.9, 10.0)
Ptrend 
d 0.74 0.35 0.10 0.93
Per 10 g -0.55 (-1.86, 0.76) -0.17 (-1.49, 1.15) 0.37 (-0.71, 1.45) -2.0 (-8.0, 4.0)
a Values are based on multivariable linear regression models and reflect differences or 
percentage change (95%CI) in kidney outcomes for tertiles of protein intake compared to 
the lowest tertile, and per 10 g of protein intake per day. Bold numbers indicate statistically 
significant results (P<0.05) 
bProtein intake is energy-adjusted using the nutrient residual method. 
Model 1 is adjusted for child’s sex, age and body surface area at 6 y visit. 
Model 2 is additionally adjusted for and maternal age, educational level, and BMI at enrolment, 
for smoking and folic acid supplement use during pregnancy, and for children’s ethnicity, and 
gestational-age adjusted birth weight. 
Model 3 is additionally adjusted for breastfeeding in the first four months of life, children’s 
television watching, total energy intake, energy-adjusted total fat intake, energy-adjusted 
sodium intake, and diet quality score.
c Albumin/creatinine ratio is log-transformed, therefore the regression coefficients reflect the 
percentage change rather than the absolute difference. 
d Ptrend is obtained by including the number of the tertiles of protein intake as continuous 
variable in the model 
ACR, albumin/creatinine ratio; eGFR, estimated glomerular filtration rate
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Figure 1. Flow chart of study participants included in the main analysis.
ACR, albumin/creatinine ratio; eGFR, estimated glomerular filtration rate; FFQ, food 
frequency questionnaire
N = 7,893
Children of mothers available for postnatal 
follow-up
N = 2,805 Excluded, 
due to no implementation of FFQ at 1 y
N = 5,088
Children of mothers who received FFQ at 1 y
N = 3,629
Children with dietary data at 1 y 
N = 2,965
Singleton born children with kidney measure-
ments at the age of 6 y
with data available on: 
Kidney volume N = 2,755
N = 1,459 Excluded,
due to missing information on FFQ (N = 1,438) or 
invalid data on FFQ (N = 21)
N = 664 Excluded,
due to loss to follow-up (N = 137), withdrawal of 
consent (N = 34), no visit to the research center 
(N = 474), kidney abnormalities (N = 8), or 
missing kidney outcome measurements (N = 11)
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Discussion
We examined the associations between protein intake in early childhood with kidney 
size and function at school age in a large prospective population-based cohort study. 
We observed that associations between higher protein intake in infancy with higher 
eGFR and lower ACR at the age of 6 years were explained by other dietary and lifestyle 
factors of the children, such as sodium intake and television watching. Furthermore, 
protein intake was not associated with kidney size and no differences in associations 
were observed for animal versus vegetable protein intake. 
Interpretation and comparison with previous studies
Contrary to findings of previous studies in infants and adults, protein intake in infancy 
was not consistently associated with combined kidney volume in our population-based 
sample of school-age children. In a multi-center trial in several European countries, 
healthy infants who received higher protein infant formula had higher kidney volumes 
at the age of 6 months than infants receiving the lower protein formula.(5) Whether 
this difference in kidney volume persisted until later age was not studied. A previous 
observational study in 631 healthy infants in Denmark reported a larger kidney size 
in 3-month-old infants who received formula feeding than in infants who received 
breastfeeding and the authors hypothesized that the effect might be attributable to 
the higher protein content in infant formula.(41) The difference was however no longer 
present at 18 months of age.(41) In line with this, in a study in young rats that received 
isocaloric high or low protein diets after weaning, a higher protein intake increased 
kidney size.(6) However, a month after discontinuation of the high protein diet, kidney 
size was comparable to that of the rats fed low protein diets. These studies suggest that 
the effect of protein intake on kidney growth could be reversible. In our study, kidney 
outcomes were measured a few years after the assessment of dietary protein intake. 
Therefore, we could speculate that a potential effect of protein intake in early life on 
kidney size might be no longer apparent in the children at the age of 6 years. Kidney 
hypertrophy in response to high protein intake could be a compensatory response to 
higher levels of nitrogenous protein metabolites (such as urea), and may be temporary 
response.(15) Alternatively, hypertrophy of the kidney in response to protein intake may 
occur via increased insulin-like growth factor I secretion, which may lead to permanent 
changes in kidney size.(42,43)
 We observed a higher eGFR in relation to higher protein intake, but this association 
was explained by other lifestyle factors. Important confounding factors were television 
watching, overall diet quality, and breastfeeding in early infancy. This is in contrast 
to finding from a small trial in preterm born infants, which report a higher eGFR with 
additional dietary protein(20) and short-term trials in adults.(12,44,11) However, in line 
with our results, the previously mentioned large trial in healthy infants did not report 
an effect of a higher protein infant formula on eGFR at the age of 6 months,(5) and 
an observational study in healthy infants reported no associations between intake of 
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infant formula and eGFR.(41) Similar to kidney growth, a higher GFR in response to high 
protein intake is considered to be an adaptive responses to high levels of circulating 
protein metabolites. This will increase the workload of the kidneys, and may lead to 
hyperfiltration.(15) Like for kidney growth, this response may be reversible.(6)
 In our population, a higher protein intake was associated with a lower albumin/
creatinine ratio in crude models, but this was no longer significant after adjustment for 
other dietary factors, such as sodium intake. This is in contrast to results from a trial in 
healthy adults which showed that increased protein increases urinary albumin levels 
(12). However, in line with our results, a few other trials reported no associations between 
protein intake and urinary albumin excretion.(11,44)
 In contrast to previous observational studies in adults,(45-47) we did not observe 
clear differences in associations for animal and vegetable protein intake. In contrast 
to studies in animals,(7,43) we also did not observe significant interactions between 
child sex and protein intake on kidney health. Furthermore, we observed no interaction 
between protein intake and birth weight or gestational age at birth. The results of our 
study do not indicate that changes in dietary recommendations for healthy infants 
are required with respect to later kidney health, however, further studies are needed 
to assess whether protein intake may specifically affect kidney outcomes in preterm or 
small-for-gestational age born children. 
Strengths and limitations 
An important strength of our study is its prospective design within a large population-
based cohort. We had information available on protein intake and kidney outcomes for 
almost 3,000 children and we had information on many potential maternal and child 
confounders, which were not always considered in previous observational studies. 
 A limitation of our dietary assessment methods is that an FFQ relies on memory and 
reported food intakes are subject to measurement error.(48) However, validation of our 
FFQ against three 24h recalls showed a good intraclass correlation coefficient for protein 
intake. Another limitation of our FFQ is that it was only validated for Dutch children.(22,24) 
However, sensitivity analyses in Dutch children only, showed similar results. Strengths of 
our dietary assessment are that an FFQ measures habitual diet rather than dietary intake 
at just one or a few days, and that we calculated not only total protein, but also from 
animal and vegetable sources. A limitation of our study is that we did not have dietary 
data at the age of 6 years available, therefore we could not assess the association of 
current diet with kidney health. 
 We performed detailed kidney measurements, using ultrasound to measure kidney 
volume, and we had blood and urine samples to estimate kidney function. Unfortunately, 
we did not measure inulin clearance to calculate actual GFR. To estimate GFR we used 
a creatinine-based formula that has been validated and is widely used in pediatric 
populations.(27) A limitation of serum creatinine as marker of kidney function is its 
strong relationship with muscle mass.(36) Cystatin C is a more sensitive marker for kidney 
function in pediatric populations than serum creatinine, since it is not affected by child 
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age, height, or weight(49,50) and we therefore also evaluated eGFR based on cystatin C 
levels.(28) This formula has been evaluated against inulin clearance and compared with 
other eGFR formulas, and was found to be accurate and precise in estimating GFR in 
addition to the Schwartz 2009 formula.(36) 
Conclusions
In this prospective cohort study, associations between protein intake in early childhood and 
kidney function at the age of 6 years were explained by other dietary and lifestyle factors 
of the children. Furthermore, protein intake was not associated with kidney size and no 
differences in associations were observed for animal versus vegetable protein intake. 
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Supplementary Figure S1. Population for analysis for children with dietary data at the 
age of 2 y.
 
N = 1,232
Children of mothers participating in focus cohort
N = 207 Excluded, 
due to no implementation of FFQ at 2 y
N = 889
Children of mothers who received FFQ at 2 y
N = 844
Children with dietary data at 2 y 
N = 660
Children with kidney measurements at 
the age of 6 y
with data available on: 
Kidney volume N = 609
Creatinine N = 435
Cystatin C N = 435
N = 55 Excluded,
due to missing information on FFQ 
N = 184 Excluded,
due to loss to follow-up (N = 8), withdrawal of 
consent (N = 7), no visit to the research center 
(N = 167), twins (N = 0), congenital kidney 
abnormalities (N = 0), or missing kidney outcome 
measurements (N = 2)
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Supplementary Table S1. Dietary characteristics for children with dietary data at 2 y.
Tertiles of energy-adjusted total protein intake at 2 y
All
(N=660)
Tertile 1
(<43.0 g/d)
(N=220)
Tertile 2
(43.0-48.2 g/d)
(N=220)
Tertile 3
(>48.2 g/d)
(N=220)
P value†
Age at FFQ (mo) 24.9 (24.3-27.5) 24.9 (24.3-27.7) 24.9 (24.3-27.5) 24.9 (24.3-27.2) 0.71
Total energy intake (kcal/d) 1301 (841-1967) 1336 (842-2049) 1244 (802-1896) 1310 (936-1996) <0.01
Protein intake (g/d)*
Total protein 46.0 (10.8) 40.0 (9.3) 44.3 (8.7) 52.4 (9.8) <0.01
Animal protein 27.8 (8.8) 22.0 (6.8) 26.7 (6.4) 34.7 (8.0) <0.01
Vegetable protein 18.1 (5.2) 17.7 (5.0) 17.6 (5.3) 18.9 (5.4) <0.01
Total fat intake (g/d) * 46.5 (13.4) 44.7 (14.4) 44.4 (12.5) 50.4 (12.5) <0.01
Sodium intake from foods (g/d) * 1.27 (0.33) 1.12 (0.30) 1.21 (0.29) 1.43 (0.33) <0.01
Protein intake (E%)
Total protein 13.9 (1.9) 11.8 (1.1) 14.0 (0.7) 15.9 (1.1) <0.01
Animal protein 8.4 (2.1) 6.5 (1.4) 8.5 (1.4) 10.3 (1.7) <0.01
Vegetable protein 5.5 (1.2) 5.1 (1.1) 5.5 (1.2) 5.6 (1.3) <0.01
Values are means (SD) for continuous variables with a normal distribution or medians 
(95% range) for continuous variables with a skewed distribution. 
† p-values for differences of means between the tertiles of protein intake, assessed using 
ANOVA for continuous variables with a normal distribution and Kruskal-Wallis test for 
continuous variables with a skewed distribution.
* Unadjusted for energy intake 
E%, energy percentage, FFQ, food frequency questionnaire
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Supplementary Table S2. Associations of protein intake at 1 y with serum creatinine 
and cystatin C levels, and microalbuminuria at 6 y.
Serum creatinine 
(µmol/l)
Serum cystatin C 
(µg/l)
eGFRCcombined
(Zappitelli 2006)
(ml/min per 1.73m²)
Microalbuminuria
(OR)
N=1,962 N=1,963 N=1,962 N=2,800
Crude model§
Tertile 1 Reference Reference Reference Reference
Tertile 2 -0.42 (-0.97, 0.13) -11.6 (-15.9, -7.2)** 2.23 (0.73, 3.74)* 0.97 (0.82, 1.16)
Tertile 3 -0.60 (-0.88, 0.32)* -10.1 (-14.5, -5.8)* 2.04 (1.27, 2.81)* 0.80 (0.56, 1.15)
Ptrend
# 0.03 0.02 <0.01 0.28
Per 10 g -0.20 (-0.34, -0.06)* -3.0 (-5.2, -0.9)* 1.02 (0.63, 1.40)** 0.92 (0.84, 1.01)
Adjusted model§
Tertile 1 Reference Reference Reference Reference
Tertile 2 -0.41 (-0.98, 0.16) -12.1 (-21.0, -3.3)** 2.32 (0.81, 3.83)** 0.99 (0.69,1.43)
Tertile 3 -0.49 (-1.12, 0.15) -9.8 (-19.5, 0.0)* 1.96 (0.46, 3.47)* 0.82 (0.54, 1.24)
Ptrend
# 0.13 0.05 0.01 0.35
Per 10 g -0.11 (-0.42, 0.21) -2.4 (-7.4, 2.6) 0.61 (-0.14, 1.36) 0.94 (0.77, 1.15)
Values are based on multivariable linear regression models and reflect differences or 
odds ratios (95%CI) in kidney outcomes for tertiles of protein intake compared to the 
lowest tertile, and per 10 g of protein intake per day.
Protein intake is energy-adjusted using the nutrient residual method.
§Crude models are adjusted for child’s sex, age and body surface area at 6 y visit. Fully 
adjusted models are additionally adjusted for child’s ethnicity, gestational-age adjusted 
birth weight, breastfeeding, total energy intake at 1 y, energy-adjusted total fat intake at 
1 y, and energy-adjusted sodium intake at 1 y; and maternal age, and smoking and folic 
acid supplement use during pregnancy.
# Ptrend  is obtained by including the number of the tertiles of protein intake as continuous 
variable in the model 
eGFR, estimated glomerular filtration rate; OR, odds ratio
* p < 0.05 and ** p < 0.01
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Supplementary Table S3. Associations of animal and vegetable protein intake at 1 y 
with kidney volume and function at 6 y (N=2,908).
Kidney volume
(mm3)
eGFRCreat
(Schwartz 2009)
(ml/min/1.73m²)
eGFRCysC
(Zappitelli 2006)
(ml/min/1.73m²)
ACR
(% change) †
N=2,699 N=1,961 N=1,961 N=2,800
Animal protein intake
Fully adjusted model §
Tertile 1 Reference Reference Reference Reference
Tertile 2 0.74 (-1.05, 2.54) 0.12 (-1.69, 1.94) -0.27 (-1.77, 1.23) 1.0 (-7.3, 9.3)
Tertile 3 0.19 (-1.54, 1.92) 1.60 (-0.08, 3.28) 0.56 (-0.83, 1.94) 2.8 (-5.1, 10.8)
Ptrend
# 0.69 0.06 0.12 0.60
Per 10 g 0.24 (-0.73, 1.20) 0.60 (-0.45, 1.54) 0.54 (-0.21, 1.30) -2.0 (-6.6, 2.5)
Vegetable protein intake
Fully adjusted model§
Tertile 1 Reference Reference Reference Reference
Tertile 2 1.41 (-0.48, 3.31) 0.96 (-0.85, 2.77) 1.77 (0.27, 3.26)* -4.9 (-13.6, 3.9)
Tertile 3 -0.38 (-2.48, 1.73) 1.65 (-0.17, 3.47) 1.52 (0.01, 3.02)* -1.9 (-11.7, 7.8)
Ptrend
# 0.75 0.06 0.04 0.74
Per 10 g -0.08 (-2.15, 1.20) 1.95 (-0.13, 4.03) 1.15 (-0.28, 2.59) -7.2 (-16.7, 2.2)
Values are based on multivariable linear regression models and reflect differences or 
percentage change (95%CI) in kidney outcomes for tertiles of protein intake compared to 
the lowest tertile, and per 10 g of protein intake per day.
Protein intake is energy-adjusted using the nutrient residual method.
§ Fully adjusted models are adjusted for child’s sex, age, ethnicity, gestational-age adjusted 
birth weight, breastfeeding, total energy intake at 1 y, energy-adjusted total fat intake at 
1 y, and energy-adjusted sodium intake at 1 y; and maternal age, and smoking and folic 
acid supplement use during pregnancy.
† Albumin/creatinine ratio is log-transformed, therefore the regression coefficients reflect 
the percentage change rather than the absolute difference. 
# Ptrend  is obtained by including the number of the tertiles of protein intake as continuous 
variable in the model 
ACR, albumin/creatinine ratio; eGFR, estimated glomerular filtration rate
* p < 0.05 and ** p < 0.01
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Supplementary Table S4. Associations of protein intake at the age of 1 y with kidney 
volume and function at 6 y in Dutch children only (N=1,994).
Combined 
kidney volume 
(mm3)
eGFRCreat 
(Schwartz 2009)
(ml/min/1.73m²)
eGFRCysC 
(Zappitelli 2006)
(ml/min/1.73m²)
ACR
(% change)
  N=1,843 N=1,356 N=1,357 N=1,920
Crude model§
Tertile 1 Reference Reference Reference Reference
Tertile 2 1.70 (-0.37, 3.77) 2.13 (0.09, 4.16)* 2.50 (1.59, 3.41)** -10.9 (-20.5, -1.3)*
Tertile 3 -0.16 (-0.88, 1.95) 1.56 (-0.49, 3.62) 1.97 (1.06, 2.89)* -15.2 (-25.0, -5.5)**
Ptrend
# 0.88 0.21 0.03 <0.01
Per 10 g -0.46 (-1.52, 0.61) 0.48 (-0.58, 1.55) 0.89 (-0.05, 1.82) -8.3 (-10.9, -5.8)**
Adjusted model§
Tertile 1 Reference Reference Reference Reference
Tertile 2 2.55 (0.41, 4.69)* 2.30 (0.19, 4.42)* 2.53 (0.73, 4.33)** -7.5 (-15.5, 0.03)
Tertile 3 1.35 (-1.05, 3.76) 1.91 (-0.47, 4.29) 2.08 (0.27, 3.89)* -7.8 (-18.8, 0.00)*
Ptrend
# 0.26 0.11 0.03 0.19
Per 10 g 0.31 (-0.93, 1.56) 0.76 (-0.50, 2.02) 1.05 (0.10, 2.00)* -4.9 (-10.8, 1.1)
Values are based on multivariable linear regression models and reflect differences or 
percentage change (95%CI) in kidney outcomes for tertiles of protein intake compared 
to the lowest tertile, and per 10 g of protein intake per day. Tertiles of protein intake are 
defined for the whole group (N=2,908), the distribution of children over the tertiles was 
similar for the subgroup of Dutch children. 
Protein intake is energy-adjusted using the nutrient residual method.
§Crude models are adjusted for child’s sex, age and body surface area at 6 y visit. Fully 
adjusted models are additionally adjusted for child’s ethnicity, gestational-age adjusted 
birth weight, breastfeeding, total energy intake at 1 y, energy-adjusted total fat intake at 
1 y, and energy-adjusted sodium intake at 1 y; and maternal age, and smoking and folic 
acid supplement use during pregnancy.
† Albumin/creatinine ratio is log-transformed, therefore the regression coefficients reflect 
the percentage change rather than the absolute difference. 
# Ptrend  is obtained by including the number of the tertiles of protein intake as continuous 
variable in the model 
* p < 0.05 and ** p < 0.01
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Supplementary Table S5. Associations of protein intake at 2 y with childhood kidney 
volume and function at 6 y (N=660).
Combined
kidney volume
(mm3)
eGFRCreat
(Schwartz 2009)
(ml/min/1.73m²)
eGFRCysC
(Zappitelli 2006)
(ml/min/1.73m²)
ACR
(% change)†
  N=609 N=435 N=435 N=628
Crude model§
Tertile 1 Reference Reference Reference Reference
Tertile 2 -0.28 (-4.16, 3.60) 2.72 (-0.90, 6.35) -2.47 (-5.63, 0.69) -12.5 (-29.8, 4.9)
Tertile 3 2.55 (-1.25, 6.36) 4.57 (0.96, 8.18)* -0.27 (-3.41, 2.88) -19.6 (-6.9, -2.3)*
Ptrend
# 0.19 0.01 0.86 0.03
Per 10 g 2.63 (0.25, 5.02)* 3.34 (1.01, 5.68)** 0.21 (-1.84, 2.26) -12.2 (-23.3, -1.1)*
Adjusted model§
Tertile 1 Reference Reference Reference Reference
Tertile 2 -1.28 (-5.30, 2.74) 1.82 (-1.98, 5.63) -2.76 (-6.08, 0.57) -9.9 (-28.1 8.3)
Tertile 3 0.78 (-3.71, 5.27) 3.86 (0.34, 8.08)* -1.51 (-5.10, 2.09) -15.6 (-35.7, 4.6)
Ptrend
# 0.75 0.07 0.40 0.13
Per 10 g 1.89 (-1.06, 4.85) 3.02 (0.14, 5.90)* -0.61 (-3.00, 1.79) -9.6 (-23.3, 4.2)
Values are based on multivariable linear regression models and reflect differences or 
percentage change (95%CI) in kidney outcomes for tertiles of protein intake compared 
to the lowest tertile, and per 10 g of protein intake per day. 
Protein intake is energy-adjusted using the nutrient residual method.
§ Crude models are adjusted for child’s sex, age and body surface area at 6 y visit. Fully 
adjusted models are additionally adjusted for child’s ethnicity, gestational-age adjusted 
birth weight, breastfeeding, total energy intake at 2 y, energy-adjusted total fat intake at 
2 y, and energy-adjusted sodium intake at 2 y; and maternal age, and smoking and folic 
acid supplement use during pregnancy.
† Albumin/creatinine ratio is log-transformed, therefore the regression coefficients 
reflect the percentage change rather than the absolute difference. 
# Ptrend  is obtained by including the number of the tertiles of protein intake as continuous 
variable in the model 
ACR, albumin/creatinine ratio; eGFR, estimated glomerular filtration rate
* p < 0.05 and ** p < 0.01.
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Supplementary Table S6. Correlations between measures of body composition and 
kidney function. 
Serum creatinine Serum cystatin C eGFRCreat
Schwartz
eGFRCysC
Zappitelli
  N=1,962 N=1,963 N=1,961 N=1,963
Age 0.147** 0.013 -0.048* -0.004
Height 0.196** 0.017 0.105* 0.000
Weight 0.204** 0.030 0.016 -0.014
Body mass index 0.13** 0.029 -0.067** -0.021
Body surface area 0.217** 0.027 0.049* -0.009
Total fat mass 0.050* 0.008 0.077* 0.003
Lean body mass 0.281** 0.063** -0.046* -0.044
Values are Pearson correlation coefficients
* p<0.05, ** p< 0.01 
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Abstract
Background: Creatinine and cystatin C concentrations are commonly used to estimate 
glomerular filtration rate (eGFR) in clinical practice and epidemiological studies. To 
estimate the influence of different body composition measures on eGFR from creatinine 
and cystatin C blood concentrations, we compared the associations of different 
anthropometric and body composition measures with eGFR derived from creatinine 
(eGFRcreat) and cystatin C (eGFRcystC) blood concentrations. 
Study design: Population-based cohort study.
Settings & participants: This study was performed among 4,305 children.
Predictors: At the age of 6.0 years (95% range 5.7 - 8.0), we measured weight and height 
and calculated body mass index and body surface area, and lean and fat mass by Dual-
energy X-ray Absorptiometry.
Outcomes & measurements: At the same age, we measured creatinine and cystatin C 
blood concentrations and estimated the GFR.
Results: Correlation between eGFR based on creatinine and cystatin C concentrations 
was r = 0.40 (p-value <0.01). Higher body mass index was associated with lower eGFRcystC 
but not with eGFRcreat. Higher body surface area was associated with higher eGFRcreat and 
lower eGFRcystC (p-values <0.05). Lean and fat mass percentages were associated with 
eGFRcreat but not with eGFRcystC.
Limitations: Lack of actual measurements of GFR.
Conclusions: Our findings suggest that both eGFRcreat and eGFRcystC are influenced 
by body mass index and body surface area. eGFRcreat is stronger influenced by body 
composition than eGFRcystC. Further studies are needed to assess whether using eGFRcystC 
instead of eGFRcreat leads to better care for pediatric kidney patients.  
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Introduction
Glomerular filtration rate (GFR) plays a key role in the management of kidney disease. Ideally, 
measuring GFR should be based on renal clearances of exogenous markers such as inulin, but 
this approach is complex, invasive and expensive.(1) Therefore, GFR is commonly estimated 
based on creatinine blood concentrations.(2) Using creatinine as marker of renal function 
has some limitations. Creatinine, is actively secreted by the proximal tubule, and is related 
to muscle mass, age, sex, ethnicity and dietary factors.(1,3) Creatinine concentrations can be 
higher in individuals with an increased muscle mass, independent of kidney function, leading 
to an underestimation of eGFR.(4) Studies in adults suggest that eGFR based on creatinine 
concentrations can be improved if lean mass percentage could be incorporated in the 
formula.(4,5) Next to creatinine, cystatin C blood concentrations can be used to estimate GFR.
(6,7) The major advantage of cystatin C is that it is considered less related to body weight and 
height in children.(8,9) Some authors report a superior sensitivity of cystatin C for detecting 
impaired GFR in pediatric patients seems superior to that of creatinine, especially in children 
with low muscle mass.(9) However, studies in kidney disease patients suggest that lean 
mass affects cystatin C concentrations.(10,11) Many studies have explored the associations 
between body mass index (BMI) and eGFR, using BMI as a proxy for body composition.(12-14) 
Studies comparing the correlations and associations of detailed body composition measures 
and the eGFR among healthy pediatric populations are lacking.
 To estimate the influence of different body composition measures on eGFR from creatinine 
and cystatin C blood concentrations, we compared the associations of different anthropometric 
and body composition measures with eGFR derived from creatinine (eGFRcreat) and cystatin 
C (eGFRcystC) blood concentrations in a population-based prospective cohort study among 
4,305, 6 year old children.
Methods 
Design and study population
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from fetal life onwards in Rotterdam, the Netherlands, which has been 
described in detail previously.(15) The study has been approved by Medical Ethical 
Committee of Erasmus MC, University Medical Center Rotterdam. All children were born 
between April 2002 and January 2006 and form a largely prenatally enrolled birth cohort 
that is currently being followed until young adulthood. Written consent was obtained 
for all children. A total of 8,305 children participated in the follow-up measurements 
at 6 years of age (median age 6.0 years; 95% range 5.7, 8.0). Of these children, 6,509 
(78%) visited the research center for body composition follow-up measurements. For this 
study, we excluded children with congenital kidney abnormalities (N=12). The present 
analyses were performed among 4,305 children with body composition and kidney 
function measures available (Supplementary Figure 3.3.1).  
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Body composition measurements
Children’s anthropometrics and body composition were measured at a median age of 
6.0 years (95% range 5.7 to 8.0).(15) Height (m) was determined in standing position to 
the nearest millimeter without shoes using a Harpenden stadiometer (Holtain Limited, 
Dyfed, U.K.). Weight was measured using a mechanical personal scale (SECA, Almere, The 
Netherlands). We calculated BMI (kg/m2) and body surface area (BSA) (m2). For BSA, we 
used the DuBois formula: BSA = weight (kg)0.425 x height (cm)0.725 x 0.007184.(16) Whole 
body dual-energy X-ray absorptiometry (DXA) scans (iDXA, GE-Lunar, 2008, Madison, WI, 
USA) were performed to estimate fat and lean mass. We calculated lean mass percentage 
as (lean mass (kg) /weight (kg)) and fat mass percentage as (fat mass (kg) /weight (kg)).(17)
Kidney function measurements
Non-fasting blood samples were drawn by antecubital venipuncture and centrifuged 
for 10 minutes and stored at -80 °C at one location in the STAR-MDC laboratory. As 
previously described, creatinine concentrations were measured with enzymatic methods 
and cystatin C concentrations with a particle enhanced immunoturbidimetric assay 
(using Cobas 8000 analyzers, Roche, Almere, the Netherlands). Quality control samples 
demonstrated intra-assay and inter-assay coefficients of variation of 0.51% for creatinine 
and 1.65% for cystatin C, and 1.37% for creatinine and 1.13% for cystatin C, respectively.
(18) We calculated the eGFR based on creatinine concentrations according to the revised 
Schwartz 2009 formula: eGFRcreat = 36.5 * (height (cm)/ serum creatinine (µmol/l)),(19) 
and eGFR based on cystatin C concentrations using Zappitelli’s formula: eGFRcystC = 75.94 
/ [CysC (mg/L)1.17].(7)
Statistical analysis
We performed a non-response analysis by comparing subject characteristics between 
children with and without kidney function measurements using T-tests, Chi-square 
tests and Mann-Whitney tests. We created standard deviations scores (SDS) for all 
body composition measures to enable comparison between effect estimates. Next, we 
examined the Pearson rank correlation coefficients between childhood anthropometrics, 
body composition and eGFR measures. Third, we used multiple linear regression analyses 
to examine the associations of anthropometric and body composition measures with 
creatinine, cystatin C, eGFRcreat and eGFRcystC. These models were adjusted for child 
sex, age at measurements, and ethnicity. Additionally, we explored the associations 
of childhood BMI clinical cut-offs with creatinine, cystatin C and eGFRs. Because of the 
already reported associations of ethnicity with kidney function markers, we performed 
a sensitivity analysis in children of European ethnicity, the largest ethnic subgroup.(20)
Based on previous literature we assessed whether the explored association differed by 
sex, which was not the case in this study.(21, 22) All analyses were performed using the 
Statistical Package for the Social Sciences version 21.0 for Windows (SPSS IBM, Chicago, 
IL, USA).
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Results
Participant characteristics
Table 3.3.1 shows the characteristics of the participants. In the full group the mean 
(SD) eGFRcreat and eGFRcystC were 118.89ml/min/1.73m
2 (15.87) and 101.59ml/min/1.73m2 
(11.24), respectively. The histograms of creatinine, cystatin C, eGFRcreat and eGFRcystC are 
provided in Supplementary Figure 3.3.2. Results from the non-response analyses are 
given in the Supplementary Table 3.3.1. Children with kidney function measurements 
had higher lean mass percentage and lower fat mass percentage compared to children 
who did not have kidney function measurements.
Correlations of childhood anthropometrics and body composition measures with eGFR
The correlation coefficient between eGFRcreat and eGFRcystC was r = 0.40 (p-value <0.01) 
(Table 3.3.2). Childhood height, weight, BMI and BSA were positively correlated with 
creatinine and cystatin C concentrations, with stronger coefficients for creatinine 
concentrations (p-values <0.01). Lean mass percentage was positively correlated with 
creatinine concentrations and negatively correlated with eGFRcreat (r = 0.13, p-value < 
0.01). Similar results, but in opposite directions were observed for fat mass percentage. 
Lean mass percentage and fat mass percentage were not correlated with cystatin C 
concentrations or eGFRcystC. 
Associations of childhood body composition measures with eGFR
Table 3.3.3 shows that childhood height was associated with creatinine concentrations 
(p-value< 0.05), but not with cystatin C concentrations. Higher childhood weight was 
associated with both higher creatinine and cystatin C concentrations (p-value <0.01). 
Higher childhood height was associated with higher eGFRcreat (p-value <0.01), but not 
with eGFRcystC whereas higher childhood weight was associated with higher eGFRcreat and 
lower eGFRcystC (p-value <0.01). 
 Each 1-SD increase in BSA was associated with 1.81 ml/min/1.73m2 (95% confidence 
interval (CI) 1.24, 2.37) higher eGFRcreat and 0.57 ml/min/1.73m
2 (95% CI -0.98, -0.17) lower 
eGFRcystC. We observed tendencies for similar effect estimates when we restricted the 
analyses to Europeans only (N=2,727) (Supplementary Table 3.3.2). BMI was negatively 
associated with eGFRcystC (p-value <0.05) but not with eGFRcreat. Among Europeans, higher 
childhood BMI was associated with higher creatinine and cystatin C concentrations 
and lower eGFRcreat and eGFRcystC (Supplementary Table 3.3.2). The associations of BMI 
clinical cut-offs with creatinine, cystatin C and the eGFR are given in Supplementary 
Table 3.3.3. 
 Higher lean mass percentage was associated with higher creatinine concentrations 
and with lower cystatin C concentrations (Table 3.3.3) (p-values <0.05). A 1-SD increase 
in lean mass percentage was associated with 2.74 ml/min/1.73m2 (95% CI -3.27, -2.20) 
lower childhood eGFRcreat. No association was observed of lean mass percentage with 
eGFRcystC. 
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Higher fat mass percentage was associated with lower creatinine concentrations and 
with higher cystatin C concentrations (Table 3.3.3, p-values <0.05). A 1-SD increase in 
fat mass percentage was associated with 2.68 ml/min/1.73m2 (95% CI 2.14, 3.21) higher 
childhood eGFRcreat. No associations were observed of fat mass percentage with eGFRcystC. 
Similar effect estimates were observed when we restricted our analyses to European 
subjects only, but not all associations were significant (Supplementary Table 3.3.2).
Table 3.3.1. Subjects characteristics (N=4,305)
Age at measurements (y) 6.02 (5.68, 7.98)
Sex, Girls (%) 48.30
Ethnicity (%)
Dutch or European 65.10
Non-European 34.90
Height (cm) 119.72 (6.00)
Weight (kg) 23.37 (4.23)
Body mass index (kg/m2) 16.21 (1.84)
Body surface area (m2) 0.88 (0.09)
Lean mass percentage (%) 71.73 (5.36)
Fat mass percentage (%) 24.66 (5.56)
Creatinine (µmol/l) 37.40 (5.27)
Cystatin C (µg/l) 787.30 (74.40)
eGFRcreat (ml/min/1.73m
2) 118.89 (15.87)
eGFRcystC (ml/min/1.73m
2) 101.59 (11.24)
Values are valid percentages for categorical variables, means (SD) for continuous 
variables with a normal distribution, or medians (95% range) for continuous variables 
with a skewed distribution.
eGFRcreat estimated glomerular filtration rate calculated based on creatinine blood 
concentrations; eGFRcreat = 36.5 * (height (cm)/ serum creatinine (µmol/l)); eGFRcystC 
estimated glomerular filtration rate calculated based on cystatin C blood concentrations 
eGFRcystC = 75.94 / [CysC(mg/L)
1.17]
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Table 3.3.2. Correlation coefficients of the investigated variables
Height Weight BMI BSA FMP LMP Creat Cyst C eGFRcreat eGFRcystC
Height 1.00
Weight 0.77** 1.00
BMI 0.31** 0.83** 1.00
BSA 0.90** 0.97** 0.69** 1,00
FMP 0.18** 0.57** 0.69** 0.46** 1,00
LMP -0.19** -0.56** -0.68** -0.45** -0.999** 1,00
Creat 0.30** 0.28** 0.16** 0.30** -0.05** 0.05** 1,00
Cyst C 0.05** 0.06** 0.05** 0.06** -0.001 0.003 0.40** 1,00
eGFRcreat 0.06
** 0.01 -0.04** 0.03 0.12** -0.13** -0.92** -0.40** 1,00
eGFRcystC -0.05
** -0.06** -0.05** -0.06** 0.01 -0.01 -0.39** -0.99** 0.40** 1,00
** Correlation is significant at the 0.01 level (2-tailed).
BMI- body mass index, BSA- body surface area, FMP- fat mass percentage, LMP- lean mass 
percentage, Creat- creatinine, Cyst C- cystatin C, eGFRcreat estimated glomerular filtration 
creatinine-based, eGFRcystC estimated glomerular filtration cystatin C-based.
Table 3.3.3. Associations of anthropometric and body composition measures with 
creatinine, cystatin C and eGFR (N=4,305)
Difference (95% Confidence Interval)
Creatinine
(µmol/l)
Cystatin C
(µg/l)
eGFRcreat
(ml/min/1.73m2)
eGFRcystC (ml/
min/1.73m2)
Anthropometrics and body composition (SDS)
Height 0.97 (0.79, 1.15)*** 1.99 (-0.70, 4.70) 2.78 (2.22, 3.35)*** -0.29 (-0.70, 0.12)
Weight 0.91 (0.73, 1.08)*** 4.49 (1.91, 7.07)*** 1.16 (0.61, 1.71)*** -0.66 (-1.05, -0.27)**
Body mass index 0.52 (0.36, 0.68)*** 4.15 (1.80, 6.51)*** -0.37 (-0.87, 0.13) -0.61 (-0.96, -0.26)**
Body surface area 1.02 (0.84, 1.20)*** 3.93 (1.27, 6.59)** 1.81 (1.24, 2.37)*** -0.57 (-0.98, -0.17)**
Lean mass percentage 0.30 (0.07, 0.54)* -2.73 (-5.28, -0.18)* -2.74 (-3.27, -2.20)*** 0.36 (-0.03, 0.74)
Fat mass percentage -0.48 (-0.65, -0.31)*** 2.86 (0.32, 5.40)* 2.68 (2.14, 3.21)*** -0.38 (-0.76, 0.01)
Values are beta coefficients and 95% Confidence Intervals, from linear regression models 
adjusted for child age, sex and ethnicity.
eGFRcreat estimated glomerular filtration rate calculated based on creatinine blood 
concentrations; eGFRcystC estimated glomerular filtration rate calculated based on 
cystatin C blood concentrations 
P value for the associations * < 0.05 ** <0.01 *** <0.001
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Discussion
Results of this cross-sectional study in healthy 6 year old children suggest that BMI and 
BSA are associated with creatinine-based eGFR and cystatin C-based eGFR. Lean mass 
percentage and fat mass percentage are associated with creatinine-based eGFR, but not 
with cystatin C-based eGFR.
Interpretation of main findings 
To our knowledge, this is the first study comparing the association of detailed 
measures of body composition with estimates of GFR based on creatinine and cystatin 
C concentrations in a population of healthy children. Both creatinine and cystatin C 
concentrations can be influenced by different factors. Creatinine is produced in active 
muscle and is reported to be determined by muscle mass and dietary intake, which may 
account for the variations in the concentrations of serum creatinine observed among 
different age and ethnic groups.(1,3,23) However, we have previously reported that 
childhood protein intake does not influence the eGFR.24 Cystatin C is another marker to 
evaluate renal function, although is not used as commonly as creatinine.(6,25) Cystatin 
C is produced by all nucleated cells and is reported to be less strongly related to body 
weight and height in children compared to creatinine.(8,9) Besides, adult studies suggest 
that cystatin C concentrations are related to age, sex, height and weight and influenced 
by corticosteroid use.(26,27)
 In children, the Schwartz formula is widely used to estimate GFR from creatinine 
concentrations.(19) The Schwartz formula is known to overestimate eGFR compared 
to inulin clearance GFR.(6,28) Schwartz formula estimates GFR using creatinine 
concentrations and child height.(19) Next to Schwartz’s formula we estimated GFR 
using the Zappitelli’s formula.(7) This formula is not dependent of any anthropometric 
measures. It estimates GFR by using only the cystatin C concentrations.(7) In a study 
among 42 healthy adults, eGFR using creatinine and cystatin C concentrations was 
compared with measured GFR. This study suggested that eGFR based on cystatin C 
concentrations was a better marker then eGFR based on creatinine concentrations for 
estimating kidney function.(29)
 It has previously been reported that lean body mass, indicating muscular mass, is an 
important determinant of the GFR.(30) So far results from studies comparing the effects of 
body composition measures on creatinine and cystatin C concentrations and their derived 
eGFR are contradictory.(10,31,32) A number of studies have explored the associations of 
BMI with eGFR, using BMI as a proxy of body composition.(12-14) The associations of 
BMI with creatinine and cystatin C differed between populations studied. We observed 
that higher BMI was associated with higher creatinine and cystatin C concentrations and 
with lower eGFRcystC, but not with eGFRcreat. In the subgroup of Europeans, we observed 
that BMI was associated with creatinine, cystatin C concentrations, and their derived 
eGFRs. In line with our findings in the European subgroup, in the general Japanese 
population, BMI was associated with lower eGFRcreat.(14) Similar to what we observe, 
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studies among both healthy and kidney diseased adults suggested that eGFR based on 
cystatin C concentrations is not independent of BMI.(10,33) These findings appear to 
be different among children with various kidney diseases, where BMI does not have a 
clinically relevant effect on eGFRcystC.(13) Next to BMI, we observed that higher BSA was 
associated with higher creatinine, cystatin C concentrations, eGFRcreat and lower eGFRcystC. 
In the general adult population no associations have been reported of BSA with eGFR 
based on creatinine concentrations.(4) Studying detailed measures of body composition 
will therefore likely add to the understanding of the associations of body composition 
and kidney function measures.
 Studies among healthy adults have shown lean mass to be associated with serum 
creatinine but not with cystatin C concentrations.(31) Also, a study among 1,630 
randomly selected individuals from the general population has shown that lean mass 
percentage, but not fat mass percentage, was associated with eGFR based on creatinine 
concentrations.(4) Another study among 67 healthy individuals of ages between 18 and 
52 years has shown that creatinine concentrations were highly affected by muscle mass, 
whereas cystatin C concentrations were affected by fat mass.(32) In children after renal or 
heart transplantation both creatinine or cystatin C-based equations tend to overestimate 
renal function at lower inulin clearance GFR values and underestimate renal function at 
higher inulin clearance GFR values.(34) The associations between lean mass and cystatin 
C are reported to be different among kidney disease patients compared to adults.(10) 
Among 77 chronic kidney disease patients lean mass affected cystatin C concentrations 
and GFR estimation based on cystatin C concentrations improved when lean mass was 
included in the formula, especially in patients with extreme body composition.(10) In 
severely obese children lean mass percentage has been reported to correlate with both 
creatinine and cystatin C concentrations.(35)  In the current study, we observed that lean 
and fat mass percentage correlate with creatinine concentrations and eGFRcreat. Higher 
lean mass percentage and lower fat mass percentage were associated with higher 
creatinine concentrations and lower eGFRcreat. We did not observe a significant correlation 
of lean mass percentage or fat mass percentage with cystatin C concentrations. Our 
study shows that eGFR based on cystatin C concentrations is independent of lean mass 
percentage and fat mass percentage.
 Our results suggest that BMI and BSA influence creatinine and cystatin C concentrations 
and their derived eGFRs. Furthermore, body composition measures are strongly related 
to creatinine derived eGFR. Therefore, increased lean mass percentage leads to a rise in 
creatinine concentration and subsequently underestimates GFR. We hypothesized that 
an increased fat mass is associated with a higher number of nucleated cells and therefore 
could increase serum cystatin C. However, eGFR based on cystatin C concentrations 
appeared to be independent of body composition measures. Meta-analyses have 
reported that cystatin C can be a better marker of kidney function compared to creatinine 
concentrations.(36-38) Comparing the effect estimates on eGFRcreat and eGFRcystC we 
observe stronger estimates on eGFRcreat suggesting that body composition measures are 
stronger associated with creatinine concentrations than with eGFRcystC. As the revised 
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Schwartz formula (eGFRcreat) is the most widely used formula both in epidemiological 
studies and clinical practice, our findings suggest that body composition measures 
should be considered when eGFR is based on creatinine concentrations. Ideally, body 
composition measures would have been incorporated in the eGFRcreat equations and 
compared with GFR based on renal clearances of exogenous markers, but unfortunately 
this is not possible in our study. Considering the feasibility and costs of performing DXA 
scans in school-aged children, whether and to what extent detailed body composition 
measures should be used in the clinical practice when eGFR can be argued. However, our 
findings suggest that eGFRcreat is stronger influenced by body composition than eGFRcystC. 
Other studies are needed to assess whether using eGFRcystC instead of eGFRcreat leads to 
better care for pediatric kidney patients.  
Strengths and limitations
To the best of our knowledge, this is the first and largest cross-sectional multiethnic 
study in a healthy pediatric population-based cohort examining the associations of 
body composition with estimates of GFR.GFR was estimated based on creatinine and 
cystatin C concentrations. Except height and weight to calculate BMI and BSA, we 
also measured fat mass and lean mass with DXA. Of all children 61% provided blood 
samples for measuring creatinine and cystatin C concentrations. Children without data 
on kidney function measures were shorter, had a higher fat mass percentage and lower 
lean mass percentage, but no difference in BMI as compared to children with available 
kidney function measures. We observed tendencies for similar effect estimates among 
Europeans only, although not all associations were significant in this subgroup. This 
might be due to the smaller study group, but may also reflect an effect of ethnicity. A 
limitation of our study is that creatinine and cystatin C concentrations were measured 
only once. Ideally, we would have been able to compare the explored associations with 
the measured GFR and validate our findings. Unfortunately, we do not have the urinary 
or plasma clearance of an ideal filtration marker, such as inulin, iothalamate or iohexol, 
as the gold standard for the measurement of GFR.39 Our findings are based on a healthy 
pediatric population of a narrow age category and may not be generalizable to older, 
younger, or diseased populations. 
Conclusion
Our results suggest that eGFR based on both creatinine and cystatin C concentrations 
are influenced by BMI and BSA, whereas only eGFR based on creatinine concentrations 
is influenced by lean mass percentage and fat mass percentage. Beside anthropometric 
measurements, body composition measures should be considered when estimating GFR 
in children. Further studies to compare these results with measured GFR are needed.
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Supplementary Figure 3.3.1. Flow chart of the study participants 
N = 8,305
Children participating at 6 years’ measurements
N = 1,796 Excluded, 
children without body composition measures
N = 6,509
Children with body composition measurement
N = 6,497
Children available for kidney function measurements
N = 4,305
Children available for the analysis with estimated 
glomerular ltration rate data available:
Creatinine
Cystatin C
eGFRcreat
eGFRcystC
N = 12 Excluded,
children with congenital kidney abnormalities 
N = 2,192 Excluded,
children who did not have kidney function measures
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Supplementary Figure 3.3.2. Histograms of kidney function measures
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Supplementary Table 3.3.1. Subject characteristics between children with and without 
kidney function measurements (N=6,509)
Subjects characteristics With eGFR data
(N=4,305)
Without eGFR data
(N=2,204)
P-value
Age at measurements (y) 6.0 (5.7, 8.0) 6.0 (5.7, 7.6) 0.20
Sex, Girls (%) 48.3 53.4 0.07
Ethnicity (%) 0.26
Dutch or European 65.1 63.8
Non-European 34.9 36.2
Height (m) 119.7 (6.0) 119.0 (6.0) <0.01
Weight (kg) 23.4 (4.2) 23.1 (4.3) 0.01
Body mass index (kg/m2) 16.2 (1.8) 16.2 (1.9) 0.74
Body surface area (m2) 0.88 (0.09) 0.87 (0.09) <0.01
Fat mass percentage (%) 24.7 (5.6) 25.3 (5.9) <0.01
Lean mass percentage (%) 71.7 (5.4) 71.1 (5.7) <0.01
Values are valid percentages for categorical variables, means (SD) for continuous 
variables with a normal distribution, or medians (95% range) for continuous variables 
with a skewed distribution.
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Discussion
Introduction
Chronic kidney disease (CKD) is a major public health problem worldwide. CKD by itself, 
and by its increasing risk of hypertension and cardiovascular disease, has a high impact 
on morbidity and mortality.(1,2) Early recognition of persons at risk for impaired kidney 
function would be helpful in developing prevention strategies for CKD. 
 The last decades, multiple studies suggest that fetal and childhood development are 
important factors in the risk of cardiovascular and renal disease in later life.(3,4) Previous 
studies show increased risks of CKD in low birth weight populations.(5,6) The specific 
roles of preterm birth and fetal growth restriction in these associations are not clear.(7-9) 
Also, adverse exposures in early life might influence fetal kidney development. Maternal 
smoking has been associated with low nephron number.(10) Early childhood dietary 
factors might influence kidney volume and function.(11,12) 
 The glomerular hyperfiltration hypothesis proposed by Brenner postulates that 
adverse factors in utero lead to a lower nephron number. A kidney with fewer nephrons 
might in response cause hyperfiltration, which can cause glomerulosclerosis and 
increase the risk of CKD in adulthood.(13,14) 
 The main aim of the studies presented in this thesis was to identify specific growth 
periods and growth patterns of body growth and kidney volume which are crucial for 
kidney function in childhood. Also, the associations of specific modifiable maternal 
and child factors with kidney function in childhood were evaluated. Since variations 
in kidney function and blood pressure track into adulthood,(15,16) it is important to 
identify individuals at risk for impaired kidney at young age. Subclinical differences in 
kidney function may already be present in childhood, and predict kidney disease in later 
life. This chapter discusses the overall findings presented in the studies in this thesis, 
addresses general methodological issues and gives perspective for future research. 
Interpretation of the main findings
Fetal and infant growth
Background
Nephrogenesis starts in first trimester of pregnancy around the 8th week of gestation 
and ceases around 36 weeks of gestation.(17) Since nephrogenesis does not proceed 
after birth, life in utero might be crucial for nephron endowment. In population studies, 
birth weight is often used as a reflection of the outcome of life in utero. The relationship 
between birth weight and kidney development has been studied extensively. However, 
birth weight is a result of multiple fetal and maternal factors, and does not fully reflect 
kidney growth. A previous study from the same cohort as the studies in this thesis, 
showed that impaired fetal growth in late pregnancy is associated with fetal kidney 
volume. Raised placental resistance and fetal blood redistribution at expense of the 
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abdominal organs, were associated with kidney volume in utero.(18) In addition, fetal 
growth was positively associated with kidney volume at the age of 2 years.(19) Smaller 
kidney volume in fetal life tracks into early childhood.(19) Not much is known about 
kidney growth and the risk of impaired kidney function in a healthy population. A 
retrospective cohort study shows that kidney size in children with renal hypoplasia was 
associated with the risk of end-stage renal disease at the age of 9 years.(20)
Main findings
Results from studies in this thesis show that fetal blood flow redistribution at expense 
of the abdominal organs is associated with decreased kidney volume and function 
in childhood (Chapter 2.1). Furthermore, impaired fetal blood flow combined with 
smaller fetal kidney volume is associated with smaller kidney volume and lower 
kidney function in childhood as compared to normal fetal blood flow and fetal kidney 
volume (Chapter 2.1). The study focused on fetal first trimester growth did not show 
consistent associations with kidney volume and function in childhood (Chapter 2.2). 
Additional growth analyses did show positive associations of second and third trimester 
fetal growth, birth weight and weight at 6 months with kidney volume in childhood 
(Chapter 2.3). Only second trimester fetal weight was associated with kidney function 
at the age of 6 years (Chapter 2.3). Body growth is often used as a proxy for kidney 
volume. However, kidney volume itself can also be measured directly by ultrasound. The 
studies in this thesis show that both fetal and infant kidney growth are associated with 
childhood kidney function (Chapter 2.4). We did not observe consistent associations 
between early growth and microalbuminuria. 
 Thus, the studies presented in this thesis suggest that impaired body and kidney 
growth, in second half of pregnancy and infancy, is associated with smaller kidney 
volume and lower kidney function in childhood.
Underlying mechanisms
The studies presented in this thesis show no associations of fetal first trimester growth 
with kidney function in childhood. An explanation might be that kidney volume growth 
rate reaches its maximum after first trimester, between 26 and 34 weeks of gestation.(21) 
Also, it is not known whether renal compensatory hypertrophy in utero occurs affecting 
these association.(22) However, further studies are needed to get more insight in 
these mechanisms. Second and third trimester body and kidney growth are positively 
associated with kidney measures in childhood. Kidney development rates increase during 
pregnancy, third trimester is specifically important since approximately 60% of total 
nephron number develops in third trimester.(23) Impaired blood flow to the abdominal 
organs is associated with smaller kidney volume in childhood. This is in line with animal 
studies showing reduced nephron number as result of placental insufficiency.(24,25) 
 Various other factors, influencing early growth and possibly through direct pathways, 
are suggested to be associated with impaired nephron endowment. For example, 
animal studies show that increased cortisol levels during pregnancy can lead to low 
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nephron number even if birth weight is normal.(26,27) Also, maternal hypertensive 
disorders during pregnancy, maternal diabetes and early life drug exposure might 
influence nephron endowment.(14) Underlying pathways are not fully known. Placental 
insufficiency may cause changes in the renin-angiotensin-system and thereby increase 
the risk of impaired kidney function.(28,29) Placental insufficiency might, next to 
impaired growth, lead to adaptations in DNA-methylation of pro-apoptotic genes which 
are related to kidney development.(30) Several genetic and epigenetic mechanisms 
are hypothesized to be crucial in nephron endowment and fetal and childhood kidney 
volume. Common variants in the PAX2(31) or RET(32,33) genes are associated with 
reduced kidney volumes at birth. DNA methylation might also play an important role in 
kidney development.(34)
Maternal and child factors
Maternal smoking
Maternal smoking is a well-known, modifiable risk factor for adverse pregnancy 
outcomes. Fetal smoke exposure is associated with increased risks of preterm birth and 
low birth weight.(35-38) Previous studies suggest that maternal smoking is associated 
with altered organ development. (39,40) A previous study in the same cohort as the 
studies presented in this thesis, shows that maternal smoking during pregnancy is 
negatively associated with third trimester fetal kidney development.(41) We observed 
that continued maternal smoking during pregnancy is associated with smaller kidney 
volume and lower eGFR at the age of 6 years. Multiple pathways might underlie these 
associations. Since maternal smoking is related with low birth weight, impaired fetal 
growth might lead to low nephron endowment in infants who are exposed to smoke 
during fetal life. However, also after adjustment for birth weight, maternal smoking was 
associated with kidney volume and function. This suggests that other pathways, apart 
from fetal growth impairment, might be involved in the observed associations. Several 
teratogenic and toxic factors in cigarettes, such as nicotine, carbon monoxide and 
cadmium, might influence placental and fetal vascular development and thereby kidney 
growth and function.(42,43) Effects of maternal smoking during pregnancy on childhood 
kidney volume and function were much stronger than effects of paternal smoking. 
Therefore, an intrauterine effect of smoking on childhood kidney volume and function 
seems more likely than a general environmental effect. Recent studies on maternal 
smoking and CKD suggests an effect of maternal smoking on DNA methylation, and fetal 
and renal mitochondrial function.(44) An animal study shows renal morphological and 
tubular renal functional changes in offspring after fetal smoke exposure.(45) The specific 
pathways are not fully known. 
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Infant protein intake
Fetal and infant growth and nutrition are important for kidney development. Previous 
studies from the same cohort show that higher total and vegetable, but not animal, 
maternal protein intake during the first trimester of pregnancy is associated with a 
higher eGFR at in childhood.(46) In addition, longer breastfeeding duration is associated 
with larger kidney volume and higher eGFR in childhood.(12) However, other studies 
show higher kidney volume and increased kidney function in formula fed infants as 
compared to breastfed children. But, at longer follow-up at the age of 18 months these 
effect had disappeared.(11,47) Studies in animal models show that early life protein 
intake may stimulate kidney growth and function, but these associations might be 
reversible.(48,49) A few previous studies observed associations of  early life protein 
intake with adult kidney function and the risk of hypertension.(50,51) The mechanisms 
underlying the associations between protein intake and kidney function are not fully 
understood. It is hypothesized that higher protein intake increases kidney volume in 
order to be able to excrete in increased levels of nitrogen metabolites. Furthermore, 
higher protein intake stimulates Insulin-Like Growth Factor (IGF) I secretion, which 
stimulates kidney volume growth. Finally, increased total protein intake might cause total 
body growth and thereby also kidney volume growth.(52) We studied the associations 
of protein intake at the age of 1 year and kidney volume and function at the age of 6 
years. We observed a positive association between protein intake and kidney function in 
basic models. However, after adjustment for dietary and lifestyle factors protein intake 
was no longer associated with kidney function in childhood. Thus, our findings do not 
support a strong effect of protein intake in early life on kidney function in childhood. 
The differences in results between our study and previous studies may be explained by 
differences is study subjects, populations and age of outcome measurements.
Childhood body composition and eGFR estimations based on creatinine and cystatin C 
concentrations
Estimations of GFR are important in screening, diagnosing and management of 
kidney disease. Direct measurement of GFR is most often based on renal clearances of 
exogenous markers such as inulin and iohexol.(53) However, these measurements are 
difficult to use for screening and clinical practice since they are complex, invasive and 
have high costs.(53) Thus, creatinine concentrations are widely used in estimating GFR 
in screening and clinical practice. However, creatinine use in GFR estimations has some 
limitations. Creatinine is actively secreted by the proximal tubule and its concentrated 
might be related with age, sex, ethnicity and dietary factors.(53,54) Moreover, creatinine 
concentrations are associated with muscle mass. In individuals with higher muscle mass, 
creatinine concentrations might be higher and therefore eGFR can be underestimated.
(55) Cystatin C is proposed as a possible better marker for GFR estimation. Cystatin C is 
produced at a constant rate and is secreted by the tubule. Also, cystatin C concentrations 
seem to be less influenced by weight and height in children.(56)
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The study presented in this thesis focused on the associations of detailed measures of body 
composition and estimations of GFR based on creatinine and cystatin C concentrations. 
Lean mass and fat mass were evaluated by Dual-energy X-ray Absorptiometry (DXA). 
We observed associations of childhood lean and fat mass percentages with both 
creatinine and cystatin C based GFR estimations. GFR estimations based on creatinine 
concentrations tended to be more strongly associated with childhood lean and fat mass 
percentages than GFR estimations based on cystatin C levels. Results of this study show 
that incorporating childhood body composition measures in GFR estimations might 
provide more accurate estimations of GFR. However, in screening programs and in clinical 
practice it is difficult and expensive to perform DXA scanning to obtain this information. 
Methodological considerations 
Specific methodological issues of the studies presented in this thesis have been 
discussed in the specific chapters of this thesis. The studies performed in this thesis have 
been conducted within the Generation R Study. This is a population-based, prospective 
cohort study which provides detailed data collection and enables the opportunity to 
assess temporal associations.
Selection bias
Selection bias can appear if the association between the determinant and outcome 
of interest is different in subjects who participate in the study and those who did not 
participate in the study, but were eligible for the study. Of all eligible children at birth, 
61% participated in the Generation R Study. Participation of mothers belonging to ethnic 
minority groups and with low socioeconomic status was lower than expected from overall 
population in Rotterdam.(57) Furthermore, mothers who were included in the study had 
less medical complications during pregnancy and unfavorable pregnancy outcomes, for 
example hypertensive disorders and low birth weight, as compared to eligible mothers 
who were not included. These differences suggest that the study population is more 
healthy and affluent then the general population. Specifically the focus cohort, the 
group of mothers in which more frequent and more detailed follow up measures were 
conducted, tended to be healthier. Since we do not expect that the associations of the 
exposures and outcomes presented in this these are different between participating and 
not participating mothers, we do not assume that the differences between those groups 
have influenced our results. This selection will probably affect the prevalence rates and 
thereby reduce statistical power and generalizability of our results.
 Selection bias may arise from non-response at baseline, and from loss to follow-up. 
Loss to follow-up can occur if the studied associations differ between those included 
in the study population and those lost to follow-up. In the studies presented in this 
thesis participation in the follow-up measurements at the age of 6 years was around 
70%. Furthermore, response rate for blood samples was around 67% of the included 
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participants at the age of 6 years. This lower percentage for serum creatinine and 
cystatin C measurements was mainly due to non-consent for venous puncture. Mothers 
of children who did not participate in the follow-up measurements at the age of 6 years, 
were more often less educated and had more unhealthy lifestyle as compared to the 
total study population. Also, children of mothers who were not participating at the age 
of 6 years had lower birth weight, but similar kidney size as compared to the included 
children. 
Information bias
Information on the determinants and outcomes in the studies described in this thesis 
are obtained by physical examinations, ultrasound examinations, blood and urine 
analyses and parental questionnaires. Differential misclassification may occur when 
misclassification of the determinant is related to the outcome, and vice versa. Differential 
misclassification can lead to underestimation or overestimation of the results. 
 Data of exposures in our study were collected prospectively and before measurement 
of the kidney outcome measures. The parents and data collectors were not aware of 
specific research questions. Therefore, differential misclassification of the exposures 
and the outcomes seems unlikely. However, underreporting or overreporting of specific 
lifestyle habits may have occurred and lead to underestimation of overestimation of 
effect of the studied association. For example, parental smoking data was obtained by 
questionnaires. Since most parents are aware of the possible negative effect of parental 
smoking on the health status of their children, they might have underreported their 
smoking habits. Also, information about infant protein intake was obtained by the food 
frequency questionnaire (FFQ) around the age of 1 year. Although this is a validated 
questionnaire,(58) we cannot exclude misclassification. Measurement error might 
occur in self-reported retrospective dietary assessment methods. We assume that this 
measurement error, misclassification of the exposure, will mainly be non-differential 
which means it is unrelated to the outcome. Non-differential misclassification may have 
resulted in attenuation of the results. However, differential misclassification might also 
occur, for example if people with unhealthy dietary patterns underreport their unhealthy 
habits as compared to the healthy aspects of their diet. Not much is known about 
misclassification of parental reporting of childhood dietary habits. Since parents were 
unaware of specific research questions on dietary habits, differential misclassification 
seems unlikely. In the studies presented in this thesis, outcome measures were 
hands-on assessments of kidney growth and laboratory analyses of kidney function. 
Observers of these outcomes were unaware of exposures status, which makes differential 
misclassification of the outcomes less likely.
Confounding
The Generation R Study is an observational study which provides a comprehensive amount 
of data about variables related to lifestyle, growth and development. A limitation of 
observational studies is the risk of confounding. A confounder is a specific variable which 
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is associated with the exposure and the outcome, and is not an intermediate in the causal 
pathway of the association between the exposure and the outcome. If a confounding 
variable is not taken into account, results might be biased because the observed effect 
estimates might be attributed to the exposure whilst the effect estimates are caused by 
the confounding variable. In this thesis, we used several approaches to explore the role 
of confounding in the studied associations. First, we adjusted all analyses for multiple 
confounders. Confounders were included in the analyses based on previous studies, 
their obvious relation with exposure and outcome or a change in effect estimate over 
10%.  Although information about many confounders is available within the Generation 
R Study, residual confounding might still be present. Furthermore, information about 
multiple confounding factors was obtained by questionnaires and this might have led to 
measurement error. Second, in the studies where it was possible, we used information 
about maternal and paternal exposures during pregnancy, for example in the study on 
parental smoking and kidney outcomes. Stronger effect estimates for maternal smoking 
as compared to effect estimates of paternal smoking suggests that a direct intra-uterine 
mechanism is more likely to explain the found associations, rather than unmeasured 
environmental factors.
Causality
The studies presented in this thesis were observational.  The longitudinal design of 
the study with repeated measurements provides the possibility to study temporal 
relationships between multiple exposures and outcomes. A disadvantage from a cohort 
study as compared to a randomized controlled trial (RCT), is that it is not possible to 
prove causal relationships between exposures and outcomes. A widely accepted method 
to assess causality in cohort studies is the use of Bradford Hill’s criteria. These criteria 
were developed as a guideline to interpretation of results.(59) In the textbox below the 
criteria with respect to the findings in this thesis are given.
Clinical implications
In this thesis, several growth periods and patterns and maternal and child factors associated 
with kidney volume and function in childhood are identified. In several of the studies in this 
thesis, the effect estimates are small. The studies were conducted in a healthy, population-
based cohort. However, these results are important from an etiological perspective. These 
results will be helpful in increasing awareness of clinicians and researchers which individuals 
might be at risk of impaired kidney function. 
 A recent review on CKD emphasizes that CKD is a disorder with high prevalence and is 
associated with increased risks of mortality and morbidity, but it’s prevalence differs among 
populations.(60) People with CKD are often a symptomatic or have nonspecific symptoms 
and diagnosis often is made in a late phase. Diagnosis can be made earlier by screening tools. 
Therefore, it is important to identify risk factors for impaired kidney function at young age. 
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 The associations between fetal and early childhood kidney and body growth and 
kidney function in later life seem to be quite convincing. It is suggested that individuals 
with impaired growth and impaired nephron endowment are at risk for CKD in later 
life. Longitudinally growth development in young children must be monitored, and 
can be used for screening for impaired kidney function at young age. Recently, it is 
hypothesized that various factors might contribute to development of CKD in these 
individuals. For example, maternal and child nutrition, childhood catch-up growth and 
childhood obesity.(14) Preventive strategies and education for parents and children 
specifically in populations at risk will be helpful in preventing CKD in later life. Further 
studies with long follow up duration are needed to develop guidelines for screening 
tools in populations at risk for impaired kidney function. 
Future research
Development during fetal life and early childhood is crucial for nephron endowment.(14) 
Identification of individuals at risk with low nephron endowment, during pregnancy 
and in early childhood, is crucial. Since nephron number cannot be measured in vivo, in 
studies and clinical practice kidney volume is used as a proxy for nephron endowment.
(61) However, ultrasound kidney volume does not take into account size, shape and 
distribution and function of separate glomeruli. Glomerular enlargement due to 
hyperfiltration may increase kidney volume when there is actually low nephron number. 
Therefore, improvement of counting nephron number in living individuals should be 
studied further. Studies in animals show that it might be possible to count glomeruli 
with cationic ferritin using MRI. This method shows that it is possible to count glomeruli 
of different sizes, which implies the possibility to count nephron number in individuals 
with glomerular hypertrophy.(62) This MRI based glomerular imaging method provides 
new potential to quantify nephron number in humans. Next to improving measurement 
of nephron endowment, more precise estimation of childhood kidney function might 
help identifying individuals at risk for impaired kidney function. Further studies need to 
focus on which formula gives the best estimation of glomerular filtration rate in childhood, 
independent from other individual characteristics, for example body composition. 
Identification possible risk factors, for example lifestyle factors and dietary habits, may 
give more insight in the biological pathways underlying  renal disease. Also, identification 
of these modifiable risk factors may help in development of prevention programs targeting 
these risk factors. We observed multiple associations between early growth and maternal 
and child factors and kidney function in childhood. In this observational study design, we 
cannot be exact sure that these assocations reflect causal relationships between exposures 
and outcomes.(63) As mentioned previously, besides impaired kidney volume, other 
pathways might be underlying the associations between adverse fetal exposures and 
smaller kidney volume and lower kidney function in childhood. Further studies focused 
on the role of alterations in the renin-angiotensin-aldosteron system (RAAS) in reduced 
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nephron number are needed.(29) Furthermore, the effect of maternal corticosteroid use 
during pregnancy and changes in tubular function and its transporters should be further 
investigated.(64) It is hypothesized that adverse fetal and early childhood exposures 
might have stronger effect in individuals with altered levels of gene expression, however 
additional studies are needed to provide more evidence.(14) Identification of potentially 
modifiable epigenetic mechanisms might provide the opportunity to develop strategies 
to extend nephrogenesis in newborns with impaired growth. 
Conclusion
Results from this thesis suggest that growth in fetal life and early childhood is associated 
with kidney volume and function in childhood. Fetal smoke exposure is associated with 
lower childhood kidney function. Further research on dietary factors and most accurate 
estimations of glomerular filtration rate is needed. As early life growth is crucial for 
childhood kidney development, future preventive strategies should focus on optimizing 
factors influencing growth. 
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Summary
In Chapter 1.1, the background and hypothesis for the studies presented in this thesis 
are described. Chronic kidney disease (CKD) is a major public health problem worldwide 
and is associated with increased risk of mortality. A few decades ago, epidemiological 
studies showed associations between early life exposures and risk of disease in later 
life. Multiple studies showed associations between low birth weight and increased risk 
of non-communicable diseases in adulthood. These findings support the hypothesis 
that adverse exposures in utero and early childhood may cause adaptations that 
might be beneficial on the short term, but are unfavourable on the long term. In low 
birth weight children, impaired fetal growth might lead to permanent adaptations in 
kidney development which might be the underlying mechanism of the increased risk 
of CKD in adulthood in this population. Subclinical differences in kidney volume and 
function, which predispose individuals for CKD in later life, might already be present in 
early childhood. Differences in kidney function at younger age tend to track into later 
life. Therefore, we consider it important to identify specific developmental periods and 
influencing factors of kidney function in childhood. More insight in factors influencing 
kidney development may give direction for prevention programmes to decrease the 
prevalence of CKD. In this thesis, we present studies which evaluate specific kidney and 
body growth periods, and specific early life factors which are relevant for kidney volume 
and function in childhood. 
 In Chapter 1.2, we present the characteristics of the study population. Descriptive 
values of kidney volume and function in the study population are given. Differences in 
kidney volume and function between boys and girls, and between individuals of different 
ethnic background are evaluated. Furthermore, the relationship between kidney volume 
and kidney function at the age of 6 years is presented.
 In Chapter 2, we studied specific body and kidney growth periods and patters, and 
their associations with kidney function in childhood. In Chapter 2.1, we examined 
childhood kidney volume and function in relation to fetal blood flow and kidney volume. 
We found that children with a preferential fetal blood flow to the upper parts of the body 
combined with small fetal kidney volume had a lower estimated glomerular filtration rate 
(eGFR) as compared to children with average fetal blood flow distributions and average 
fetal kidney volume. The results of this study show that maternal and fetal vascular and 
growth characteristics in pregnancy are associated with subclinical differences in kidney 
function in childhood. 
 Chapter 2.2 describes the relationship between fetal first trimester growth and kidney 
volume and function at the age of 6 years. We found no consistent associations between 
fetal first trimester crown-rump length and kidney volume and function in childhood. 
First trimester growth measurements around 12 weeks gestational might be too early in 
kidney development to be associated with kidney outcomes in later life.
 In Chapter 2.3, we evaluated the associations of longitudinal fetal and infant body 
growth patterns and kidney volume and function in childhood. We observed that fetal 
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weight in second and third trimester, birth weight and infant weight at 6 months was 
positively associated with higher kidney volume at the age of 6 years. Only higher 
second trimester fetal weight was associated with higher eGFR. These associations were 
independent from growth measures at other ages. Fetal and childhood length were 
not consistently associated with kidney volume and function. The results of this study 
indicate that lower fetal and infant growth might be associated with subclinical lower 
kidney outcomes in childhood. These differences might lead to an increased risk of CKD 
in later life. 
 In Chapter 2.4, we focused on the longitudinal fetal and infant kidney growth 
patterns and kidney function at the age of 6 years. We showed that small kidney volume 
in fetal life which persisted to be small at the age of 6 years, is associated with lower 
eGFR as compared to persistent large kidney volume from fetal life into childhood. Also, 
children at the age of 6 years with lower eGFR had smaller combined kidney volume 
growth patterns as compared to children with high eGFR. Furthermore, fetal and early 
childhood kidney growth are, independently from kidney growth at other time points, 
positively associated with eGFR based on creatinine levels. These associations were fully 
explained by kidney volume at the age of 6 years. Results from this study suggest that 
both fetal and childhood kidney growth are positively associated with kidney function 
in childhood. 
Studies focused on the identification of maternal and child, modifiable, factors which 
might be associated with childhood kidney outcomes are described in Chapter 3. 
 In Chapter 3.1 we evaluated the associations of fetal smoke exposure and kidney 
volume and function in childhood. We found that continued maternal smoking during 
pregnancy is associated with smaller kidney volume and lower eGFR in children at the 
age of 6 years. Effect estimates for maternal smoking are stronger than effect estimates 
for paternal smoking, this suggests that intrauterine adaptations may play a role in the 
biological pathway underlying these associations. 
 In Chapter 3.2, we studied the relationship between dietary protein intake in 
infancy and kidney volume and function in childhood. We found associations between 
higher protein intake and better kidney function. However, these associations are fully 
explained by dietary and life style factors of the children. No associations are observed 
with kidney volume, and no differences in associations between animal and vegetable 
protein intake are found. This study does not support the hypothesis that high protein 
intake is associated with kidney volume and function. 
 Chapter 3.3 evaluates the associations of different body composition measurements 
and eGFR based on creatinine and cystatin C levels. Results of this study show that both 
creatinine based and cystatin C based GFR estimations are associated with body mass 
index and body surface area. Only eGFR based on creatinine levels is associated with 
lean mass percentage and fat mass percentage. It is concluded that implications of these 
findings for clinical practice need to be studied further. 
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In Chapter 4, we discuss the results presented in this thesis in a broader perspective. 
Implications for clinical practice are given, and methodological considerations and 
suggestions for future research are discussed. 
 In conclusion, results from this thesis suggest that growth in fetal life and early 
childhood is associated with kidney volume and function in childhood. Fetal smoke 
exposure is associated with lower childhood kidney function. Further research on dietary 
factors and most accurate estimations of glomerular filtration rate is needed. Early life 
growth is crucial for childhood kidney development, future preventive strategies should 
focus on optimizing factors influencing growth. 
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Samenvatting
In Hoofdstuk 1.1 beschrijven we de achtergrond en hypothese voor de studies 
beschreven in dit proefschrift. Chronische nierziekten zijn groot probleem voor de 
volksgezondheid in de hele wereld en is geassocieerd met een toegenomen risico op 
mortaliteit. Enkele decennia geleden toonden de eerste epidemiologische onderzoeken 
een verband aan tussen specifieke blootstellingen in het jonge leven and het risico op 
ziekte in het latere leven. Meerdere studies hebben associaties aangetoond tussen een 
laag geboortegewicht en een toename van het risico op chronische, niet overdraagbare 
ziekte in het latere leven. Deze resultaten onderschrijven de hypothese dat blootstelling 
aan ongunstige factoren tijdens de zwangerschap en de jonge kinderleeftijd gunstig 
kan zijn op de korte termijn, maar ongunstige zijn op de langere termijn. In kinderen 
met een laag geboortegewicht, veroorzaakt de groeivertraging in het foetale leven 
mogelijk permanente veranderingen in de nierontwikkeling en verhoogt daardoor het 
risico op chronische nierziekten op de volwassen leeftijd. Verschillen in nier grootte en 
nierfunctie, die nog niet leiden tot ziekte op de jonge leeftijd maar mogelijk wel het risico 
op chronische nierziekte op latere leeftijd verhogen, zijn mogelijk al op de kinderleeftijd 
aanwezig. Verschillen in nierfunctie op jongere leeftijd persisteren op latere leeftijd. 
Meer inzicht in factoren die de vroege ontwikkeling van de nieren beïnvloeden kunnen 
van belang zijn bij de ontwikkeling van preventie programma’s om de prevalentie van 
chronische nierziekten te verlagen. In dit proefschrift beschrijven we studies welke 
specifieke periodes van niergroei en lichaamsgroei van belang voor nierfunctie op de 
kinderleeftijd onderzoeken. Daarnaast presenteren we studies die gericht zijn op het 
verband van specifieke, deels beïnvloedbare, factoren in het vroege leven en nierfunctie 
op de kinderleeftijd. 
 In Hoofdstuk 1.2, worden kenmerken van de onderzoeksgroep waarin de studies in dit 
proefschrift zijn uitgevoerd vermeld. Beschrijvende waardes van niergrootte en nierfunctie 
worden gegeven. Verschillen in nier grootte en nierfunctie tussen jongens en meisjes, en 
tussen individuen van verschillende etnische afkomst worden onderzocht. Daarnaast wordt 
de relatie tussen nier grootte en nierfunctie op de leeftijd van 6 jaar beschreven. 
 In Hoofdstuk 2, onderzochten we specifieke periodes en patronen van niergroei 
en lichaamsgroei en de associatie daarvan met nierfunctie op de kinderleeftijd. In 
Hoofdstuk 2.1, hebben we de relatie tussen foetale bloed voorziening en foetale nier 
grootte met grootte en functie van de nier op de kinderleeftijd onderzocht. We toonden 
aan dat foetale bloedvoorziening met voorkeur voor de bovenste lichaamshelft in 
combinatie met een kleine foetale nier grootte geassocieerd was met een lagere geschatte 
glomerulaire filtratie snelheid (estimated glomerular filtration rate; eGFR) in vergelijking 
met een gemiddelde foetale bloedvoorziening en gemiddelde foetale nier grootte. 
Deze resultaten laten zien dat maternale en foetale vasculaire en groeikenmerken zijn 
geassocieerd met kleine verschillen in nierfunctie op de kinderleeftijd. 
 Hoofdstuk 2.2 beschrijft de relatie tussen foetale groei in het eerste trimester van 
de zwangerschap en nier grootte en nierfunctie op de leeftijd van 6 jaar. We vonden 
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geen consistent verband tussen foetale kruin-romp lengte in het eerste trimester en 
nier grootte en nierfunctie op de kinderleeftijd. Het is mogelijk dat groei metingen rond 
de 12e week van de zwangerschap te vroeg zijn in de nierontwikkeling en vandaar niet 
geassocieerd zijn met nierfunctie op de kinderleeftijd. 
 In Hoofdstuk 2.3 onderzochten we het verband tussen patronen van herhaalde 
groeimetingen op de foetale en vroege kinderleeftijd de grootte en functie van de nier op 
de kinderleeftijd. We toonden aan dat foetaal gewicht in het tweede en derde trimester 
van de zwangerschap, geboortegewicht en gewicht op de leeftijd van 6 maanden een 
positieve associatie heeft met de grootte van de nier op de leeftijd van 6 jaar. Alleen 
hoger foetaal gewicht in het tweede trimester van de zwangerschap was geassocieerd 
met een hoge eGFR op de kinderleeftijd. Deze associaties waren onafhankelijk van 
groeimetingen op andere leeftijden. Lengte in het foetale leven en op de kinderleeftijd 
toonde geen consistent verband met de grootte en functie van de nier. De uitkomsten 
van deze studie impliceren dat en verminderde groei gedurende het foetale leven en de 
vroege kinderleeftijd mogelijk verband houdt met kleine verschillen in de grootte en 
functie van de nier op de kinderleeftijd. Deze verschillen verhogen mogelijk het risico op 
chronische nierziekte op latere leeftijd. 
 Hoofdstuk 2.4  is gericht op de mogelijke associatie tussen patronen van herhaalde 
niergroei metingen op de foetale en vroege kinderleeftijd en de nierfunctie  op de 
kinderleeftijd. We vonden dat kinderen met kleinere nieren in het foetale leven, die klein 
bleven op de leeftijd van 6 jaar, een lagere eGFR hadden dan kinderen met persisterende 
grote nieren. Daarnaast toonden we aan kinderen met een lagere eGFR op de leeftijd van 
6 jaar een patroon van kleinere niergroei hadden in vergelijking met kinderen met een 
hogere eGFR. Gedetailleerde analyses lieten zien dat niergroei in het foetale leven en op 
de vroege kinderleeftijd, onafhankelijke van niergroei metingen op de andere leeftijden, 
positief is geassocieerd met eGFR gebaseerd creatinine waarden. Deze resultaten 
werden verklaard door de grootte van de nier op de leeftijd van 6 jaar. Uitkomsten van 
deze studie suggereren dat groei op de foetale en op de vroege kinderleeftijd positief 
verband houdt met nierfunctie op de leeftijd van 6 jaar.
Studies gericht op het identificeren van, gedeeltelijk beïnvloedbare, maternale en 
kind factoren die mogelijk zijn geassocieerd met de grootte en functie van de nieren 
op de kinderleeftijd worden besproken in Hoofdstuk 3. In Hoofdstuk 3.1 hebben we 
mogelijk verbanden tussen foetale blootstelling aan roken en grootte en functie van 
de nieren onderzocht. Deze studie toonde aan roken tijdens de gehele zwangerschap 
is geassocieerd met kleinere nieren en een lagere eGFR op de leeftijd van 6 jaar. De 
gevonden effecten waren groter voor roken van de moeder tijdens de zwangerschap 
dan roken door vader tijdens de zwangerschap, dit suggereert dat aanpassingen in de 
baarmoeder een rol kunnen spelen in het onderliggende biologische mechanisme van 
deze associaties.
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In Hoofdstuk 3.2 onderzochten we het verband tussen eiwit inname via de voeding 
op de peuterleeftijd en de grootte en functie van de nieren op de kinderleeftijd. We 
toonden een relatie aan tussen hogere eiwit inname en betere nierfunctie. Deze relatie 
werd echter volledig verklaard door andere voedingsfactoren en leefstijl kenmerken 
van kinderen. Er weden geen associaties gevonden met de grootte van de nieren, en er 
waren geen verschillen tussen dierlijke en plantaardige eiwitten. De resultaten van deze 
studie ondersteunen de hypothese dat eiwit inname is geassocieerd met de grootte en 
functie van de nieren niet.  
 In Hoofdstuk 3.3 bestuderen we de relatie tussen verschillende lichaamssamenstelling 
metingen en eGFR gebaseerd op creatinine en cystatine C waardes. De resultaten tonen 
aan dat schattingen van GFR gebaseerd op creatinine en cystatine C waardes zijn 
geassocieerd met body mass index en body surface area. Alleen schattingen van GFR 
gebaseerd op creatinine waardes zijn geassocieerd met lean mass percentage en fat 
mass percentage. We stellen vast dat verdere onderzoeken nodig zijn om de praktische 
gevolgen voor de klinische praktijk van deze verbanden te beoordelen. 
 In Hoofdstuk 4 bespreken we de uitkomsten van de studies in dit proefschrift in een
breder perspectief. Aanwijzingen voor de klinische praktijk worden gegeven, en 
methodologische overwegingen worden besproken en suggesties voor vervolgonderzoek 
worden gegeven. 
Concluderend, suggereren de resultaten van dit proefschrift dat groei in het foetale leven 
en op de vroege kinderleeftijd zijn geassocieerd met de grootte en de functie van nieren 
op de kinderleeftijd. Foetale blootstelling aan rook heeft een relatie met verminderde 
grootte en functie van de nieren op de kinderleeftijd. Aanvullend onderzoek naar 
voedingsfactoren en de meest nauwkeurige schattingen van GFR is nodig. Groei in het 
vroege leven is cruciaal voor de ontwikkeling van de nieren, toekomstige preventie 
programma’s moeten gericht zijn op het optimaliseren van factoren die van invloed zijn 
op groei.
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